US20230165596A1 - Sealed neurovascular extendable catheter - Google Patents
Sealed neurovascular extendable catheter Download PDFInfo
- Publication number
- US20230165596A1 US20230165596A1 US18/074,378 US202218074378A US2023165596A1 US 20230165596 A1 US20230165596 A1 US 20230165596A1 US 202218074378 A US202218074378 A US 202218074378A US 2023165596 A1 US2023165596 A1 US 2023165596A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- distal
- proximal
- expandable
- neurovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007789 sealing Methods 0.000 claims abstract description 129
- 239000000017 hydrogel Substances 0.000 claims abstract description 19
- 238000011010 flushing procedure Methods 0.000 claims abstract description 18
- 238000013519 translation Methods 0.000 claims abstract description 16
- 239000012530 fluid Substances 0.000 claims description 58
- 210000004204 blood vessel Anatomy 0.000 claims description 19
- 229920000642 polymer Polymers 0.000 claims description 7
- 230000006835 compression Effects 0.000 claims description 6
- 238000007906 compression Methods 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 claims description 2
- 210000005166 vasculature Anatomy 0.000 abstract description 10
- 239000000463 material Substances 0.000 description 25
- 230000007704 transition Effects 0.000 description 23
- 208000006011 Stroke Diseases 0.000 description 16
- 239000012528 membrane Substances 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 12
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 11
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 229960000187 tissue plasminogen activator Drugs 0.000 description 10
- 229920002614 Polyether block amide Polymers 0.000 description 9
- 230000004888 barrier function Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000004323 axial length Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 208000032382 Ischaemic stroke Diseases 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 239000003146 anticoagulant agent Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 210000004004 carotid artery internal Anatomy 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 210000003657 middle cerebral artery Anatomy 0.000 description 4
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000032109 Transient ischaemic attack Diseases 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000007917 intracranial administration Methods 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 201000010875 transient cerebral ischemia Diseases 0.000 description 3
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920006099 Vestamid® Polymers 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000012212 insulator Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007971 neurological deficit Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000013151 thrombectomy Methods 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 240000005020 Acaciella glauca Species 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 208000022211 Arteriovenous Malformations Diseases 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012758 Diastolic hypertension Diseases 0.000 description 1
- 206010014498 Embolic stroke Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010022840 Intraventricular haemorrhage Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 206010042957 Systolic hypertension Diseases 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229940099983 activase Drugs 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000011256 aggressive treatment Methods 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000005744 arteriovenous malformation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001269 cardiogenic effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000005248 left atrial appendage Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008289 pathophysiological mechanism Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000003499 redwood Nutrition 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/005—Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22031—Gripping instruments, e.g. forceps, for removing or smashing calculi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00942—Material properties hydrophilic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22062—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22079—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with suction of debris
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/30—Surgical pincettes without pivotal connections
- A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0004—Catheters; Hollow probes having two or more concentrically arranged tubes for forming a concentric catheter system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0175—Introducing, guiding, advancing, emplacing or holding catheters having telescopic features, interengaging nestable members movable in relations to one another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0272—Electro-active or magneto-active materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0054—Catheters; Hollow probes characterised by structural features with regions for increasing flexibility
Definitions
- Stroke is the third most common cause of death in the United States and the most disabling neurologic disorder. Approximately 700,000 patients suffer from stroke annually. Stroke is a syndrome characterized by the acute onset of a neurological deficit that persists for at least 24 hours, reflecting focal involvement of the central nervous system, and is the result of a disturbance of the cerebral circulation. Its incidence increases with age. Risk factors for stroke include systolic or diastolic hypertension, hypercholesterolemia, cigarette smoking, heavy alcohol consumption, and oral contraceptive use.
- Hemorrhagic stroke accounts for 20% of the annual stroke population. Hemorrhagic stroke often occurs due to rupture of an aneurysm or arteriovenous malformation bleeding into the brain tissue, resulting in cerebral infarction. The remaining 80% of the stroke population are ischemic strokes and are caused by occluded vessels that deprive the brain of oxygen-carrying blood. Ischemic strokes are often caused by emboli or pieces of thrombotic tissue that have dislodged from other body sites or from the cerebral vessels themselves to occlude in the narrow cerebral arteries more distally. When a patient presents with neurological symptoms and signs which resolve completely within 1 hour, the term transient ischemic attack (TIA) is used. Etiologically, TIA and stroke share the same pathophysiologic mechanisms and thus represent a continuum based on persistence of symptoms and extent of ischemic insult.
- TIA transient ischemic attack
- Emboli occasionally form around the valves of the heart or in the left atrial appendage during periods of irregular heart rhythm and then are dislodged and follow the blood flow into the distal regions of the body. Those emboli can pass to the brain and cause an embolic stroke. As will be discussed below, many such occlusions occur in the middle cerebral artery (MCA), although such is not the only site where emboli come to rest.
- MCA middle cerebral artery
- a diagnostic hypothesis for the cause of stroke can be generated based on the patient's history, a review of stroke risk factors, and a neurologic examination. If an ischemic event is suspected, a clinician can tentatively assess whether the patient has a cardiogenic source of emboli, large artery extracranial or intracranial disease, small artery intraparenchymal disease, or a hematologic or other systemic disorder.
- a head CT scan is often performed to determine whether the patient has suffered an ischemic or hemorrhagic insult. Blood would be present on the CT scan in subarachnoid hemorrhage, intraparenchymal hematoma, or intraventricular hemorrhage.
- contraindications include the following: if the patient has had a previous stroke or serious head trauma in the preceding 3 months, if the patient has a systolic blood pressure above 185 mm Hg or diastolic blood pressure above 110 mmHg, if the patient requires aggressive treatment to reduce the blood pressure to the specified limits, if the patient is taking anticoagulants or has a propensity to hemorrhage, and/or if the patient has had a recent invasive surgical procedure. Therefore, only a small percentage of selected stroke patients are qualified to receive t-PA.
- Obstructive emboli have also been mechanically removed from various sites in the vasculature for years. Mechanical therapies have involved capturing and removing the clot, dissolving the clot, disrupting and suctioning the clot, and/or creating a flow channel through the clot.
- One of the first mechanical devices developed for stroke treatment is the MERCI Retriever System (Concentric Medical, Redwood City, Calif.).
- a balloon-tipped guide catheter is used to access the internal carotid artery (ICA) from the femoral artery.
- ICA internal carotid artery
- a microcatheter is placed through the guide catheter and used to deliver the coil-tipped retriever across the clot and is then pulled back to deploy the retriever around the clot.
- microcatheter and retriever are then pulled back, with the goal of pulling the clot, into the balloon guide catheter while the balloon is inflated and a syringe is connected to the balloon guide catheter to aspirate the guide catheter during clot retrieval.
- This device has had initially positive results as compared to thrombolytic therapy alone.
- thrombectomy devices utilize expandable cages, baskets, or snares to capture and retrieve clot.
- Temporary stents sometimes referred to as stentrievers or revascularization devices, are utilized to remove or retrieve clot as well as restore flow to the vessel.
- a series of devices using active laser or ultrasound energy to break up the clot have also been utilized.
- Other active energy devices have been used in conjunction with intra-arterial thrombolytic infusion to accelerate the dissolution of the thrombus. Many of these devices are used in conjunction with aspiration to aid in the removal of the clot and reduce the risk of emboli.
- Suctioning of the clot has also been used with single-lumen catheters and syringes or aspiration pumps, with or without adjunct disruption of the clot.
- Devices which apply powered fluid vortices in combination with suction have been utilized to improve the efficacy of this method of thrombectomy.
- balloons or stents have been used to create a patent lumen through the clot when clot removal or dissolution was not possible.
- a sealed neurovascular extendable catheter having an outer catheter, an inner catheter, and an annular gap between an outer surface of the inner catheter and an inner surface of the outer catheter.
- the outer catheter has a proximal end and a distal end and the inner catheter has a proximal end and a distal end.
- the outer catheter is extendable through the outer catheter such that the distal end of the inner catheter is configured to extend beyond the distal end of the outer catheter.
- the extendable catheter also has a sealing feature positioned between the inner catheter and the outer catheter.
- the sealing feature is configured to fluidly seal at least a portion of a length of the annular gap.
- the sealing feature is configured to allow axial translation of the inner catheter relative to the outer catheter.
- the sealing feature may have at least one annular protrusion extending around a circumference of the inner catheter.
- the at least one protrusion may be compliant and may comprise an outer diameter slightly larger than an inner diameter of the outer catheter.
- the at least one protrusion may be a plurality of protrusions.
- the at least one protrusion may have a chevron-shape pointing in the distal direction and/or a chevron-shape pointing in the proximal direction.
- the protrusion may be a skirt-shaped protrusion configured to allow distal fluid flow but not proximal fluid flow through the sealing feature.
- the sealing feature may be an expandable bulge surrounding a circumference of the inner catheter.
- the expandable bulge may have a sealed configuration in which an outer diameter of the expandable bulge seals the annular gap and an unsealed configuration in which the outer diameter of the expandable bulge does not seal the annular gap.
- the expandable bulge may be mechanically expandable.
- the expandable bulge may be positioned at a proximal end of the inner catheter.
- a tension cable may be joined to the expandable bulge at or near a distal end of the expandable bulge and pulling the tension cable proximally may be configured to axially contract and radially expand the expandable bulge.
- the expandable bulge may be expandable in response to receiving an electric current and/or in response to stimulation by light.
- the expandable bulge may be a hydrogel.
- the expandable bulge may be inflatable.
- the inner catheter may have a proximal spine having a lumen. The lumen may be configured to transmit a stimulus to the expandable bulge for activating the expandable bulge and causing it to expand.
- the sealing feature may be an elastic flange positioned at a distal tip of the outer catheter.
- the elastic flange may have an inner diameter smaller than an outer diameter of the inner catheter.
- the sealing feature may be a hub having an expanded diameter.
- the hub may be positioned at a proximal end of the inner catheter and be configured to form an interference fit with an inner diameter of the outer catheter.
- the inner catheter may have a proximal spine having a lumen. The lumen may extend through the hub to form a fluid port through the sealing feature. A flushing solution may be delivered through the fluid port to the annular gap in a space distal to the sealing feature.
- the sealing feature may have a proximal sliding ring and a distal sliding ring surrounding the inner catheter.
- Each sliding ring may have an inner annulus configured to form a sliding interference fit around the inner catheter and an outer annulus configured to form a sliding interference fit with an inner diameter of the outer catheter.
- Each sliding ring may have a plurality of spokes joining the inner annulus and the outer annulus.
- the sealing feature may have one or more springs surrounding the inner catheter and joining the inner annulus of the proximal sliding ring to the inner annulus of the distal sliding ring and an elastic membrane configured to form a fluid barrier.
- the elastic membrane may be coupled to the one or more springs such that the fluid barrier circumferentially surrounds the inner catheter and extends from the proximal sliding ring to the distal sliding ring.
- the sealing feature may further have a ridge feature fixed to an outer surface of the inner catheter.
- the ridge feature may be positioned between the proximal sliding ring and the distal sliding ring and may be configured to catch and pull the proximal sliding ring in a proximal direction and to catch and pull the distal sliding ring in a distal direction.
- the one or more springs may force the elastic membrane into compression against an inner surface of the outer catheter to seal the annular gap in an unbiased configuration.
- Translating the inner catheter to pull one of the sliding rings in a proximal or distal direction may cause the pulled sliding ring to axially extend and radially compress the one or more springs. Radially compressing the one or more springs may cause the elastic membrane to be at least partially retracted from the inner surface of the outer catheter, breaking the fluid seal for a period while the inner catheter is in motion.
- the sealing feature may have a large diameter ring surrounding the inner catheter and a small diameter ring surrounding the inner catheter.
- the large diameter ring may have an inner annulus configured to receive the inner catheter, an outer annulus configured to form a sliding interference fit with an inner diameter of the outer catheter, and a plurality of spokes joining the inner annulus and the outer annulus.
- the small diameter ring may be positioned either proximally or distally of the large diameter ring and may form a sliding interference fit with an outer surface of the inner catheter.
- the small diameter ring may have one or more recesses configured to receive one or more key features extending axially along at least a portion of the inner catheter. The one or more recesses may be configured to rotate the small diameter ring with the inner catheter.
- the sealing feature may also have a torsion spring surrounding the inner catheter and joining the small diameter ring to the large diameter ring and an elastic membrane coupled to the torsion spring.
- the elastic membrane may be configured to form a fluid barrier circumferentially surrounding the inner catheter and extending from the large diameter ring to the small diameter ring.
- the torsion spring may force the elastic membrane into compression against an inner surface of the outer catheter to seal the annular gap in an unbiased configuration. Rotating the inner catheter to rotate the small diameter ring may cause the torsion spring to axially extend and radially compress such that elastic membrane is at least partially retracted from the inner surface of the outer catheter, breaking the fluid seal for a period while the inner catheter is in motion.
- a neurovascular catheter for sealing a blood vessel.
- the neurovascular catheter has an elongate body having a proximal end and a distal end and a sealing feature configured to fluidly seal an annular gap positioned between an outer surface of the elongate body and the blood vessel.
- the sealing feature has a compliant annular ring configured to be placed into compression with a wall of the blood vessel without damaging the blood vessel.
- the ring may comprise an elastomeric polymer.
- the ring may be a hydrogel.
- the hydrogel may be electrosensitive and configured to expand upon receiving an electric current and/or may be photosensitive and configured to expand upon receiving a light stimulus.
- the hydrogel may be configured to expand upon exposure the intravascular physiological environment.
- the ring may be inflatable.
- the outer surface of the elongate body may have a recess for receiving the ring.
- the ring may be detachable from the elongate body.
- the ring may be custom-formed to the size of the blood vessel.
- the neurovascular catheter may further include a replacement ring that is sized differently from the ring and interchangeable with the ring.
- FIG. 1 is a side elevational schematic view of an intracranial aspiration catheter in accordance with the present invention, with a distal segment in a proximally retracted configuration.
- FIG. 2 is a side elevational view as in FIG. 1 , with the distal segment in a distally extended configuration.
- FIGS. 3 A- 3 B are cross-sectional elevational views of a distal end of catheter 10 , with the distal section 34 fully extended.
- FIG. 4 schematically illustrates a device comprising an inner catheter extendable through an outer catheter in which a protrusion serves as a sealing feature for sealing an annular gap between the inner catheter and the outer catheter.
- FIG. 5 schematically illustrates a device comprising a skirt shaped protrusion or flange for creating a one-way valve to seal the annular gap.
- FIG. 6 schematically illustrates an inner device comprising multiple protrusions.
- FIGS. 7 A- 7 F schematically illustrate various examples of side views of slanted protrusions which extend at an angle along the axial length of the inner catheter.
- FIGS. 8 A- 8 E schematically illustrate side views of two examples of inner catheters which comprise a chevron-shaped protrusion for sealing the device.
- FIG. 8 A depicts an inner catheter comprising a substantially constant diameter.
- FIG. 8 B depicts an inner catheter comprising a reduced distal diameter.
- FIGS. 8 C- 8 E illustrate close-up side views of an example of chevron-shaped protrusions on the inner device.
- the view in FIG. 8 D is approximately 90 degrees offset around the circumference of the inner device from the view in FIG. 8 C .
- FIG. 8 E is the same as FIG. 8 C but also showing the orientation of the seal on the back side of the catheter.
- FIG. 9 schematically illustrates a device comprising a mechanically expandable bulge for sealing the annular gap.
- FIG. 10 schematically illustrates a device comprising a distal flange for sealing the annular gap.
- FIG. 11 schematically illustrates a device in which the inner catheter comprises a proximal hub for sealing the annular gap and in which a fluid port extends through the proximal hub.
- FIGS. 12 A- 12 C schematically illustrate a device comprising a spring sealing feature in which axial translation of the inner catheter axially extends and radially contracts the spring sealing mechanism.
- FIG. 12 A depicts the device in a sealed configuration.
- FIG. 12 B depicts the device in an unsealed configuration.
- FIG. 12 C depicts a sliding ring used in the spring sealing feature.
- FIGS. 13 A- 13 C schematically illustrate a device comprising a spring sealing feature in which rotation of the inner catheter axially extends and radially contracts the spring sealing mechanism.
- FIG. 13 A depicts the device in an unsealed configuration.
- FIG. 13 B depicts a cross section of the inner catheter including a plurality of key features for rotating the torsion spring.
- FIG. 13 C depicts a ring actuated by the key features to turn the torsion spring.
- FIG. 14 schematically illustrates a catheter device comprising a vessel sealing feature configured to fluidly seal the gap between the outer diameter of the catheter and the blood vessel or other body lumen the device is inserted within.
- FIG. 15 illustrates a cross-sectional elevational view of a catheter wall according to an embodiment.
- FIG. 16 A illustrates a side elevational view of a progressively enhanced flexibility catheter according to an embodiment.
- FIG. 16 B is a proximal end view of the enhanced flexibility catheter of FIG. 34 A .
- catheter 10 in accordance with one aspect of the present invention.
- catheters of the present invention can readily be modified to incorporate additional structures, such as permanent or removable column strength enhancing mandrels, two or more lumen such as to permit drug, contrast or irrigant infusion or to supply inflation media to an inflatable balloon carried by the catheter, or combinations of these features, as will be readily apparent to one of skill in the art in view of the disclosure herein.
- the present invention will be described primarily in the context of removing obstructive material from remote vasculature in the brain, but has applicability as an access catheter for delivery and removal of any of a variety of diagnostics or therapeutic devices with or without aspiration.
- catheters disclosed herein may readily be adapted for use throughout the body wherever it may be desirable to distally advance a low profile distal catheter segment from a larger diameter proximal segment.
- axially extendable catheter shafts in accordance with the present invention may be dimensioned for use throughout the coronary and peripheral vasculature, the gastrointestinal tract, the urethra, ureters, Fallopian tubes and other lumens and potential lumens, as well.
- the telescoping structure of the present invention may also be used to provide minimally invasive percutaneous tissue access, such as for diagnostic or therapeutic access to a solid tissue target (e.g., breast or liver or brain biopsy or tissue excision), delivery of laparoscopic tools or access to bones such as the spine for delivery of screws, bone cement or other tools or implants.
- a solid tissue target e.g., breast or liver or brain biopsy or tissue excision
- laparoscopic tools or access to bones such as the spine for delivery of screws, bone cement or other tools or implants.
- the catheter 10 generally comprises an elongate tubular body 16 extending between a proximal end 12 and a distal functional end 14 .
- the length of the tubular body 16 depends upon the desired application. For example, lengths in the area of from about 120 cm to about 140 cm or more are typical for use in femoral access percutaneous transluminal coronary applications. Intracranial or other applications may call for a different catheter shaft length depending upon the vascular access site, as will be understood in the art.
- FIG. 2 is a side elevational view of the catheter 10 shown in FIG. 1 , with the distal segment in a distally extended configuration.
- Distal segment 34 extends between a proximal end 36 and a distal end 38 and defines at least one elongate central lumen 40 extending axially therethrough.
- Distal end 38 may be provided with one or more movable side walls or jaws 39 , which move laterally in the direction of an opposing side wall or jaw 41 under the influence of aspiration, to enable the distal end 38 to bite or break thrombus or other material into smaller particles, to facilitate aspiration through lumen 40 . Both walls 39 and 41 may be movable towards and away from each other to break up thrombus as is discussed further below.
- the inner diameter of the distal section 34 may be between about 0.030 inches and about 0.112 inches, between about 0.040 inches and about 0.102 inches, between about 0.045 inches and about 0.097 inches, between about 0.050 inches and about 0.092 inches, between about 0.055 inches and about 0.087 inches, between about 0.060 inches and about 0.082 inches, between about 0.062 inches and about 0.080 inches, between about 0.064 inches and about 0.078 inches, between about 0.066 inches and about 0.076 inches, between about 0.068 inches and about 0.074 inches, or between about 0.070 inches and about 0.072 inches.
- the inner diameter and the outer diameter of the distal section 34 may be constant or substantially constant along its longitudinal length.
- the inner diameter may be at least about 0.06 inches, 0.065 inches, 0.07 inches, 0.075 inches, 0.08 inches, or more than 0.08 inches.
- the outer diameter may be at least about 0.07 inches, 0.075 inches, 0.08 inches, 0.085 inches, 0.09 inches, 0.095 inches, 0.1 inches, or more than 0.1 inches.
- the total thickness of the sidewall extending between the inner and outer diameter may be at least about 0.005 inches, 0.010 inches, 0.015 inches, 0.02 inches, 0.025 inches, or more than 0.025 inches.
- the distal section may 34 may have an inner diameter of about 0.071 inches and an outer diameter of about 0.083 inches.
- the distal section 34 may be tapered near its distal end.
- a larger lumen (internal diameter) may increase the applied aspiration force through the distal end of the distal section 34 .
- a smaller outer diameter may provide better catheter trackability and/or may better enable the catheter to reach more distal anatomy (e.g. neuroanatomy), as the tapered distal end may be better accommodated in smaller blood vessels.
- the inner and outer diameters of the distal section 34 may be correlated in order to maintain a sufficient sidewall thickness that provides sufficient structural integrity to the catheter.
- the distal section 34 may be tapered at less than or equal to about 5 cm, about 10 cm, about 15 cm, about 20 cm, about 23 cm, about 25 cm, about 30 cm, about 31 cm, about 35 cm, about 40 cm, about 45 cm, about 50 cm, about 60 cm, or about 70 cm from its distal end.
- the taper may be positioned between about 25 cm and about 35 cm from the distal end of the distal section 34 .
- the taper may be positioned between about 15 cm and about 25 cm from the distal end of the distal section 34 .
- the inner diameter of the distal section 34 may be tapered or decreased in the distal direction near the distal end to an internal diameter that is less than or equal to about 95%, about 90%, about 85%, about 80%, about 75%, about 70%, about 65%, about 60%, about 55%, or about 50% of the adjacent, untapered internal diameter.
- the internal diameter of the tapered distal section 34 may be between about 50% and about 70% of the adjacent, untapered internal diameter.
- the untapered internal diameter at the proximal end of the distal section 34 may be about 0.071 inches and the tapered internal diameter at the distal end of the distal section 34 may be about 0.035 inches, 0.045 inches, or 0.055 inches.
- the inner diameter of the distal section 34 may be tapered or increased near the distal end by greater than or equal to about 102%, 104%, 106%, 108%, or more of the internal diameter just proximal to a transition into the taper.
- the tapered inner diameter of the distal section 34 may be less than or equal to about 0.11 inches, about 0.1 inches, about 0.090 inches, about 0.080 inches, about 0.070 inches, about 0.065 inches, about 0.060 inches, about 0.055 inches, about 0.050 inches, about 0.045 inches, about 0.040 inches, about 0.035 inches, about 0.030 inches, about 0.025 inches, about 0.020 inches, about 0.015 inches, or about 0.010 inches.
- the taper in the outer diameter of the tapered portion of the distal section 34 may be matched to maintain a constant thickness of the sidewall.
- the sidewall may be thinner along the tapered portion.
- the sidewall may be no greater than 95%, 90%, 85%, 80%, 75%, 70%, or less than 70% of the thickness of the sidewall along the proximal portion of the distal section 34 .
- the length of the distal tapered portion of the distal section 34 may be between about 25 cm and about 35 cm, between about 25 cm and about 30 cm, between about 30 cm and 35 cm, or approximately 30 cm.
- the proximal segment 33 may have an inner diameter of at least about 0.07 inches, 0.075 inches, 0.08 inches, 0.085 inches, 0.09 inches, 0.1 inches, 0.105 inches, or more than 0.105 inches.
- the proximal segment 33 may have an outer diameter of at least about 0.08 inches, 0.085 inches, 0.09 inches, 0.095 inches, 0.01 inches, 0.105 inches, 0.11 inches, 0.0115 inches, 0.012 inches, or more than 0.012 inches.
- the inner diameter may be approximately 0.088 inches and the outer diameter may be approximately 0.106 inches.
- the sidewall of the proximal segment 33 may have a thickness of at least about 0.005 inches, 0.01 inches, 0.015 inches, 0.02 inches, 0.025 inches, or more than 0.25 inches.
- the proximal segment 33 has a constant inner and/or outer diameter along its length.
- the proximal segment 33 may slightly taper or decrease in diameter along the distal direction.
- the outer diameter of the proximal segment 33 may be about 0.106 inches at the distal end and about 0.108 inches at the proximal end.
- the length of the proximal segment 33 may be at least about 90 cm, 95 cm, 100 cm, 105 cm, 110 cm, 115 cm, 120 cm, 125 cm, 130 cm, 135 cm, or more than 135 cm. For example, in one embodiment the length is approximately 106 cm. In another embodiment, the length is approximately 117 cm. In some neurovascular applications, the distal end of the proximal segment 33 may extend at least to the Horizontal Petrous segment of the vasculature.
- the length of the distal section 34 may be between about 13 cm and about 53 cm, between about 18 cm and about 48 cm, between about 23 cm and about 43 cm, between about 28 cm and about 38 cm, between about 20 cm and 30 cm, or between about 25 cm and 30 cm.
- the length of the distal section 34 may be less than or equal to about 20 cm, about 25 cm, about 30 cm, about 33 cm, about 35 cm, about 40 cm, about 41 cm, about 45 cm, about 50 cm, about 55 cm, about 60 cm, about 70 cm, or about 80 cm.
- the length of the distal section 34 may depend on the degree of tapering of the internal diameter of the distal section 34 .
- the proximal end 36 of distal section 34 is provided with a proximally extending pull wire 42 .
- Pull wire 42 extends proximally throughout the length of the tubular body 16 , to control 24 which may be carried by manifold 18 .
- Axial movement of control 24 produces a corresponding axial movement of distal section 34 with respect to proximal section 33 as has been discussed.
- the proximal end of pull wire 42 may exit through a port on manifold 18 , such that it may be manually grasped and pulled or pushed by the clinician to extend or retract the distal section 34 .
- the length of the pull wire 42 may be between about 700 mm and about 1556 mm, between about 800 mm and about 1456 mm, between about 850 mm and about 1406 mm, between about 900 mm and about 1356 mm, between about 950 mm and about 1306 mm, between about 1000 mm and about 1256 mm, between about 1020 mm and about 1236 mm, between about 1040 mm and about 1216 mm, between about 1060 mm and about 1196 mm, between about 1080 mm and about 1176 mm, between about 1100 mm and about 1156 mm, between about 1110 mm and about 1146 mm, or between about 1120 mm and about 1136 mm. In some preferred embodiments, the length of the pull wire 42 may be between approximately 110-120 cm.
- an overlap 44 remains between the proximal end 36 of distal section 34 and the proximal section 33 .
- This overlap 44 is configured to provide a seal to enable efficient transmission of vacuum from proximal section 33 to distal section 34 .
- the length of the pull wire 42 may be limited to ensure that there is a minimal overlap 44 between the proximal segment 33 and the distal segment 34 when the pull wire 42 is fully inserted into the proximal segment 33 or attached manifold in a distal direction.
- the length of the proximal segment 33 may be sufficiently long for neurovascular applications such that when the proximal segment is positioned in a relatively proximal position (e.g., the horizontal petrous segment), the neuroanatomy effectively limits the distance by which the distal segment 34 may be extended, ensuring a sufficient overlap 44 .
- the distal segment 34 may not be able to extend further than the M2 segment of the middle cerebral artery (MCA) given its dimensions.
- Overlap 44 may be provided with any of a variety of additional features to facilitate a seal, such as a gasket, coating or tightly toleranced sliding fit, as described elsewhere herein.
- the proximal end of the distal segment 34 may be slightly expanded to create a seal.
- the outer diameter of the proximal end of the distal segment 34 and the inner diameter of the proximal segment 33 may both be about 0.088 inches.
- the clearance between the OD of the distal section 34 and ID of the proximal section 33 , at least in the vicinity of transition 32 will be no more than about 0.005 inches and preferably no more than about 0.003 inches to provide an effective seal in a blood environment.
- a larger clearance may be more feasible in embodiments comprising a sealing feature as described elsewhere herein.
- the control 24 is manipulated to distally advance distal section 34 deeper into the vasculature.
- the pull wire 42 will be provided with sufficient column strength to enable distal advance of the distal tip 38 as will be discussed below.
- the pull wire 42 and distal section 34 may be integrated into a catheter as illustrated in FIGS. 1 and 2 .
- distal section 34 and pull wire 42 may be configured as a stand-alone catheter extension device as is discussed in greater detail below.
- the catheter extension device may be introduced into the proximal end of proximal section 33 after placement of proximal section 33 and advanced distally there through as illustrated in FIG. 3 A , to telescopically extend the reach of the aspiration system.
- the pull wire 42 may comprise a tubular wall having an axially extending central lumen 45 .
- the central lumen 45 permits introduction of media such as lubricants, drugs, contrast agents or others into the distal section 34 .
- the central lumen 45 extending through pull wire 42 permits introduction of an agitator as is discussed in greater detail below.
- the central lumen 45 may open into the lumen 40 .
- the distal opening of the central lumen 45 may be positioned at a point along the length of the distal section 34 such that the central lumen 45 terminates where the lumen 40 begins (the distal opening of central lumen 45 may be longitudinally aligned with the proximal opening of lumen 40 ).
- the proximal opening of lumen 40 may be angled or slanted as shown in FIG. 3 B .
- the opening of lumen 40 may be flat.
- the distal opening of central lumen 45 may be flat as shown in FIG. 3 B .
- the opening may be angled or slanted, similar to the opening of lumen 40 in FIG. 3 B .
- the central lumen 45 may terminate proximal to the opening of the lumen 40 . In some embodiments, the central lumen 45 may terminate distal to the opening of the lumen 40 and/or the proximal end of the distal section 34 (e.g., at a point within the lumen 40 ). For example, the central lumen 45 may terminate at the distal end of the distal section or just short of the distal end (e.g., no more than approximately 1 cm from the distal end).
- the portion of the pull wire 42 may decrease in stiffness (durometer) in a distal direction.
- the pull wire 42 may be relatively stiff along the portion proximal to the proximal end of the distal section 34 in order to provide sufficient pushability of the extension catheter.
- the stiffness of the portion of the pull wire 42 distal of the proximal end of the distal section 34 may substantially match or be less than the stiffness of the distal section 34 along the length of the distal section 34 .
- the portion of the pull wire 42 distal of the proximal end of the distal section 34 may have a uniform stiffness less than the stiffness of the portion proximal of the proximal end of the distal section 34 or it may have a gradated or gradually decreasing stiffness in the distal direction, decreasing from the stiffness of the portion proximal of the proximal end of the distal section 34 .
- the pull wire 42 may comprise metal along the portion proximal to the proximal end of the distal section 34 and may comprise a polymer, softer than the metal, along the portion distal to the proximal end of the distal section 34 .
- the portion distal to the proximal end in some embodiments, may be extruded with decreasing stiffness in the distal direction.
- an inner device 3402 such as a tube or catheter
- an outer device 3404 such as a tube or catheter
- the inner device 3402 may be the axially translatable distal section 34 of the tubular body 16 of catheter 10 and the outer device 3404 may be the fixed proximal section 33 of the tubular body 16 of catheter 10 .
- the inner device 3402 and the outer device 3404 may form a sealed extendable catheter device 3400 .
- the device 3400 may be sealed within an area of overlap, such as the overlap 44 between the proximal section 33 and the distal section 34 by a sealing feature or mechanism 3406 . See FIG. 3 B
- sealing feature 3406 between the proximal section 33 and the distal section 34 may advantageously provide a seal, and eliminate or reduce the volume of space and/or surface area of device that can act as a stagnation zone for blood that is drawn into the annular gap, which may help reduce or mitigate thrombogenesis. See FIG. 4 . Mitigating the opportunity for thrombogenesis to occur may help prevent formation of emboli resulting from the intravascular treatment. It is to be understood that sealing features 3406 disclosed herein may just as suitably apply to an extendable device in which the inner device 3402 is fixed and the outer device 3404 is extendable/retractable relative to the inner device 3402 .
- the sealing feature 3406 may be a protrusion 3408 extending from either the outer surface of the inner device 3402 (e.g., an expanded diameter section) or the inner surface of the outer device 3404 (e.g., a reduced diameter section).
- the protrusion 3408 may form a ring or ring-like annular feature around the outer surface of the inner device 3402 or the inner surface of the outer device 3404 .
- annular merely requires that the sealing feature extend all the way or substantially all the way around the inner device, sufficient to achieve the sealing function. However it does not require that the seal reside within a single transverse plane as shown in FIG. 4 . Annular rings may also reside on a plane that is angled other than 90° from the longitudinal axis, such as for example shown in FIGS. 7 and 8 .
- the protrusion 3408 may operate by forming a close or slight interference sliding fit with the opposing device (the outer diameter of the inner device 3402 or the inner diameter of the outer device 3404 ).
- FIG. 4 schematically illustrates a cross section of a device 3400 , which may comprise the same or similar features as device 10 described elsewhere herein, comprising a single protrusion 3408 extending from the inner device 3402 .
- the protrusion 3408 may comprise an outer diameter substantially equal to the inner diameter of the outer device 3404 .
- the protrusion 3408 may comprise an outer diameter slightly larger than the inner diameter of the outer device 3404 but be compliant enough such that the outer device 3404 radially compresses the protrusion 3408 in order to accommodate the protrusion 3408 forming a sliding fluid seal in the process.
- the protrusion 3408 prevents or inhibits blood flow which may enter the annular gap between the inner device 3402 and the outer device 3404 from flowing proximally past the protrusion 3408 .
- the annular gap may be flushed with a solution in the volume proximal to the protrusion 3408 .
- the solution may be saline.
- the solution may contain heparin and/or another anticoagulant which helps reduce the risk of thrombogenesis.
- the flushing solution may be particularly beneficial for washing the surfaces of the inner device 3402 and/or outer device 3404 along a length that was previously exposed to blood flow when the inner device 3402 and protrusion 3408 were in a retracted position, once the device is in a relatively extended position such that the protrusion 3408 is now positioned distally of that length of the outer device 3404 . If the inner device 3402 is subsequently retracted again such that the protrusion 3408 is now positioned proximally to that previously exposed length of device, the flushing solution, particularly one comprising an anticoagulant, will reduce the risk that any thrombus, or activated coagulation factors, will be re-exposed to the blood stream.
- the protrusion 3408 may prevent the flushing solution from flowing distally beyond the protrusion 3408 (distal or antegrade flow). In some embodiments, the protrusion 3408 may act as a one-way valve allowing distal flow but not fluid flow proximally past the protrusion 3408 (proximal or retrograde flow). The protrusion 3408 may be shaped or otherwise constructed to more easily bend in a distal direction than in a proximal direction to achieve a one-way valve effect. In some embodiments, the protrusion 3408 may be configured to allow distal fluid flow only upon surpassing a threshold fluid pressure.
- a flushing fluid could be continually maintained proximal the protrusion 3408 and forced to flow past the protrusion 3408 on demand by increasing the fluid pressure, such as with a syringe or other control at a proximal end of the device 3400 .
- the flushing fluid may be provided through a separate tube or lumen which is configured to extend into the annular gap.
- the flushing fluid may be provided at times when aspiration is not provided through the catheter 10 or the flushing fluid may be provided contemporaneously with aspiration.
- the flushing fluid may flush the portion of the gap proximal to the protrusion 3408 and be aspirated via the aspiration provided through the catheter 10 .
- the pressure of the flushing fluid may be sufficient to overpower the suction pressure, at least transiently, and force the one-way fluid seal open to distal flow to flush the portion of the annular gap distal to the protrusion 3408 .
- flushing fluid may be provided through the entire catheter 10 so as to flush through the inner device 3402 , the outer device 3404 , and the annular gap between the inner device and outer device, at times when aspiration is not provided through the catheter.
- FIG. 5 schematically illustrates a device 3400 comprising a skirt-shaped protrusion 3408 .
- the skirt-shaped protrusion 3408 may comprise an annular conical flap 3409 which extends radially outward from the inner device 3402 and distally.
- the flap 3409 may be compliant enough to deform in a distal direction under the pressure of the flushing solution, bending toward the axis of the inner device 3402 , in order to allow distal fluid flow.
- the flap 3409 may be forced under pressure from the proximal blood flow and/or aspiration to deform or extend in a more radial direction, normal to the longitudinal axis of the inner device 3402 , so as to form a tighter seal with the outer device 3404 .
- the annular protrusion 3408 may comprise a non-uniform stiffness around the circumference of the protrusion 3408 .
- certain segments of the circumference may be softer or more compliant than other segments forming flaps 3409 or one-way valves while other portions of the circumference may be sufficiently rigid such that neither distal nor proximal fluid flow is permitted.
- the protrusion 3408 may be the same material or a different material as the portion of the device (e.g., tubular body 16 ) from which it extends.
- the protrusion 3408 may comprise polyether block amide (e.g., PEBAX®), polyethylene, polyurethane, Tecothane®, nylon, etc.
- the protrusion 3408 may be formed from a softer material than the inner device 3402 , or at least an outer layer (e.g., an outer jacket) of the inner device 3402 .
- the protrusion 3408 may be formed from a softer material than the outer device 3404 or at least an inner layer (e.g., an inner liner) of the outer device 3404 .
- the protrusion 3408 may be formed as part of an outer jacket of the inner device 3402 .
- the protrusion 3408 may be coextruded with the outer jacket.
- the protrusion may be adhered to the outer jacket, such as with a biocompatible adhesive, melted onto the outer jacket, molded onto the outer jacket, or otherwise adhered to the outer diameter of the inner device 3402 .
- the protrusion 3408 may be formed by a discrete tubular segment of the outer jacket having a larger outer diameter than two adjacent segments of the outer jacket which the protrusion 3408 is positioned between.
- the protrusion 3408 may be formed as an expanded diameter portion of a tubular segment of the outer jacket.
- the protrusion 3408 may be solid throughout.
- the protrusion 3408 may be at least partially hollow, which may increase the flexibility of the protrusion 3408 .
- the protrusion 3408 may have a cross-section along its circumferential axis (around the outer diameter of the outer device 3404 ) of any suitable shape.
- the cross-section may be rectangular, square, rounded, triangular, etc.
- the cross-section may be symmetric or asymmetric about a proximal-to-distal midline.
- the protrusion 3408 may comprise a proximal surface and a distal surface.
- the distal surface may be convex, concave, and/or substantially flat.
- the proximal surface may be convex, concave, and/or substantially flat.
- the proximal surface and distal surface may have different degrees of stiffness or flexibility.
- the proximal surface may more easily bend to produce a one-way valve effect as described elsewhere herein.
- the protrusion 3408 may be shaped with a hinge feature (e.g., a divot in the distal surface) that allows fluid flow in the distal direction but not the proximal direction. Thinner portions of the cross section may be more flexible than thicker portions of the cross-section.
- the cross-section may thin-out towards the outer diameter of the protrusion 3408 to facilitate bending of the protrusion 3408 near the point of contact with the outer device 3404 and axial translation of the sealing protrusion 3408 along the inner surface of the outer device 3404 .
- the protrusion 3408 or other sealing feature 3406 may be positioned on an inner surface of the outer device 3404 .
- the protrusion 3408 may be fabricated in the same or similar manner (e.g., from the inner liner of the outer device 3404 ).
- both the inner device 3402 and the outer device 3402 may comprise protrusions 3408 or other sealing feature 3406 .
- a protrusion 3408 on the outer device 3404 may be positioned to be proximal to, distal to, or axially aligned with a protrusion 3408 on the inner device 3402 when the extendable device 3400 is in a fully extended position or when the extendable device 3400 is in a fully retracted position.
- a protrusion 3408 on the inner device 3402 may be configured to axially cross over a protrusion 3408 on the outer device 3404 as the inner device 3402 is axially translated relative to the fixed outer device 3404 , or the inner device 3402 and outer device 3404 may be configured such that the protrusions 3408 remain in their respective proximal/distal spatial relationships.
- protrusions 3408 on the inner device 3402 and the outer device 3404 may be configured to serve as stops that abut one another and limit axial translation of the inner device 3402 with respect to the outer device 3404 in a distal and/or proximal direction.
- the inner device 3402 may contain one or more protrusions 3408 (e.g., 1, 2, 3, 4, 5, etc.) and/or the outer device 3404 may contain one or more protrusions 3408 (e.g., 1, 2, 3, 4, 5, etc.).
- FIG. 6 schematically depicts an inner device 3402 having multiple axially spaced protrusions 3408 or multiple revolutions of one or two or more helical protrusions spiraling or positioned along a proximal end of the inner device 3402 .
- the protrusion 3408 may be arranged in any combination of the spatial relationships described elsewhere herein.
- the inner device 3402 may comprise a protrusion 3408 surrounded on its proximal and distal sides by protrusions 3408 on the outer device 3404 or vice-versa.
- the inner device 3402 may comprise a protrusion 3408 and the outer device 3404 may comprise multiple protrusions 3408 positioned proximally and/or distally of the protrusion 3408 on the inner device or vice-versa.
- Some or all of the protrusions 3408 on the inner device 3402 may be positioned to be axially translatable over some or all of the protrusions 3408 on the outer device 3408 or vice-versa.
- one or more protrusions 3408 on the inner device 3402 may be configured to extend distally beyond the distal end of the outer device 3404 , such as in a fully extended configuration. In some embodiments, one or more protrusions 3408 on the inner device 3402 may be configured not to extend distally beyond the distal end of the outer device 3404 such that they remain within the annular gap, such as in a fully extended configuration. In some embodiments, one or more protrusions 3408 on the outer device 3404 may be configured to extend proximally beyond the proximal end of the inner device 3402 , such as in a fully extended configuration. In some embodiments, one or more protrusions 3408 on the outer device 3404 may be configured not to extend proximally beyond the proximal end of the inner device 3402 , such as in a fully extended configuration.
- the protrusion 3408 may be uniformly distributed around the circumference of the inner device 3402 or outer device 3404 at a given axial position along the length of the inner device 3402 or outer device 3404 , forming a simple ring defining a transverse plane that is 90° from the longitudinal axis of the catheter. In other embodiments, the protrusion 3408 may incline in an axial direction as it circumnavigates the outer circumference of the inner device 3402 or the inner circumference of the outer device 3404 .
- the protrusion 3408 may shaped as an annular circle (90° to the longitudinal axis), oval (inclined at an angle other than 90°), diamond, or other suitable shape that is slanted along the axial direction such that the protrusion 3408 forms a proximal tip 3408 a and/or a distal tip 3408 b.
- FIGS. 7 A- 7 F schematically illustrate side views of various configurations of inclined or angled protrusions 3408 .
- the slanted protrusion 3408 may form a rounded proximal and/or distal edge as shown in FIG. 7 A , showing a proximal tip 3408 a .
- FIG. 7 B showing a distal tip 3408 b rotationally offset from the proximal tip 3408 a.
- the slanted protrusion may form a pointed tip as shown in FIG. 7 C , showing the proximal tip 3408 a , and 7 D, showing the distal tip 3408 b , in which the tips comprise a chevron-shaped profile.
- the views in FIGS. 7 A and 7 C may be substantially rotationally opposite the views in FIGS. 7 B and 7 D , respectively, such that the proximal tip 3408 a and the distal tip 3408 b are positioned on substantially opposite sides of the inner device 3402 .
- FIGS. 7 E and 7 F show examples of side views which may be approximately 90 degrees offset from the views in FIGS. 7 A- 7 D .
- Protrusions 3408 may comprise any combination of the views and shapes depicted as well as other shapes.
- the protrusion 3408 may comprise a rounded proximal tip 3408 a and a pointed distal tip 3408 b or vice versa.
- the protrusion may comprise a proximal tip 3408 a but no defined distal tip 3408 b (e.g., the protrusion is distributed evenly around at least a portion of the circumference at its distal end) or vice versa.
- the configuration of the slanted protrusions 3408 particularly the chevron-shaped profiles, may reduce the force required to axially translate the inner device 3402 relative to the outer device 3404 , while maintaining a sealed space.
- FIGS. 8 A and 8 B schematically illustrate two examples of a spined catheter inner device 3402 , similar to those described elsewhere herein, in which a proximal end of the catheter extension tube portion of the device 3402 comprises a chevron-shaped protrusion 3408 .
- the tubular body 3400 in FIG. 8 A comprises a constant internal diameter, which may be approximately 0.71 inches.
- the device 3400 in FIG. 8 B comprises an expanded diameter portion at the proximal end, which may have an internal diameter of about 0.71 inches, and transitions to a reduced diameter portion near the distal diameter, which may have an inner diameter of approximately, 0.35 inches, 0.45 inches, 0.55 inches, or any diameter in a range defined there between.
- FIG. 8 C- 8 E illustrate close-up views of an example of chevron-shaped protrusions 3408 on the inner device 3402 .
- the view in FIG. 8 D is approximately 90 degrees offset around the circumference of the inner device 3402 from the view in FIG. 8 C .
- FIG. 8 E is a view like FIG. 8 C , but also showing the orientation of the protrusion on the back side of the catheter.
- the protrusion 3408 may comprise dimensions including a width 3407 a in an axial direction and an angle ⁇ defined relative to the longitudinal axis of the inner tubular body 3402 .
- the width 3407 a of the protrusion 3408 may be substantially constant around the circumference of the inner device 3402 .
- the width 3407 a may be between approximately 0.01 and 0.3 inches, 0.02 and 0.2 inches, 0.03 and 0.1 inches, 0.035 and 0.08 inches, 0.04 and 0.06 inches, or 0.045 and 0.055 inches.
- the width 3407 a may be larger at and/or near the proximal trailing tip 3408 a and/or the distal leading tip 3408 b of the protrusion 3408 , as shown in FIG. 8 C .
- the width 3407 a at these points may be approximately 1.5 ⁇ , 1.75 ⁇ , 2 ⁇ , 2.25 ⁇ , 2.5 ⁇ , 2.75 ⁇ , 3 ⁇ , 3.25 ⁇ , 3.5 ⁇ , 3.75 ⁇ , 4 ⁇ , 4.25 ⁇ , 4.5 ⁇ , 4.75 ⁇ , or 5 ⁇ larger than the width 3407 b at a point where it is the smallest (e.g., halfway between the proximal point 3408 a and the distal point 3408 b ).
- the width 3407 a near the proximal point 3408 a and/or the distal point 3408 b may be between approximately 0.05 and 0.3 inches, 0.1 and 0.2 inches, or 0.11 and 0.13 inches.
- the width 3407 a may vary in a continuous pattern across the circumference of the inner device 3402 .
- the angle ⁇ may be defined via a straight line connecting the proximal tip 3408 a to a point 3452 on the proximal edge opposite the distal tip 3408 b or connecting the distal tip 3408 b to a point 3452 on the distal edge opposite the proximal tip 3408 a , which in the illustrated embodiment lies on a proximal edge 3409 of the inclined seal.
- the angle ⁇ may be defined by a best fit straight line along the proximal and/or distal edge of the protrusion, in the case of nonlinear edges.
- the other examples of protrusions 3408 disclosed herein may have the same or similar dimensions.
- the trailing and/or leading edge of the protrusion 3408 may form an angle ⁇ relative to the longitudinal axis that is no larger than about 10 degrees, 15 degrees, 20 degrees, 25 degrees, 30 degrees, 35 degrees, 40 degrees, 45 degrees, 50 degrees, 55 degrees, or 60 degrees. In some embodiments, the angle ⁇ may be between about 15 and 45 degrees, 20 and 40 degrees, 20 and 30 degrees, or 30 and 40 degrees. Protrusions 3408 having a lower angle ⁇ may facilitate sliding of the inner device 3402 within the outer device 3404 in an axial direction.
- the illustrated protrusion 3408 is in the form of an inclined annular seal having a distal edge 3450 on the opposite axial end of the seal from proximal edge 3409 .
- the distal edge 3450 may reside on a plane that is substantially parallel to the proximal edge 3409 in an embodiment having a constant thickness 3407 a , both of which are non perpendicular to the longitudinal axis of the catheter.
- the inclined distal edge 3450 has a first, distal transition or limit at leading point 3408 b and a second, proximal limit 3452 which is axially proximally offset from the first distal limit by at least about 2 mm; at least about 3 mm or 4 mm or more.
- the inclined proximal edge 3409 extends between a distal limit 3454 and a proximal limit 3408 a .
- a window 3456 may be formed between the distal limit 3454 and proximal limit 3452 of the opposing edges of the seal depending upon the incline angle of the seal. See FIG. 8 E .
- a distal sliding surface 3458 is thus axially offset from a proximal sliding surface 3460 by an amount that corresponds to the axial length of the window 3456 .
- the window 3456 has a major axis extending in the catheter longitudinal axis direction. At any point within the window, a line can be drawn transverse through the catheter without intersecting the protrusion 3408 .
- the window 3456 may have a major axis within the range of from about negative 0.5 mm (slight axial overlap of the distal sliding surface 3458 and proximal sliding surface 3460 ) to about 4 mm, and in some implementations at least about 1 mm or 2 mm and in some cases within the range of from about 2 mm to about 3 mm.
- the major axis of the window 3456 is about 2.6 mm in one implementation having a seal width 3407 a of about 2 mm and a catheter OD of about 0.086 inches.
- An end view of the distal edge 3450 and or proximal edge 3409 taken along a viewing axis that is perpendicular to the plane of the respective edge can define an ellipse.
- the ellipse dimensions are 0.086′′ in the minor axis direction, which is equal to the OD of the catheter.
- the ellipse is about 0.2057′′ in the major axis direction, about 2 to 2.5 times the catheter diameter. This means the seal inclines at about 30 degrees to the long axis of the catheter. At an incline of about 15 degrees the long axis increases to almost 4 times the catheter diameter. This is rather steep and may be a reasonable limit.
- the trailing edge 3454 (inside the ellipse) of the seal on one side should overlap minimally, or ideally not at all with the leading edge 3452 (inside of the ellipse) of the seal on the opposite side.
- the overall length in the catheter axial direction from distal tip 3408 b to proximal tip 3408 a will often be at least about 1.5 times or two times the width 3407 a .
- the overall tip to tip length may be at least about 2.5 times or 3 times the width 3407 a . Multiples within the range of from about 1.5 times and about 5 times, or from about 2 times and about 3.5 times may be utilized depending upon desired performance.
- the overall axial length from tip to tip is between about 4 mm and about 8 mm, between about 6 mm and about 7 mm and optionally about 6.7 mm.
- the overall length may be elongated further by introducing an axial extension segment on each side of the catheter such as at about the midpoint between proximal tip 3408 a and distal tip 3408 b .
- the distal edge 3450 for example would not appear as it does in side elevational view ( FIG. 8 D ) to be a linear edge between 3408 a and 3408 b .
- a distally facing segment extending proximally from point 3408 b and a distally facing segment extending distally from point 3408 a would be separated by a central segment facing a different angle such as laterally in the case of an axially extending central extension segment.
- the chevron configured seal allows for effective sealing inside another tube by not requiring the other (outer) tube to have a friction fit around a full 360 degrees at the same axial location transverse plane.
- the contact points of the chevron allow the inner and outer tubes to be inclined slightly to each other to relieve the friction of the sealing surface and at the midpoint of the chevron the outer tube can ovalize slightly while never allowing a leak path to form.
- the protrusions 3408 disclosed herein may be any suitable thickness.
- the protrusions 3408 may be no greater than approximately 0.01 mm, 0.025 mm, 0.05 mm, 0.075 mm, 0.1 mm, 0.25 mm, 0.5 mm, 0.75 mm, 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, less than 0.1 mm, more than 5 mm, or a thickness within a range defined there between.
- the protrusions 3408 may have uniform thickness.
- the thickness may be between about 0.001 and 0.005 inches, 0.0015 and 0.004 inches, or 0.002 and 0.003 inches.
- the protrusions 3408 may have variable thickness as they extend circumferentially around the circumference of the inner device 3402 or outer device 3404 .
- the protrusion 3408 may have an outer diameter that is substantially equal to the inner diameter of the outer device 3404 .
- both diameters may be between about 0.085 and 0.09 inches, 0.086 and 0.089 inches, or 0.087 and 0.088 inches.
- the outer diameter of the protrusion 3408 and the inner diameter of the outer device 3404 may vary by less than about 0.002 inches, 0.001 inches, or 0.005 inches.
- the protrusion 3408 may be formed from the same material as an outer layer of the inner device 3402 , such as Pebax®.
- the protrusion may be formed by extruding the material in a similar way one or more layers of the inner device 3402 are formed. The extruded material may be cut (e.g., diagonally cut) to form the shape of the ring having dimensions 3407 a and 3408 b .
- the protrusion 3408 may be positioned around the inner device 3402 and then heated to laminate the protrusion 3408 to the outer surface of the inner device 3402 , such as in a hot box.
- the protrusion 3408 may be adhered to the inner device 3402 using an adhesive, such as a biocompatible adhesive.
- the protrusion may be post-processed.
- the protrusion may be shaped by heating in a mold.
- the mold may be a glass mold.
- the mold may have an inner diameter approximately equal to the inner diameter of the outer device 3404 or slightly larger.
- the mold may have an inner diameter of about 0.088 inches to achieve a protrusion 3408 having a diameter of approximately 0.0874 inches.
- the protrusion 3408 may be molded or otherwise processed prior to attachment of the protrusion 3408 to the inner device 3408 .
- the protrusion 3408 may be attached or formed near the proximal end of the inner device 3402 as described elsewhere herein.
- the protrusion 3408 may be formed within 5 cm, 4 cm, 3 cm, or 2 cm from the proximal end of the inner tubular body 3402 .
- the protrusion 3408 may be attached or formed on the most proximal Pebax® segment (e.g. a 72D segment).
- the protrusion 3408 may be attached or formed distally to any proximal Vestamid® segments.
- the protrusion When attached or formed near the proximal end of the inner device 3402 , the protrusion may have a durometer that is the same or less than that of the inner device 3402 at the same location.
- the protrusion 3408 may have a durometer between about 45D and 70D, 50D and 65D, or 55D and 60D.
- a 55D protrusion 3408 may be positioned around a 72D segment of the outer jacket of the inner device 3402 .
- the protrusion 3408 may be a spiral that extends along an axial length of the inner device 3402 and/or the outer device 3404 .
- the spiral may terminate at either its distal end and/or proximal end in closed circumference rings or connect to closed circumference rings.
- the spiral may terminate at its distal end and/or proximal end in an open configuration which may allow some blood to pass through a helical passage formed by the spiral. The spiral may nonetheless impede the flow of blood into the annular gap.
- the smaller the pitch of the spiral the larger the impediment the spiral may provide against blood ingress.
- Rotation of the inner device 3402 in a first direction may cause the spiral to expel fluid in a distal direction while rotation in a second direction may draw in blood.
- Rotation in the first direction may be used to expel a flushing solution as described elsewhere herein.
- the sealing feature 3406 may be an active feature which expands or otherwise activates to seal the annular gap and/or which can be deactivated to allow flow through the annular gap.
- the sealing feature 3406 may be deactivated when the inner device 3402 and the outer device 3404 are axially translated relative to one another so as to allow easier movement (e.g., less friction).
- the sealing feature 3406 may be activated when the inner device 3402 and the outer device 3404 are being used in a fixed position, such as a fully retracted and/or fully extended position.
- the active sealing feature 3406 may be an expandable bulge 3410 .
- the expandable bulge 3410 may be activated via a connection extending through the central lumen 3401 of a spine 3403 of the inner device 3402 , such as the lumen 45 extending through the pull wire 42 described elsewhere herein.
- the expandable bulge 3410 may be mechanically expandable.
- the expandable bulge 3410 may be formed from a soft or compliant polymer, such as an elastomeric polymer.
- the soft expandable bulge 3410 may be formed such that in an inactivated or un-expanded state the outer profile of the expandable bulge 3410 is in a reduced profile configuration such as flush with or in-line with the outer diameter of the inner device 3402 .
- the inner device 3402 may comprise a reduced diameter recess for receiving the expandable bulge 3410 .
- the expandable bulge 3410 may be ring-shaped or cuff-shaped.
- the expandable bulge 3410 may replace an outer layer of the inner device 3410 (e.g., the outer jacket) over a small axial length of the inner device 3410 .
- the expandable bulge 3410 may not be adhered or fixed to the outer diameter of the inner device 3402 or it may be partially fixed, such as at a proximal end of the expandable bulge 3410 .
- the expandable bulge 3410 may be coupled to the inner device 3410 in a manner that allows axial compression of the expandable bulge 3410 along the outer surface of the inner device 3402 .
- the outer diameter of the expandable bulge 3410 in an un-activated or un-expanded state may extend beyond the outer diameter of the inner device 3402 but may not extend to the inner diameter of the outer device 3404 such that it does entirely seal the annular gap.
- the expandable bulge 3410 may be applied over a smooth portion of the outer circumference of the inner device 3402 .
- the expandable bulge 3410 may be fixed, such as at a proximal end, to the inner device 3402 .
- the expandable bulge 3410 may be positioned at a proximal end of the inner device 3402 .
- the expandable bulge 3410 may be sandwiched between a portion of the outer jacket of the inner device 3410 and a proximal structure.
- the proximal structure may be, for example, a radiopaque ring for determining the location of the proximal end of the inner device 3402 .
- a tension cable or wire 3411 may extend from a proximal end of the device 3400 to the expandable bulge 3410 .
- the tension cable 3411 may attach to a distal end of the expandable bulge 3410 .
- Proximal retraction of the tension cable 3411 may apply an axially compressive force to the expandable bulge 3410 which causes the axial length of the expandable bulge 3410 to be compressed and the radial diameter of the expandable bulge 3410 to expand.
- Full expansion of the expandable bulge 3410 may increase the outer diameter of the expandable bulge 3410 to a size such that it is compressed against the inner diameter of the outer device 3404 and forms a fluid seal with the inner diameter of the outer device 3404 .
- Providing a distally directed counterforce on the inner device 3402 such as by pushing on the inner device 3402 (e.g., pushing on the spine 3403 through which the tension cable 3411 extends) may facilitate expanding the expandable bulge 3410 without axially translating the inner device 3402 relative to the outer device 3402 , such as pulling the inner device 3410 proximally along with the tension cable 3411 .
- the expandable bulge 3410 may be compressed by pushing on a push wire which may be connected to a proximal end of the expandable bulge 3410 .
- the expandable bulge 3410 may be fixed to the inner device 3410 at a distal end of the expandable bulge 3402 .
- the expandable bulge 3402 may be positioned at a distal end or intermediate portion of the inner device 3402 .
- the expandable bulge 3410 may be expandable by non-mechanical means.
- the expandable bulge 3410 may comprise a light-sensitive or electrosensitive material, such as a light-sensitive hydrogel and/or an electrosensitive hydrogel.
- An electric current or light may be passed through the lumen, which may serve as or may comprise an insulator or fiber optic cable.
- the hydrogel may expand upon the application of light and/or an electric current and may collapse upon removal of the stimuli or vice-versa.
- the expandable bulge 3410 may be inflatable and the lumen may serve as a passage for providing pressurized fluid (e.g. a gas or liquid, such as saline) which serves to inflate the expandable bulge 3410 .
- the expandable bulge 3410 may be inflated and deflated to a controllable extent by controlling the pressure applied to the inflating fluid.
- the sealing feature 3406 may comprise a flange 3412 .
- FIG. 10 schematically illustrates an example of a device 3400 comprising a flange 3412 .
- the flange 3412 may be annular in shape.
- the flange 3412 may be located at the distal end of the outer device 3404 .
- the flange 3412 may comprise similar features as the protrusion 3408 described elsewhere herein.
- the flange 3412 may incline radially inward toward the inner device 3402 to form a frusto conical skirt configuration.
- the flange 3412 may extend from an inner diameter of the outer device 3404 .
- the flange 3412 may be coupled to a distal face of the outer device 3404 .
- the flange 3412 may comprise a soft and/or elastic material.
- the flange 3412 may be relatively softer and/or more flexible than the outer device 3404 or one or more layers of the outer device 3404 and/or relatively softer and/or more flexible than the inner device 3402 or one or more layers of the inner device 3402 .
- the flange 3412 may be formed integrally with the outer device 3404 .
- the flange 3412 may be extruded as a part of an inner liner and/or a part of an outer jacket of the outer device 3412 .
- the flange 3412 may be the same material as a layer of the outer device 3412 but may be formed relatively thinner so that it is more flexible.
- the flange 3412 may be formed as a separate component which is coupled to the outer device 3404 .
- the flange 3412 may be adhered to the outer device 3404 or melted or molded onto the outer device 3404 .
- the flange may be a distal segment of an outer jacket of the outer device 3404 .
- the flange 3412 may be relatively compliant.
- the flange 3412 may be configured to extend, in an unbiased configuration, radially inward in a substantially normal relation to the inner surface of the outer device 3404 .
- the flange 3412 may be configured to extend, in an unbiased configuration, radially inward and somewhat in a distal direction such that it forms an oblique angle with the inner surface of the outer device 304 .
- the flange 3412 may comprise an inner diameter in an unbiased configuration which is smaller than the outer diameter of the inner device 3402 .
- the flange 3412 may be thicker along or near its outer diameter than along or near its inner diameter.
- the flange 3412 may comprise uniform thickness. Extending the inner device 3402 past the distal end of the outer device 3404 may cause the flange 3412 to bend in a distal direction such that the inner diameter of the flange 3412 expands to accommodate the inner device 3404 and form a fluid seal along the outer surface of the inner device 3402 as shown in FIG. 10 . An inner-most portion of the flange 3412 may deform to lie substantially flat against the outer surface of the inner device 3402 .
- the flange 3412 may act like a squeegee along the outer surface of the inner device 3404 .
- the flange 3412 may be made of a lubricious material and/or coated with a lubricious material to promote smooth translation of the inner device 3402 relative to the outer device 3404 .
- the flange 3414 may maintain a flushing fluid proximal to the flange 3414 and/or may act as a one-way valve in the same manner as described with various configurations of the protrusion 3408 described elsewhere herein.
- Providing a flange 3414 or other sealing feature 3406 at a distal end of the outer device 3404 may advantageously maximize the volume of the annular gap which is sealed from the physiological environment.
- the inner device 3402 may comprise a flange 3412 extending from its outer diameter in a radially outward direction, which may comprise features similar to the flange 3412 extending from the outer device 3402 .
- the outer diameter of the flange 3412 may be larger than the inner diameter of the outer device 3404 .
- the flange 3412 may be positioned at a proximal end of the inner device 3402 .
- the sealing feature 3406 may comprise an expanded diameter portion of the inner device 3402 , such as a hub 3414 .
- FIG. 11 schematically illustrates an example of a device 3400 comprising a hub 3414 .
- the hub 3414 may be configured to form a tight interference fit with the inner surface of the outer device 3404 .
- the hub 3404 may prevent or reduce the amount of contact between a portion of the inner device 3402 distal to and/or proximal to the hub 3414 with the outer device 3404 , which may reduce friction and facilitate translation of the inner device 3402 relative to the outer device 3404 .
- the hub 3414 may comprise the same material as an outer jacket of the inner device 3404 or as any other layer of the inner device 3402 . In some embodiments, the hub 3414 may be relatively softer and/or more flexible than the remaining length of the inner device 3402 . In some embodiments, the hub 3414 may be relatively harder and/or stiffer than the remaining length of the inner device 3402 . In some embodiments, the hub 3414 may comprise a uniform material extending between the non-expanded outer diameter of the inner device 3402 and the inner diameter of the outer device 3404 . In some embodiments, the hub 3414 may comprise multiple layers between the non-expanded outer diameter of the inner device 3402 and the inner diameter of the outer device 3404 .
- the layers may be of the same or different materials.
- one or more outer layers may be softer, more flexible, and/or more lubricious than one or more inner layers.
- the outer layer or layers may facilitate smooth interaction with the outer device 3404 and the inner layers may provide structural support to the outer layers.
- the hub 3414 may be positioned adjacent to a radiopaque ring as illustrated in FIG. 11 , such as distally adjacent to the radiopaque ring.
- the inner device 3404 may comprise a spine 3403 (e.g., a hypotube spine) as described elsewhere herein.
- the spine 3403 may comprise a lumen 3401 .
- the spine 3403 may be positioned along an outer-most diameter of the inner device 3402 .
- the spine 3403 may merge with the hub 3414 as shown in FIG. 11 .
- the lumen 3401 may extend through the hub 3414 and open on a distal face of the hub 3414 .
- the outer diameter of the lumen 3401 may be flush with the non-expanded outer diameter of the inner device 3402 .
- the outer diameter of the lumen 3401 may be entirely surrounded by portions of the hub 3414 .
- a portion of outer diameter of the lumen 3401 may be positioned along the outer diameter of the hub 3414 , such that the lumen 3404 forms a groove along an outer surface of the hub 3414 .
- the hub 3414 may thereby comprise a distal port 3454 on a lumen extending through the seal which allows delivery of flushing fluid through the lumen 3401 across the seal and into the annular gap. Providing pressure from the proximal end of the lumen 3401 may allow delivery of flushing fluid while preventing proximal fluid flow through the port of the sealing feature 3406 .
- the lumen 3401 may extend linearly through the hub 3414 such that the port 3454 is collinear with the remainder of the lumen 3401 .
- the lumen may turn, such as in a circumferential direction, and/or branch off into multiple ports. Multiple ports may be positioned, for example, at different circumferential points around the hub 3414 .
- the sealing feature 3406 may be dynamically responsive to movements of the inner device 3402 and/or outer device 3404 .
- the sealing feature 3406 may comprise spring devices which expand in an unbiased state and contract under force provided by movement of the inner device 3402 , for example, and a counter frictional force between the inner device 3402 and the outer device 3404 .
- FIGS. 12 A- 12 C schematically illustrate an example of a device 3400 comprising a spring sealing feature 3416 which is radially compressed and axially extended by axial movement of the inner device 3402 .
- FIG. 12 A depicts the spring sealing feature 3416 in an axially compressed/radially expanded sealed configuration.
- FIG. 12 B depicts the spring sealing feature 3416 in an axially extended/radially compressed non-sealed configuration.
- FIG. 12 C depicts an example of a sliding ring 3418 used in the spring sealing feature 3416 of FIGS. 12 A and 12 B .
- the inner device 3402 may be coupled to the outer device 3404 by two sliding rings 3418 .
- One sliding ring 3418 may be positioned at a distal end of the spring sealing feature 3416 and one sliding ring 3418 may be positioned at a proximal end of the spring sealing feature 3416 .
- the sliding ring 3418 may comprise an inner annulus 3418 a , an outer annulus 3418 b , and one or more spokes 3418 c joining the inner annulus 3418 a and the outer annulus 3418 b .
- Multiple spokes 3418 c may be positioned substantially uniformly around the circumference of the sliding ring 3418 . Fluid may generally flow through the sliding rings 3418 between the spokes 3418 c.
- the inner annulus 3418 a may be configured to form a sliding interference fit with the outer diameter of the inner device 3402 .
- the outer annulus 3418 b may be configured to form a sliding interference fit with the inner diameter of the outer device 3404 .
- the inner annulus 3418 a may have a first coefficient of friction with respect to the inner device 3402 and the outer annulus 3418 b may have a second coefficient of friction with respect to the outer device 3404 .
- the first and second coefficients of friction may be the same or one may be larger than the other.
- the outer annulus 3418 is shown as comprising a complete circumference in FIG. 12 C , in some embodiments, the outer annulus 3418 b may not extend around the complete circumference.
- the circumference of the outer annulus 3418 b may be broken up into one or more partial arcuate sections, each section being connected to one or more spokes 3418 c . Reducing the circumferential coverage of the outer annulus 3418 b may decrease friction between the sliding ring 3418 and the outer device 3404 and promote easier sliding of the sliding ring 3418 over the inner surface of the outer device 3404 .
- the inner device 3402 may comprise a ridge feature 3420 projecting from the outer surface of the inner device 3402 .
- the ridge feature 3420 may be a ring fixed to the outer surface of the inner device 3402 .
- the ridge feature 3420 may be positioned between the proximal and distal sliding rings 3418 .
- the ridge feature 3420 may be configured to abut a proximal side of the distal sliding ring 3418 and push the sliding ring 3418 in a distal direction along the inner surface of the outer device 3404 . Likewise, the ridge feature 3420 may be configured to abut a distal side of the proximal sliding ring 3418 and push the sliding ring 3418 in a proximal direction along the inner surface of the outer device 3404 .
- the spring sealing feature 3416 may comprise one or more radially compressible support structures such as springs 3422 extending from around the circumference of the inner annulus 3418 a of the proximal sliding ring 3418 to the inner annulus 3418 a of the distal sliding ring 3418 .
- the springs 3422 may comprise a plurality of spring struts extending parallel to a longitudinal axis of the device 3400 from one sliding ring 3418 to another.
- the spring 3422 may comprise a coil spring wrapping helically around the inner device 3402 .
- the spring 3422 may comprise a spring mesh.
- the spring 3422 may be convex around the inner device 3402 or configured to bulge radially outward, within at least one portion positioned intermediately between the proximal end and distal end of the spring 3422 , when in an unbiased or relaxed state, as shown in FIG. 12 A .
- the spring or springs 3422 may be covered or coated with an elastic membrane or film (not shown) which covers an outer and/or inner surface of the springs 3422 such that a fluid barrier is formed by the membrane circumferentially around the inner device 3402 , the fluid barrier extending from the proximal sliding ring 3418 to the distal sliding ring 3418 .
- the spring 3422 and the elastic membrane are compressed against an inner surface of the outer device 3404 , as depicted in FIG. 12 A , such that the fluid barrier forms a fluid seal around the entire circumference of the inner surface of the outer device 3404 .
- the spring sealing feature 3416 may inhibit or prohibit distal and proximal fluid flow through or across the spring sealing feature 3416 in a fully expanded configuration.
- FIG. 12 B schematically illustrates the device 3400 of FIG. 12 A with the spring sealing feature 3416 in an axially extended/radially compressed unsealed configuration during translational movement of the inner device 3402 .
- the inner device 3402 has been sufficiently translated in a proximal direction such that the ridge feature 3420 is pushing against the proximal sliding ring 3418 .
- the ridge 3420 causes the proximal sliding ring 3418 to slide in a proximal direction along the inner surface of the outer device 3404 .
- proximal sliding ring 3418 As the proximal sliding ring 3418 slides in a proximal direction it exerts a force on the spring 3422 in the proximal direction.
- the spring 3422 may stretch in the axial direction thereby reducing its outer diameter.
- the outer diameter of the spring 3422 may be reduced such that the spring 3422 and/or elastic membrane no longer contacts the inner surface of the outer device 3404 , at least along a portion of the circumference, and allows fluid flow across the spring sealing feature 3416 .
- Fluid may flow between the spokes 3418 c of the proximal and distal sliding rings 3418 to flow across the surface of the fluid barrier formed around the inner device 3402 .
- Removing contact between the membrane-encompassed spring 3422 and the inner surface of the outer device 3402 may reduce overall friction and facilitate axial translation of the inner device 3402 relative to the outer device 3404 .
- the axial extension of the spring 3422 may reduce the compressive force of the spring sealing feature 3416 against the outer device 3404 but still maintain the spring sealing feature 3416 in contact with the outer device 3404 . Reducing the compressive force may reduce friction and facilitate translation of the inner device 3402 with respect to the outer device 3404 while maintaining, at least to a degree, a fluid seal.
- the tension may be removed from the spring 3422 and the spring 3422 may contract bringing the proximal and distal rings 3418 closer together.
- the spring 3422 may expand to the inner surface of the outer device 3404 sealing device 3400 , blocking fluid flow across the spring sealing feature 3416 .
- the spring 3422 may be designed with a spring constant, such that it requires less force to deform the spring 3422 than to overcome the friction resisting sliding between the outer annulus 3418 b and the inner surface of the outer device 3404 .
- the spring 3422 may be configured to extend before the lagging sliding ring 3418 begins to translate, following the leading sliding ring 3418 .
- the spring sealing feature 3416 may use two ridge features 3420 , one positioned on a distal side of the distal sliding ring 3418 and one positioned on the proximal side of the proximal sliding ring 3418 , in addition to or alternatively to the intermediate ridge feature 3420 .
- Providing a transient seal that only allows fluid flow during axial translation of the inner device may significantly reduce exposure of the annular gap to proximal blood flow.
- Providing a transient seal that reduces friction upon axial translation of the inner device 3402 may improve the ability to readily translate the inner device 3402 while generally maintaining a fluid seal. The same tradeoff between friction that seals the annular gap and friction that inhibits smooth axial translation is not necessarily required with a dynamic seal.
- FIGS. 13 A- 13 C schematically illustrate an example of a device 3400 comprising a spring sealing feature 3426 which is compressed by rotational movement of the inner device 3402 relative to the outer device 3404 .
- FIG. 13 A depicts the device 3400 in a torqued/radially compressed non-sealed configuration.
- FIG. 13 B depicts a cross section of the inner device 3402 in FIG. 13 A taken along the longitudinal axis at a point comprising a key feature 3432 .
- FIG. 13 C depicts an example of a small diameter ring 3430 used in the spring sealing feature 3426 of FIGS. 13 A and 13 B .
- the spring sealing feature 3426 may comprise a large diameter ring 3428 and a small diameter ring 3430 .
- the large diameter ring 3428 may be positioned proximal to the small diameter ring 3430 or vice versa.
- the large diameter ring 3428 may be similar to the sliding rings 3418 described elsewhere herein.
- the large diameter ring 3428 may be fixed to the internal diameter of the outer device 3404 , as depicted in FIG. 13 A , such that the large diameter ring 3428 neither translates (e.g., slides) nor rotates with respect to the outer device 3404 .
- the small diameter ring 3430 may extend around the circumference of the inner device and may have an outer diameter that does not extend to or near the inner surface of the outer device 3404 . In some embodiments, the outer diameter of the small diameter ring 3430 may be minimized, such as to a size sufficient to couple to a torsion spring 3434 .
- the inner device 3402 may comprise one or more key features 3432 as illustrated in FIG. 13 B .
- the key features 3432 may lock into the small diameter ring at particular circumferential locations.
- FIG. 13 C depicts a small diameter ring comprising a plurality of recesses or grooves 3433 , each being configured to receive one of the key features 3432 depicted in FIG. 13 B .
- the key features 3432 may extend axially along the entire length or a portion of the length of the inner device configured to interact with the spring sealing feature 3426 , as shown in FIG. 13 A .
- the inner device 3402 may be axially translatable (e.g., slidable) within the inner diameter of the small diameter ring 3430 .
- the key features 3432 may rotationally lock the small diameter ring 3430 to the inner device 3402 such that the small diameter ring 3430 rotates with the inner device 3432 .
- a torsion spring 3434 may extend between the large diameter ring 3428 and the small diameter ring 3430 .
- the torsion spring 3434 may have a convex configuration around the inner device 3402 such that it extends radially outward between the large diameter ring 3428 and the small diameter ring 3430 so as to compress against the inner surface of the outer device 3404 .
- the spring sealing device 3426 may comprise an elastic membrane or film coupled to the torsion spring 3434 to form a fluid barrier circumferentially surrounding the inner device 3402 as described elsewhere herein.
- Rotation of the small diameter ring 3430 in a first direction may cause the torsion spring 3434 to collapse such that the elastic membrane is no longer pressed into contact with the outer device 3404 .
- the elastic membrane may form a fluid seal around the circumference of the inner surface of the outer device 3404 when compressed against the outer device 3404 , similar to the spring sealing feature shown in FIG. 12 A .
- the small diameter ring 3430 may be free to axially translate as needed along the outer surface of the inner device, such as to accommodate the radial compression of the torsion spring 3434 .
- Rotation of the inner device 3404 may thereby allow fluid flow across the spring sealing device 3426 .
- the inner device 3404 may be rotated and maintained in a rotated position to allow axial translation of the inner device 3402 with respect to the outer device 3404 in order to reduce the friction between the inner device 3402 and outer device 3404 .
- the large diameter ring 3428 may be fixed to the outer device 3404 near a distal end of the outer device 3404 , maximizing the length of the annular gap that is sealed from blood exposure.
- the small diameter ring 3430 may be fixed to the inner device 3402 such that it is not axially translatable with respect to the inner device 3402 .
- the small diameter ring 3430 may be an annular projection extending from the inner device 3402 .
- the small diameter ring 3430 may be integral with the inner device 3402 .
- the large diameter ring 3428 may be axially translatable (e.g., slidable) with respect to the inner surface of the outer device 3404 .
- the large diameter ring 3428 may resist or prohibit rotation with respect to the inner surface of the outer device 3404 .
- the spring constant of the torsion spring 3434 may be configured such that less torque is required to collapse the spring than to rotate the large diameter ring 3428 with respect to the outer device 3404 .
- the large diameter ring may provide a counter force that allows the torsion spring 3434 to collapse.
- the large diameter ring 3428 may be mechanically prevented from rotating with respect to the outer device 3404 .
- the large diameter ring may comprise key features and the inner surface of the outer device 3404 may comprises corresponding recesses or grooves, as described elsewhere herein or vice versa.
- the torsion spring 3434 and/or the elastic membrane may extend from the small diameter ring to an outer annulus of the large diameter ring 3428 or some circumference between an inner diameter and outer diameter of the large diameter ring 3428 .
- Rotation of the inner device 3402 may collapse the torsion spring 3434 to allow fluid flow and/or reduce friction between the inner device 3402 and outer device 3404 as described with respect to FIGS. 13 A- 13 C .
- the spring sealing feature 3426 may be axially translatable with respect to the outer device 3404 such that it may move along with the inner device 3402 .
- vascular device such as device 3400 , described elsewhere herein
- a body vessel such as a blood vessel (e.g., a neurovascular artery).
- Sealing a blood vessel around a catheter device, particularly a catheter configured for the removal (e.g., aspiration) of a blood clot may advantageously prevent blood flow from carrying a clot or fragment of a clot, such as a clot captured on a distal end of the catheter, further downstream.
- the seal between the device and the blood vessel may prevent antegrade blood flow from dislodging a captured blood clot from a distal end of the device and carrying it downstream, which could result in an embolism in a downstream location.
- the device 3400 may comprise a vessel sealing feature 3440 positioned on an outer surface of the device 3400 (e.g., on an outer surface of the outer access catheter device 3404 ).
- FIG. 14 schematically illustrates an example of a device 3400 comprising a vessel sealing feature 3440 .
- the vessel sealing feature 3440 may be annular and may extend around the entire circumference of the device 3400 .
- the vessel sealing feature 3440 may be positioned at a distal end of the device 3400 , near a proximal end of the device 3400 , or somewhere intermediate the distal end and proximal end.
- the vessel sealing feature 3440 may be passive comprising a static structure that seals the vessel or it may be active comprising a dynamic structure that is activated and/or deactivate to transition between a sealing state and a non-sealing state.
- the vessel sealing feature 3440 may comprise the same or similar features as protrusion 3408 configured to extend around the outer surface of the inner device 3402 , except that it is configured to extend around the outer surface of the outer device 3404 .
- the vessel sealing feature 3440 may form an expanded diameter portion of the device 3400 (or at least of a portion of the device inserted into the vasculature to be occluded by the vessel sealing feature 3440 ).
- the vessel sealing feature 3440 may be extremely compliant such that it may have a diameter large enough to seal a blood vessel of an unknown or variable diameter while being soft and deformable enough to be compressed and placed contact with the blood vessel wall without damaging (e.g., rupturing or tearing) the blood vessel wall or intima.
- the vessel sealing feature 3440 may be formed as a part of an outer jacket as described elsewhere herein.
- the vessel sealing feature 3440 may comprise a soft elastomeric polymer.
- the vessel sealing feature 3440 may be formed from a same or different material as the device 3400 (e.g., the outer jacket of the device).
- the vessel sealing feature 3440 may be a separate component which is coupled to the device 3400 .
- the vessel sealing feature 3440 may be a preformed ring, similar to a wide O-ring, which is placed over the outer surface of the device 3400 .
- the device 3400 may be configured with a circumferential recess or groove configured to receive the vessel sealing feature 3440 .
- the vessel sealing feature 3440 may have an inner diameter that is smaller, in an unbiased state, than the outer diameter of the device 3400 (or the recessed diameter of the groove).
- the vessel sealing feature 3440 may need to be at least partially expanded (e.g., stretched) in order to position the vessel sealing feature 3440 over the device 3400 and the compressive elastic force of the vessel sealing feature 3440 may frictionally secure the vessel sealing feature 3440 to the device 3400 .
- the vessel sealing feature 3440 may be additionally or alternatively secured to the device by melting or molding the sealing feature onto the device 3400 or using an adhesive (e.g., a biocompatible adhesive).
- the vessel sealing feature 3400 may be softer and more flexible or compliant along an outer diameter than along an inner diameter.
- the vessel sealing feature 3400 may be thinner along an outer diameter than along an inner diameter.
- the vessel sealing feature 3440 may be custom-formed in size and/or shape to the anatomy of a particular vessel. The anatomy may be patient-specific.
- the vessel sealing feature 3440 is interchangeable such that a custom or otherwise specifically shaped and/or sized vessel sealing feature 3440 may be replaceably attached to the device 3400 .
- the vessel sealing feature 3440 may be a soft hydrogel. The hydrogel may be configured to swell nominally or not at all in situ.
- the vessel sealing feature 3440 may be active.
- the vessel sealing feature 3440 may comprise the same or similar features as the expandable bulge 3410 described elsewhere herein.
- the vessel sealing feature 3440 may comprise a light-sensitive or electrosensitive material, such as a light-sensitive hydrogel and/or an electrosensitive hydrogel.
- An electric current or light may be passed through an insulator or fiber optic cable to the hydrogel or other active material.
- the hydrogel may expand upon the application of light and/or an electric current and may collapse upon removal of the stimuli or vice-versa.
- a hydrogel may be configured to swell to a controlled or expected volume when exposed to the physiological environment in situ.
- the hydrogel may be configured to swell in response to body temperature, blood exposure, and/or interaction with a physiological factor, such as an enzyme.
- the amount of swelling may be controlled by a parameter of the stimulus (e.g, the amount of current or intensity of the light).
- the vessel sealing feature 3440 may be inflatable via pressurized fluid (e.g. a gas or liquid, such as saline) which serves to inflate the vessel sealing feature 3440 such as an inflatable balloon.
- the vessel sealing feature 3440 may be inflated and deflated to a controllable extent by controlling the pressure applied to the inflating fluid.
- the vessel sealing feature 3440 may be configured to be in-line or flush with the outer diameter of the device 3400 in an inactivated state. In other embodiments, the vessel sealing feature 3440 may extend slightly beyond the outer diameter of the device 3400 in an inactivate state, but not to the extent that it seals the blood vessel or comes into significantly increased contact with the blood vessel creating additional friction.
- any of the catheter shaft or sections of the catheter shaft or telescoping extensions in accordance with the present invention may comprise a multi-layer construct having a high degree of flexibility and sufficient push ability to reach deep into the cerebral vasculature, such as at least as deep as the petrous, cavernous, or cerebral segment of the internal carotid artery (ICA).
- ICA internal carotid artery
- a catheter 3000 which may be the same or similar to device 3400 , may have an effective length from the manifold to distal tip from about 70 cm to about 150 cm, from about 80 cm to about 140 cm, from about 90 cm to about 130 cm, from about 100 cm to about 120 cm, or from about 105 cm to about 115 cm.
- the outer diameter of the catheter 3000 may be from about 0.07 inches to about 0.15 inches, from about 0.08 inches to about 0.14 inches, from about 0.09 inches to about 0.13 inches, from about 0.1 inches to about 0.12 inches, or from about 0.105 inches to about 0.115 inches, and may be lower in a distal segment than in a proximal segment.
- the inner diameter 3108 of the catheter 3000 in a single central lumen embodiment may be greater than or equal to about 0.11 inches, greater than or equal to about 0.1 inches, greater than or equal to about 0.09 inches, greater than or equal to about 0.088 inches, greater than or equal to about 0.08 inches, greater than or equal to about 0.07 inches, greater than or equal to about 0.06 inches, or greater than or equal to about 0.05 inches.
- the inner diameter 3108 of the catheter 3000 in a single central lumen embodiment may be less than or equal to about 0.11 inches, less than or equal to about 0.1 inches, less than or equal to about 0.09 inches, less than or equal to about 0.088 inches, less than or equal to about 0.08 inches, less than or equal to about 0.07 inches, less than or equal to about 0.06 inches, or less than or equal to about 0.05 inches.
- an inner liner 3014 may be formed by dip coating a mandrel (not shown) to provide a thin walled tubular inside layer of the catheter body 3000 .
- the dip coating may be produced by coating a wire such as a silver coated copper wire in PTFE.
- the mandrel may thereafter be axially elongated to reduce diameter, and removed to leave the tubular inner liner.
- the outside surface of the tubular inner liner 3014 may thereafter be coated with a soft tie layer 3012 such as polyurethane (e.g., TecoflexTM), to produce a layer having a thickness of no more than about 0.005 inches, and in some implementations approximately 0.001 inches.
- the tie layer 3012 will generally extend along at least about the most distal 10 cm or 20 cm of the catheter shaft 3000 generally less than about 50 cm and may in one implementation extend approximately the distal 30 cm of the catheter shaft 3000 , 3100 .
- a braid such as a 75 ppi stainless steel braid 3010 may thereafter be wrapped around the inner liner 3014 through a proximal zone up to a distal transition 3011 .
- a coil 3024 comprising a shape memory material such as a Nitinol alloy may thereafter be wrapped around the inner liner 3014 .
- the Nitinol coil has a transition temperature below body temperature so that the Nitinol resides in the austinite (springy) state at body temperature.
- Adjacent loops or filars of the coil 3024 may be closely tightly wound in a proximal zone with a distal section having looser spacing between adjacent loops.
- At least the distal 1 or 2 or 3 or 4 cm of the coil will have a spacing that is at least about 130%, and in some implementations at least about 150% or more than the spacing in the proximal coil section.
- the spacing in the proximal coil may be about 0.004 inches and in the distal section may be at least about 0.006 inches or 0.007 inches or more.
- the distal extendable section of the catheter may be constructed according to the foregoing.
- the length of the coil 3024 may be proportioned to the length of the extendable catheter segment or the total (e.g., extended) length of the catheter 3000 .
- the coil 3024 may extend from a distal end of the extendable segment over at least about 50%, 60%, 70%, 80%, or 90% of the length of the extendable segment.
- the catheter 3000 or the extendable segment may not comprise a braid and the coil 3024 may extend to the proximal end of the extendable segment (100% of the length).
- the distal end of the coil 3024 can be spaced proximally from the distal end of the inner liner 3014 , for example, to provide room for an annular radiopaque marker 3040 .
- the coil 3024 may be set back proximally from the distal end, in some embodiments, by approximately no more than 1 cm, 2 cm, or 3 cm.
- the distal end of the catheter 3000 is provided with a beveled distal surface 3006 residing on a plane having an angle of at least about 10° or 20° and in one embodiment about 30° with respect to a longitudinal axis of the catheter 3000 .
- the radiopaque marker 3040 may reside in a plane that is transverse to the longitudinal axis.
- at least the distally facing edge of the annular radiopaque marker 3040 may be an ellipse, residing on a plane which is inclined with respect to the longitudinal axis to complement the bevel angle of the distal surface 3006 .
- an outer Jacket 3020 maybe applied such as a shrink wrap tube to enclose the catheter body 3000 .
- the outer shrink-wrapped sleeve 3020 may comprise any of a variety of materials, such as polyethylene, polyurethane, polyether block amide (e.g., PEBAXTM) nylon or others known in the art. Sufficient heat is applied to cause the polymer to flow into and embed the proximal braid and distal coil.
- the outer shrink wrap jacket 3020 is formed by sequentially advancing a plurality of short tubular segments 3022 , 3026 , 3028 , 3030 , 3032 , 3034 , 3036 , 3038 concentrically over the catheter shaft subassembly, and applying heat to shrink the sections on to the catheter 3000 and provide a smooth continuous outer tubular body.
- the foregoing construction may extend along at least the most distal 10 cm, and preferably at least about the most distal 20 cm, 25 cm, 30 cm, 35 cm, 40 cm, or more than 40 cm of the catheter body 3000 .
- the entire length of the outer shrink wrap jacket 3020 may be formed from tubular segments and the length of the distal tubular segments (e.g., 3022 , 3026 , 3028 , 3030 , 3032 , 3034 , 3036 , 3038 ) may be shorter than the one or more tubular segments forming the proximal portion of the outer shrink wrap jacket 3020 in order to provide steeper transitions in flexibility toward the distal end of the catheter 3000 .
- the durometer of the outer wall segments may decrease in a distal direction.
- proximal segments such as 3022 and 3026
- proximal segments such as 3022 and 3026
- a 25 cm section may have at least about 3 or 5 or 7 or more segments and the catheter 3000 overall may have at least about 6 or 8 or 10 or more distinct flexibility zones.
- the distal 1 or 2 or 4 or more segments 3036 , 3038 may have a smaller OD following shrinking than the more proximal segments 3022 - 3034 to produce a step down in OD for the finished catheter body 3000 .
- the length of the lower OD section 3004 may be within the range of from about 3 cm to about 15 cm and in some embodiments is within the range of from about 5 cm to about 10 cm such as about 7 or 8 cm, and may be accomplished by providing the distal segments 3036 , 3038 with a lower wall thickness.
- a distal segment 3038 may have a length within the range of about 1-3 cm, and a durometer of less than about 35D or 30D.
- An adjacent proximal segment 3036 may have a length within the range of about 4-6 cm, and a durometer of less than about 35D or 30D.
- An adjacent proximal segment 3034 may have a length within the range of about 4-6 cm, and a durometer of about 35D or less.
- An adjacent proximal segment 3032 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35D to about 45D (e.g., 40D).
- An adjacent proximal segment 3030 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 50D to about 60D (e.g., about 55D).
- An adjacent proximal segment 3028 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35D to about 50D to about 60D (e.g., about 55D).
- An adjacent proximal segment 3026 may have a length within the range of about 1-3 cm, and a durometer of at least about 60D and typically less than about 75D. More proximal segments may have a durometer of at least about 65D or 70D.
- the distal most two or three segments may comprise a material such as Tecothane, and more proximal segments may comprise PEBAX or other catheter jacket materials known in the art.
- At least three or five or seven or nine or more discrete segments may be utilized, having a change in durometer between highest and lowest along the length of the catheter shaft of at least about 10D, preferably at least about 20D and in some implementations at least about 30D or 40D or more.
- the most distal portion of the catheter 3000 may comprise a durometer of less than approximately 35D (e.g., 25D) to form a highly flexible distal portion of the catheter and have a length between approximately 25 cm and approximately 35 cm. In other embodiments, the length may be between approximately 15 cm and approximately 25 cm.
- the distal portion may comprise one or more tubular segments of the same durometer (e.g., segment 3038 ) or of different durometers.
- one or more of the distal most segments may comprise a polyether-based thermoplastic polyurethane (e.g., Tecothane®). More proximal segments may comprise a polyether block amide (e.g., PEBAX®).
- a series of proximally adjacent tubular segments to the distal portion may form a transition region between a proximal stiffer portion of the catheter 3000 and the distal highly flexible portion of the catheter.
- the series of tubular segments forming the transition region may have the same or substantially similar lengths, such as approximately 1 cm.
- the relatively short length of the series of tubular segments may provide a steep drop in durometer over the transition region.
- the transition region may have a proximal tubular segment 3036 (proximally adjacent the distal portion) having a durometer of approximately 35D.
- An adjacent proximal segment 3034 may have a durometer of approximately 55D.
- An adjacent proximal segment 3032 may have a durometer of approximately 63D.
- An adjacent proximal segment 3030 may have a durometer of approximately 72D.
- One or more of the segments within the transition region may comprise a length between about 1 and 4 cm.
- the transition region may comprise a proximal segment 3036 approximately 4 cm and 35D, an adjacent segment 3034 approximately 3 cm and 37D, an adjacent segment 3032 approximately 1 cm and 47D, an adjacent segment 3030 approximately 1 cm and 55D, an adjacent segment 3028 approximately 1 cm and 63D, and an adjacent segment 3026 approximately 1 cm and 72D.
- the length of the distal portion of the catheter 3000 including the highly flexible distal portion and the transition region, may be between about 25-30 cm, between about 30-35 cm, between about 35 to 40 cm, or between about 40-45 cm.
- More proximal segments may comprise a durometer or durometers greater than approximately 72D and may extend to the proximal end of the catheter or extension catheter segment.
- an extension catheter segment may comprise a proximal portion greater than approximately 72D between about 1 cm and about 3 cm. In some embodiments, the proximal portion may be about 2 cm long.
- the most distal segments (e.g., 3038 - 3030 ) or at least the transition region may comprise PEBAX® and more proximal segments may comprise a generally stiffer material, such as Vestamid®.
- the inner diameter of the catheter 3000 or catheter extension segment may be between approximately 0.06 and 0.08 inches, between approximately 0.065 and 0.075 inches, or between 0.068 and 0.073 inches. In some embodiments, the inner diameter is approximately 0.071 inches.
- the distal most portion may taper to a decreased inner diameter as described elsewhere herein. The taper may occur approximately between the distal highly flexible portion and the transition region (e.g., over the most proximal portion of the distal highly flexible portion). The taper may be relatively gradual (e.g., occurring over approximately 10 or more cm) or may be relatively steep (e.g., occurring over less than approximately 5 cm). The inner diameter may taper to an inner diameter between about 0.03 and 0.06 inches.
- the inner diameter may be about 0.035 inches, about 0.045 inches, or about 0.055 inches at the distal end of the catheter 3000 . In some embodiments, the inner diameter may remain constant, at least over the catheter extension segment.
- the coil 3024 may extend from a distal end of the catheter 3000 along the highly flexible distal portion ending at the distal end of the transition region. In other embodiments, the coil 3024 may extend from a distal end of the catheter to the proximal end of the transition region, to a point along the transition region, or proximally beyond the transition region. In other embodiments, the coil 3024 may extend the entire length of the catheter 3000 or catheter extension segment as described elsewhere herein.
- the braid 3010 when present, may extend from the proximal end of the coil 3024 to the proximal end of the catheter 3000 or catheter extension segment.
- the catheters of the present invention may be composed of any of a variety of biologically compatible polymeric resins having suitable characteristics when formed into the tubular catheter body segments.
- Exemplary materials include polyvinyl chloride, polyethers, polyamides, polyethylenes, polyurethanes, copolymers thereof, and the like.
- both the proximal body segment 33 and distal body segment 34 will comprise a polyvinyl chloride (PVC), with the proximal body segment being formed from a relatively rigid PVC and the distal body segment being formed from a relatively flexible, supple PVC.
- PVC polyvinyl chloride
- the proximal body segment may be reinforced with a metal or polymeric braid or other conventional reinforcing layer.
- references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
- spatially relative terms such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under.
- the device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly.
- the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
- first and second may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
- a numeric value may have a value that is +/ ⁇ 0.1% of the stated value (or range of values), +/ ⁇ 1% of the stated value (or range of values), +/ ⁇ 2% of the stated value (or range of values), +/ ⁇ 5% of the stated value (or range of values), +/ ⁇ 10% of the stated value (or range of values), etc.
- Any numerical values given herein should also be understood to include about or approximately that value, unless the context indicates otherwise. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 16/503,899, filed on Jul. 5, 2019, and issued as U.S. Pat. No. 11,517,335 on Dec. 6, 2022, which claims the benefit of U.S. Provisional Application No. 62/694,796, filed Jul. 6, 2018, the entirety of each of these applications is hereby incorporated by reference herein.
- Stroke is the third most common cause of death in the United States and the most disabling neurologic disorder. Approximately 700,000 patients suffer from stroke annually. Stroke is a syndrome characterized by the acute onset of a neurological deficit that persists for at least 24 hours, reflecting focal involvement of the central nervous system, and is the result of a disturbance of the cerebral circulation. Its incidence increases with age. Risk factors for stroke include systolic or diastolic hypertension, hypercholesterolemia, cigarette smoking, heavy alcohol consumption, and oral contraceptive use.
- Hemorrhagic stroke accounts for 20% of the annual stroke population. Hemorrhagic stroke often occurs due to rupture of an aneurysm or arteriovenous malformation bleeding into the brain tissue, resulting in cerebral infarction. The remaining 80% of the stroke population are ischemic strokes and are caused by occluded vessels that deprive the brain of oxygen-carrying blood. Ischemic strokes are often caused by emboli or pieces of thrombotic tissue that have dislodged from other body sites or from the cerebral vessels themselves to occlude in the narrow cerebral arteries more distally. When a patient presents with neurological symptoms and signs which resolve completely within 1 hour, the term transient ischemic attack (TIA) is used. Etiologically, TIA and stroke share the same pathophysiologic mechanisms and thus represent a continuum based on persistence of symptoms and extent of ischemic insult.
- Emboli occasionally form around the valves of the heart or in the left atrial appendage during periods of irregular heart rhythm and then are dislodged and follow the blood flow into the distal regions of the body. Those emboli can pass to the brain and cause an embolic stroke. As will be discussed below, many such occlusions occur in the middle cerebral artery (MCA), although such is not the only site where emboli come to rest.
- When a patient presents with neurological deficit, a diagnostic hypothesis for the cause of stroke can be generated based on the patient's history, a review of stroke risk factors, and a neurologic examination. If an ischemic event is suspected, a clinician can tentatively assess whether the patient has a cardiogenic source of emboli, large artery extracranial or intracranial disease, small artery intraparenchymal disease, or a hematologic or other systemic disorder. A head CT scan is often performed to determine whether the patient has suffered an ischemic or hemorrhagic insult. Blood would be present on the CT scan in subarachnoid hemorrhage, intraparenchymal hematoma, or intraventricular hemorrhage.
- Traditionally, emergent management of acute ischemic stroke consisted mainly of general supportive care, e.g. hydration, monitoring neurological status, blood pressure control, and/or anti-platelet or anti-coagulation therapy. In 1996, the Food and Drug Administration approved the use of Genentech Inc.'s thrombolytic drug, tissue plasminogen activator (t-PA) or Activase®, for treating acute stroke. A randomized, double-blind trial, the National Institute of Neurological Disorders and t-PA Stroke Study, revealed a statistically significant improvement in stoke scale scores at 24 hours in the group of patients receiving intravenous t-PA within 3 hours of the onset of an ischemic stroke. Since the approval of t-PA, an emergency room physician could, for the first time, offer a stroke patient an effective treatment besides supportive care.
- However, treatment with systemic t-PA is associated with increased risk of intracerebral hemorrhage and other hemorrhagic complications. Patients treated with t-PA were more likely to sustain a symptomatic intracerebral hemorrhage during the first 36 hours of treatment. The frequency of symptomatic hemorrhage increases when t-PA is administered beyond 3 hours from the onset of a stroke. Besides the time constraint in using t-PA in acute ischemic stroke, other contraindications include the following: if the patient has had a previous stroke or serious head trauma in the preceding 3 months, if the patient has a systolic blood pressure above 185 mm Hg or diastolic blood pressure above 110 mmHg, if the patient requires aggressive treatment to reduce the blood pressure to the specified limits, if the patient is taking anticoagulants or has a propensity to hemorrhage, and/or if the patient has had a recent invasive surgical procedure. Therefore, only a small percentage of selected stroke patients are qualified to receive t-PA.
- Obstructive emboli have also been mechanically removed from various sites in the vasculature for years. Mechanical therapies have involved capturing and removing the clot, dissolving the clot, disrupting and suctioning the clot, and/or creating a flow channel through the clot. One of the first mechanical devices developed for stroke treatment is the MERCI Retriever System (Concentric Medical, Redwood City, Calif.). A balloon-tipped guide catheter is used to access the internal carotid artery (ICA) from the femoral artery. A microcatheter is placed through the guide catheter and used to deliver the coil-tipped retriever across the clot and is then pulled back to deploy the retriever around the clot. The microcatheter and retriever are then pulled back, with the goal of pulling the clot, into the balloon guide catheter while the balloon is inflated and a syringe is connected to the balloon guide catheter to aspirate the guide catheter during clot retrieval. This device has had initially positive results as compared to thrombolytic therapy alone.
- Other thrombectomy devices utilize expandable cages, baskets, or snares to capture and retrieve clot. Temporary stents, sometimes referred to as stentrievers or revascularization devices, are utilized to remove or retrieve clot as well as restore flow to the vessel. A series of devices using active laser or ultrasound energy to break up the clot have also been utilized. Other active energy devices have been used in conjunction with intra-arterial thrombolytic infusion to accelerate the dissolution of the thrombus. Many of these devices are used in conjunction with aspiration to aid in the removal of the clot and reduce the risk of emboli. Suctioning of the clot has also been used with single-lumen catheters and syringes or aspiration pumps, with or without adjunct disruption of the clot. Devices which apply powered fluid vortices in combination with suction have been utilized to improve the efficacy of this method of thrombectomy. Finally, balloons or stents have been used to create a patent lumen through the clot when clot removal or dissolution was not possible.
- Notwithstanding the foregoing, there remains a need for new devices and methods for treating vasculature occlusions in the body, including acute ischemic stroke and occlusive cerebrovascular disease.
- Disclosed herein is a sealed neurovascular extendable catheter having an outer catheter, an inner catheter, and an annular gap between an outer surface of the inner catheter and an inner surface of the outer catheter. The outer catheter has a proximal end and a distal end and the inner catheter has a proximal end and a distal end. The outer catheter is extendable through the outer catheter such that the distal end of the inner catheter is configured to extend beyond the distal end of the outer catheter. The extendable catheter also has a sealing feature positioned between the inner catheter and the outer catheter. The sealing feature is configured to fluidly seal at least a portion of a length of the annular gap. The sealing feature is configured to allow axial translation of the inner catheter relative to the outer catheter.
- The sealing feature may have at least one annular protrusion extending around a circumference of the inner catheter. The at least one protrusion may be compliant and may comprise an outer diameter slightly larger than an inner diameter of the outer catheter. The at least one protrusion may be a plurality of protrusions. The at least one protrusion may have a chevron-shape pointing in the distal direction and/or a chevron-shape pointing in the proximal direction. The protrusion may be a skirt-shaped protrusion configured to allow distal fluid flow but not proximal fluid flow through the sealing feature.
- The sealing feature may be an expandable bulge surrounding a circumference of the inner catheter. The expandable bulge may have a sealed configuration in which an outer diameter of the expandable bulge seals the annular gap and an unsealed configuration in which the outer diameter of the expandable bulge does not seal the annular gap. The expandable bulge may be mechanically expandable. The expandable bulge may be positioned at a proximal end of the inner catheter. A tension cable may be joined to the expandable bulge at or near a distal end of the expandable bulge and pulling the tension cable proximally may be configured to axially contract and radially expand the expandable bulge. The expandable bulge may be expandable in response to receiving an electric current and/or in response to stimulation by light. The expandable bulge may be a hydrogel. The expandable bulge may be inflatable. The inner catheter may have a proximal spine having a lumen. The lumen may be configured to transmit a stimulus to the expandable bulge for activating the expandable bulge and causing it to expand.
- The sealing feature may be an elastic flange positioned at a distal tip of the outer catheter. The elastic flange may have an inner diameter smaller than an outer diameter of the inner catheter.
- The sealing feature may be a hub having an expanded diameter. The hub may be positioned at a proximal end of the inner catheter and be configured to form an interference fit with an inner diameter of the outer catheter. The inner catheter may have a proximal spine having a lumen. The lumen may extend through the hub to form a fluid port through the sealing feature. A flushing solution may be delivered through the fluid port to the annular gap in a space distal to the sealing feature.
- The sealing feature may have a proximal sliding ring and a distal sliding ring surrounding the inner catheter. Each sliding ring may have an inner annulus configured to form a sliding interference fit around the inner catheter and an outer annulus configured to form a sliding interference fit with an inner diameter of the outer catheter. Each sliding ring may have a plurality of spokes joining the inner annulus and the outer annulus. The sealing feature may have one or more springs surrounding the inner catheter and joining the inner annulus of the proximal sliding ring to the inner annulus of the distal sliding ring and an elastic membrane configured to form a fluid barrier. The elastic membrane may be coupled to the one or more springs such that the fluid barrier circumferentially surrounds the inner catheter and extends from the proximal sliding ring to the distal sliding ring. The sealing feature may further have a ridge feature fixed to an outer surface of the inner catheter. The ridge feature may be positioned between the proximal sliding ring and the distal sliding ring and may be configured to catch and pull the proximal sliding ring in a proximal direction and to catch and pull the distal sliding ring in a distal direction. The one or more springs may force the elastic membrane into compression against an inner surface of the outer catheter to seal the annular gap in an unbiased configuration. Translating the inner catheter to pull one of the sliding rings in a proximal or distal direction may cause the pulled sliding ring to axially extend and radially compress the one or more springs. Radially compressing the one or more springs may cause the elastic membrane to be at least partially retracted from the inner surface of the outer catheter, breaking the fluid seal for a period while the inner catheter is in motion.
- The sealing feature may have a large diameter ring surrounding the inner catheter and a small diameter ring surrounding the inner catheter. The large diameter ring may have an inner annulus configured to receive the inner catheter, an outer annulus configured to form a sliding interference fit with an inner diameter of the outer catheter, and a plurality of spokes joining the inner annulus and the outer annulus. The small diameter ring may be positioned either proximally or distally of the large diameter ring and may form a sliding interference fit with an outer surface of the inner catheter. The small diameter ring may have one or more recesses configured to receive one or more key features extending axially along at least a portion of the inner catheter. The one or more recesses may be configured to rotate the small diameter ring with the inner catheter. The sealing feature may also have a torsion spring surrounding the inner catheter and joining the small diameter ring to the large diameter ring and an elastic membrane coupled to the torsion spring. The elastic membrane may be configured to form a fluid barrier circumferentially surrounding the inner catheter and extending from the large diameter ring to the small diameter ring. The torsion spring may force the elastic membrane into compression against an inner surface of the outer catheter to seal the annular gap in an unbiased configuration. Rotating the inner catheter to rotate the small diameter ring may cause the torsion spring to axially extend and radially compress such that elastic membrane is at least partially retracted from the inner surface of the outer catheter, breaking the fluid seal for a period while the inner catheter is in motion.
- In another aspect of the present disclosure, disclosed herein is a neurovascular catheter for sealing a blood vessel. The neurovascular catheter has an elongate body having a proximal end and a distal end and a sealing feature configured to fluidly seal an annular gap positioned between an outer surface of the elongate body and the blood vessel. The sealing feature has a compliant annular ring configured to be placed into compression with a wall of the blood vessel without damaging the blood vessel.
- The ring may comprise an elastomeric polymer. The ring may be a hydrogel. The hydrogel may be electrosensitive and configured to expand upon receiving an electric current and/or may be photosensitive and configured to expand upon receiving a light stimulus. The hydrogel may be configured to expand upon exposure the intravascular physiological environment. The ring may be inflatable. The outer surface of the elongate body may have a recess for receiving the ring. The ring may be detachable from the elongate body. The ring may be custom-formed to the size of the blood vessel. The neurovascular catheter may further include a replacement ring that is sized differently from the ring and interchangeable with the ring.
- Any feature, structure, or step disclosed herein can be replaced with or combined with any other feature, structure, or step disclosed herein, or omitted. Further, for purposes of summarizing the disclosure, certain aspects, advantages, and features of the embodiments have been described herein. It is to be understood that not necessarily any or all such advantages are achieved in accordance with any particular embodiment disclosed herein. No individual aspects of this disclosure are essential or indispensable. Further features and advantages of the embodiments will become apparent to those of skill in the art in view of the Detailed Description which follows when considered together with the attached drawings and claims.
-
FIG. 1 is a side elevational schematic view of an intracranial aspiration catheter in accordance with the present invention, with a distal segment in a proximally retracted configuration. -
FIG. 2 is a side elevational view as inFIG. 1 , with the distal segment in a distally extended configuration. -
FIGS. 3A-3B are cross-sectional elevational views of a distal end of catheter 10, with thedistal section 34 fully extended. -
FIG. 4 schematically illustrates a device comprising an inner catheter extendable through an outer catheter in which a protrusion serves as a sealing feature for sealing an annular gap between the inner catheter and the outer catheter. -
FIG. 5 schematically illustrates a device comprising a skirt shaped protrusion or flange for creating a one-way valve to seal the annular gap. -
FIG. 6 schematically illustrates an inner device comprising multiple protrusions. -
FIGS. 7A-7F schematically illustrate various examples of side views of slanted protrusions which extend at an angle along the axial length of the inner catheter. -
FIGS. 8A-8E schematically illustrate side views of two examples of inner catheters which comprise a chevron-shaped protrusion for sealing the device.FIG. 8A depicts an inner catheter comprising a substantially constant diameter.FIG. 8B depicts an inner catheter comprising a reduced distal diameter.FIGS. 8C-8E illustrate close-up side views of an example of chevron-shaped protrusions on the inner device. The view inFIG. 8D is approximately 90 degrees offset around the circumference of the inner device from the view inFIG. 8C .FIG. 8E is the same asFIG. 8C but also showing the orientation of the seal on the back side of the catheter. -
FIG. 9 schematically illustrates a device comprising a mechanically expandable bulge for sealing the annular gap. -
FIG. 10 schematically illustrates a device comprising a distal flange for sealing the annular gap. -
FIG. 11 schematically illustrates a device in which the inner catheter comprises a proximal hub for sealing the annular gap and in which a fluid port extends through the proximal hub. -
FIGS. 12A-12C schematically illustrate a device comprising a spring sealing feature in which axial translation of the inner catheter axially extends and radially contracts the spring sealing mechanism.FIG. 12A depicts the device in a sealed configuration.FIG. 12B depicts the device in an unsealed configuration.FIG. 12C depicts a sliding ring used in the spring sealing feature. -
FIGS. 13A-13C schematically illustrate a device comprising a spring sealing feature in which rotation of the inner catheter axially extends and radially contracts the spring sealing mechanism.FIG. 13A depicts the device in an unsealed configuration. -
FIG. 13B depicts a cross section of the inner catheter including a plurality of key features for rotating the torsion spring.FIG. 13C depicts a ring actuated by the key features to turn the torsion spring. -
FIG. 14 schematically illustrates a catheter device comprising a vessel sealing feature configured to fluidly seal the gap between the outer diameter of the catheter and the blood vessel or other body lumen the device is inserted within. -
FIG. 15 illustrates a cross-sectional elevational view of a catheter wall according to an embodiment. -
FIG. 16A illustrates a side elevational view of a progressively enhanced flexibility catheter according to an embodiment. -
FIG. 16B is a proximal end view of the enhanced flexibility catheter ofFIG. 34A . - Referring to
FIG. 1 , there is disclosed a catheter 10 in accordance with one aspect of the present invention. Although primarily described in the context of an axially extendable distal segment aspiration catheter with a single central lumen, catheters of the present invention can readily be modified to incorporate additional structures, such as permanent or removable column strength enhancing mandrels, two or more lumen such as to permit drug, contrast or irrigant infusion or to supply inflation media to an inflatable balloon carried by the catheter, or combinations of these features, as will be readily apparent to one of skill in the art in view of the disclosure herein. In addition, the present invention will be described primarily in the context of removing obstructive material from remote vasculature in the brain, but has applicability as an access catheter for delivery and removal of any of a variety of diagnostics or therapeutic devices with or without aspiration. - The catheters disclosed herein may readily be adapted for use throughout the body wherever it may be desirable to distally advance a low profile distal catheter segment from a larger diameter proximal segment. For example, axially extendable catheter shafts in accordance with the present invention may be dimensioned for use throughout the coronary and peripheral vasculature, the gastrointestinal tract, the urethra, ureters, Fallopian tubes and other lumens and potential lumens, as well. The telescoping structure of the present invention may also be used to provide minimally invasive percutaneous tissue access, such as for diagnostic or therapeutic access to a solid tissue target (e.g., breast or liver or brain biopsy or tissue excision), delivery of laparoscopic tools or access to bones such as the spine for delivery of screws, bone cement or other tools or implants.
- The catheter 10 generally comprises an elongate
tubular body 16 extending between aproximal end 12 and a distalfunctional end 14. The length of thetubular body 16 depends upon the desired application. For example, lengths in the area of from about 120 cm to about 140 cm or more are typical for use in femoral access percutaneous transluminal coronary applications. Intracranial or other applications may call for a different catheter shaft length depending upon the vascular access site, as will be understood in the art. - In the illustrated embodiment, the
tubular body 16 is divided into at least a fixedproximal section 33 and an axially extendable and retractabledistal section 34 separated at atransition 32.FIG. 2 is a side elevational view of the catheter 10 shown inFIG. 1 , with the distal segment in a distally extended configuration. - Referring to
FIGS. 3A and 3B , there is illustrated a cross-sectional view of thedistal segment 34 shown extended distally from theproximal segment 33 in accordance with the present invention.Distal segment 34 extends between a proximal end 36 and a distal end 38 and defines at least one elongate central lumen 40 extending axially therethrough. Distal end 38 may be provided with one or more movable side walls or jaws 39, which move laterally in the direction of an opposing side wall or jaw 41 under the influence of aspiration, to enable the distal end 38 to bite or break thrombus or other material into smaller particles, to facilitate aspiration through lumen 40. Both walls 39 and 41 may be movable towards and away from each other to break up thrombus as is discussed further below. - The inner diameter of the
distal section 34 may be between about 0.030 inches and about 0.112 inches, between about 0.040 inches and about 0.102 inches, between about 0.045 inches and about 0.097 inches, between about 0.050 inches and about 0.092 inches, between about 0.055 inches and about 0.087 inches, between about 0.060 inches and about 0.082 inches, between about 0.062 inches and about 0.080 inches, between about 0.064 inches and about 0.078 inches, between about 0.066 inches and about 0.076 inches, between about 0.068 inches and about 0.074 inches, or between about 0.070 inches and about 0.072 inches. - The inner diameter and the outer diameter of the
distal section 34 may be constant or substantially constant along its longitudinal length. The inner diameter may be at least about 0.06 inches, 0.065 inches, 0.07 inches, 0.075 inches, 0.08 inches, or more than 0.08 inches. The outer diameter may be at least about 0.07 inches, 0.075 inches, 0.08 inches, 0.085 inches, 0.09 inches, 0.095 inches, 0.1 inches, or more than 0.1 inches. The total thickness of the sidewall extending between the inner and outer diameter may be at least about 0.005 inches, 0.010 inches, 0.015 inches, 0.02 inches, 0.025 inches, or more than 0.025 inches. For example, the distal section may 34 may have an inner diameter of about 0.071 inches and an outer diameter of about 0.083 inches. Alternatively, thedistal section 34 may be tapered near its distal end. A larger lumen (internal diameter) may increase the applied aspiration force through the distal end of thedistal section 34. A smaller outer diameter may provide better catheter trackability and/or may better enable the catheter to reach more distal anatomy (e.g. neuroanatomy), as the tapered distal end may be better accommodated in smaller blood vessels. The inner and outer diameters of thedistal section 34 may be correlated in order to maintain a sufficient sidewall thickness that provides sufficient structural integrity to the catheter. Thedistal section 34 may be tapered at less than or equal to about 5 cm, about 10 cm, about 15 cm, about 20 cm, about 23 cm, about 25 cm, about 30 cm, about 31 cm, about 35 cm, about 40 cm, about 45 cm, about 50 cm, about 60 cm, or about 70 cm from its distal end. In some embodiments, the taper may be positioned between about 25 cm and about 35 cm from the distal end of thedistal section 34. In some embodiments, the taper may be positioned between about 15 cm and about 25 cm from the distal end of thedistal section 34. - The inner diameter of the
distal section 34 may be tapered or decreased in the distal direction near the distal end to an internal diameter that is less than or equal to about 95%, about 90%, about 85%, about 80%, about 75%, about 70%, about 65%, about 60%, about 55%, or about 50% of the adjacent, untapered internal diameter. In some embodiments, the internal diameter of the tapereddistal section 34 may be between about 50% and about 70% of the adjacent, untapered internal diameter. For example, the untapered internal diameter at the proximal end of thedistal section 34 may be about 0.071 inches and the tapered internal diameter at the distal end of thedistal section 34 may be about 0.035 inches, 0.045 inches, or 0.055 inches. The inner diameter of thedistal section 34 may be tapered or increased near the distal end by greater than or equal to about 102%, 104%, 106%, 108%, or more of the internal diameter just proximal to a transition into the taper. The tapered inner diameter of thedistal section 34 may be less than or equal to about 0.11 inches, about 0.1 inches, about 0.090 inches, about 0.080 inches, about 0.070 inches, about 0.065 inches, about 0.060 inches, about 0.055 inches, about 0.050 inches, about 0.045 inches, about 0.040 inches, about 0.035 inches, about 0.030 inches, about 0.025 inches, about 0.020 inches, about 0.015 inches, or about 0.010 inches. The taper in the outer diameter of the tapered portion of thedistal section 34 may be matched to maintain a constant thickness of the sidewall. Alternatively, the sidewall may be thinner along the tapered portion. For instance, the sidewall may be no greater than 95%, 90%, 85%, 80%, 75%, 70%, or less than 70% of the thickness of the sidewall along the proximal portion of thedistal section 34. In some embodiments, the length of the distal tapered portion of thedistal section 34 may be between about 25 cm and about 35 cm, between about 25 cm and about 30 cm, between about 30 cm and 35 cm, or approximately 30 cm. - In some embodiments, the
proximal segment 33 may have an inner diameter of at least about 0.07 inches, 0.075 inches, 0.08 inches, 0.085 inches, 0.09 inches, 0.1 inches, 0.105 inches, or more than 0.105 inches. Theproximal segment 33 may have an outer diameter of at least about 0.08 inches, 0.085 inches, 0.09 inches, 0.095 inches, 0.01 inches, 0.105 inches, 0.11 inches, 0.0115 inches, 0.012 inches, or more than 0.012 inches. For example, the inner diameter may be approximately 0.088 inches and the outer diameter may be approximately 0.106 inches. The sidewall of theproximal segment 33 may have a thickness of at least about 0.005 inches, 0.01 inches, 0.015 inches, 0.02 inches, 0.025 inches, or more than 0.25 inches. In some embodiments, theproximal segment 33 has a constant inner and/or outer diameter along its length. In some embodiments, theproximal segment 33 may slightly taper or decrease in diameter along the distal direction. For example, in some embodiments, the outer diameter of theproximal segment 33 may be about 0.106 inches at the distal end and about 0.108 inches at the proximal end. - The length of the
proximal segment 33 may be at least about 90 cm, 95 cm, 100 cm, 105 cm, 110 cm, 115 cm, 120 cm, 125 cm, 130 cm, 135 cm, or more than 135 cm. For example, in one embodiment the length is approximately 106 cm. In another embodiment, the length is approximately 117 cm. In some neurovascular applications, the distal end of theproximal segment 33 may extend at least to the Horizontal Petrous segment of the vasculature. - In some embodiments, the length of the
distal section 34 may be between about 13 cm and about 53 cm, between about 18 cm and about 48 cm, between about 23 cm and about 43 cm, between about 28 cm and about 38 cm, between about 20 cm and 30 cm, or between about 25 cm and 30 cm. The length of thedistal section 34 may be less than or equal to about 20 cm, about 25 cm, about 30 cm, about 33 cm, about 35 cm, about 40 cm, about 41 cm, about 45 cm, about 50 cm, about 55 cm, about 60 cm, about 70 cm, or about 80 cm. The length of thedistal section 34 may depend on the degree of tapering of the internal diameter of thedistal section 34. - The proximal end 36 of
distal section 34 is provided with a proximally extending pull wire 42. Pull wire 42 extends proximally throughout the length of thetubular body 16, to control 24 which may be carried bymanifold 18. Axial movement ofcontrol 24 produces a corresponding axial movement ofdistal section 34 with respect toproximal section 33 as has been discussed. Alternatively, the proximal end of pull wire 42 may exit through a port onmanifold 18, such that it may be manually grasped and pulled or pushed by the clinician to extend or retract thedistal section 34. The length of the pull wire 42 may be between about 700 mm and about 1556 mm, between about 800 mm and about 1456 mm, between about 850 mm and about 1406 mm, between about 900 mm and about 1356 mm, between about 950 mm and about 1306 mm, between about 1000 mm and about 1256 mm, between about 1020 mm and about 1236 mm, between about 1040 mm and about 1216 mm, between about 1060 mm and about 1196 mm, between about 1080 mm and about 1176 mm, between about 1100 mm and about 1156 mm, between about 1110 mm and about 1146 mm, or between about 1120 mm and about 1136 mm. In some preferred embodiments, the length of the pull wire 42 may be between approximately 110-120 cm. - Upon distal advance of pull wire 42 to its limit of travel, an overlap 44 remains between the proximal end 36 of
distal section 34 and theproximal section 33. This overlap 44 is configured to provide a seal to enable efficient transmission of vacuum fromproximal section 33 todistal section 34. In some embodiments, the length of the pull wire 42 may be limited to ensure that there is a minimal overlap 44 between theproximal segment 33 and thedistal segment 34 when the pull wire 42 is fully inserted into theproximal segment 33 or attached manifold in a distal direction. In some embodiments, the length of theproximal segment 33 may be sufficiently long for neurovascular applications such that when the proximal segment is positioned in a relatively proximal position (e.g., the horizontal petrous segment), the neuroanatomy effectively limits the distance by which thedistal segment 34 may be extended, ensuring a sufficient overlap 44. For example, thedistal segment 34 may not be able to extend further than the M2 segment of the middle cerebral artery (MCA) given its dimensions. Overlap 44 may be provided with any of a variety of additional features to facilitate a seal, such as a gasket, coating or tightly toleranced sliding fit, as described elsewhere herein. In some embodiments, the proximal end of thedistal segment 34 may be slightly expanded to create a seal. For instance, the outer diameter of the proximal end of thedistal segment 34 and the inner diameter of theproximal segment 33 may both be about 0.088 inches. Preferably the clearance between the OD of thedistal section 34 and ID of theproximal section 33, at least in the vicinity oftransition 32, will be no more than about 0.005 inches and preferably no more than about 0.003 inches to provide an effective seal in a blood environment. A larger clearance may be more feasible in embodiments comprising a sealing feature as described elsewhere herein. - Following positioning of the distal end of
proximal section 33 within the vasculature, such as within the cervical carotid artery, thecontrol 24 is manipulated to distally advancedistal section 34 deeper into the vasculature. For this purpose, the pull wire 42 will be provided with sufficient column strength to enable distal advance of the distal tip 38 as will be discussed below. - The pull wire 42 and
distal section 34 may be integrated into a catheter as illustrated inFIGS. 1 and 2 . Alternatively,distal section 34 and pull wire 42 may be configured as a stand-alone catheter extension device as is discussed in greater detail below. The catheter extension device may be introduced into the proximal end ofproximal section 33 after placement ofproximal section 33 and advanced distally there through as illustrated inFIG. 3A , to telescopically extend the reach of the aspiration system. - Referring to
FIG. 3B , the pull wire 42 may comprise a tubular wall having an axially extendingcentral lumen 45. Thecentral lumen 45 permits introduction of media such as lubricants, drugs, contrast agents or others into thedistal section 34. In addition, thecentral lumen 45 extending through pull wire 42 permits introduction of an agitator as is discussed in greater detail below. As shown inFIG. 3B , thecentral lumen 45 may open into the lumen 40. The distal opening of thecentral lumen 45 may be positioned at a point along the length of thedistal section 34 such that thecentral lumen 45 terminates where the lumen 40 begins (the distal opening ofcentral lumen 45 may be longitudinally aligned with the proximal opening of lumen 40). The proximal opening of lumen 40 may be angled or slanted as shown inFIG. 3B . In some embodiments, the opening of lumen 40 may be flat. The distal opening ofcentral lumen 45 may be flat as shown inFIG. 3B . In some embodiments, the opening may be angled or slanted, similar to the opening of lumen 40 inFIG. 3B . - In some embodiments, the
central lumen 45 may terminate proximal to the opening of the lumen 40. In some embodiments, thecentral lumen 45 may terminate distal to the opening of the lumen 40 and/or the proximal end of the distal section 34 (e.g., at a point within the lumen 40). For example, thecentral lumen 45 may terminate at the distal end of the distal section or just short of the distal end (e.g., no more than approximately 1 cm from the distal end). In some implementations, the portion of the pull wire 42, with or without acentral lumen 45, which extends beyond the proximal end of the distal section 34 (e.g., into lumen 40) may decrease in stiffness (durometer) in a distal direction. The pull wire 42 may be relatively stiff along the portion proximal to the proximal end of thedistal section 34 in order to provide sufficient pushability of the extension catheter. The stiffness of the portion of the pull wire 42 distal of the proximal end of thedistal section 34 may substantially match or be less than the stiffness of thedistal section 34 along the length of thedistal section 34. The portion of the pull wire 42 distal of the proximal end of thedistal section 34 may have a uniform stiffness less than the stiffness of the portion proximal of the proximal end of thedistal section 34 or it may have a gradated or gradually decreasing stiffness in the distal direction, decreasing from the stiffness of the portion proximal of the proximal end of thedistal section 34. For example, the pull wire 42 may comprise metal along the portion proximal to the proximal end of thedistal section 34 and may comprise a polymer, softer than the metal, along the portion distal to the proximal end of thedistal section 34. The portion distal to the proximal end, in some embodiments, may be extruded with decreasing stiffness in the distal direction. - Disclosed herein are various embodiments for sealing an annular gap between an
inner device 3402, such as a tube or catheter, and anouter device 3404, such as a tube or catheter. Theinner device 3402 may be the axially translatabledistal section 34 of thetubular body 16 of catheter 10 and theouter device 3404 may be the fixedproximal section 33 of thetubular body 16 of catheter 10. Theinner device 3402 and theouter device 3404 may form a sealedextendable catheter device 3400. Thedevice 3400 may be sealed within an area of overlap, such as the overlap 44 between theproximal section 33 and thedistal section 34 by a sealing feature ormechanism 3406. SeeFIG. 3B - Providing a
sealing feature 3406 between theproximal section 33 and thedistal section 34 may advantageously provide a seal, and eliminate or reduce the volume of space and/or surface area of device that can act as a stagnation zone for blood that is drawn into the annular gap, which may help reduce or mitigate thrombogenesis. SeeFIG. 4 . Mitigating the opportunity for thrombogenesis to occur may help prevent formation of emboli resulting from the intravascular treatment. It is to be understood that sealing features 3406 disclosed herein may just as suitably apply to an extendable device in which theinner device 3402 is fixed and theouter device 3404 is extendable/retractable relative to theinner device 3402. - In some embodiments, the
sealing feature 3406 may be aprotrusion 3408 extending from either the outer surface of the inner device 3402 (e.g., an expanded diameter section) or the inner surface of the outer device 3404 (e.g., a reduced diameter section). Theprotrusion 3408 may form a ring or ring-like annular feature around the outer surface of theinner device 3402 or the inner surface of theouter device 3404. As used herein, “annular” merely requires that the sealing feature extend all the way or substantially all the way around the inner device, sufficient to achieve the sealing function. However it does not require that the seal reside within a single transverse plane as shown inFIG. 4 . Annular rings may also reside on a plane that is angled other than 90° from the longitudinal axis, such as for example shown inFIGS. 7 and 8 . - The
protrusion 3408 may operate by forming a close or slight interference sliding fit with the opposing device (the outer diameter of theinner device 3402 or the inner diameter of the outer device 3404).FIG. 4 schematically illustrates a cross section of adevice 3400, which may comprise the same or similar features as device 10 described elsewhere herein, comprising asingle protrusion 3408 extending from theinner device 3402. Theprotrusion 3408 may comprise an outer diameter substantially equal to the inner diameter of theouter device 3404. Theprotrusion 3408 may comprise an outer diameter slightly larger than the inner diameter of theouter device 3404 but be compliant enough such that theouter device 3404 radially compresses theprotrusion 3408 in order to accommodate theprotrusion 3408 forming a sliding fluid seal in the process. - As shown in
FIG. 4 , theprotrusion 3408 prevents or inhibits blood flow which may enter the annular gap between theinner device 3402 and theouter device 3404 from flowing proximally past theprotrusion 3408. In some implementations, the annular gap may be flushed with a solution in the volume proximal to theprotrusion 3408. The solution may be saline. The solution may contain heparin and/or another anticoagulant which helps reduce the risk of thrombogenesis. The flushing solution may be particularly beneficial for washing the surfaces of theinner device 3402 and/orouter device 3404 along a length that was previously exposed to blood flow when theinner device 3402 andprotrusion 3408 were in a retracted position, once the device is in a relatively extended position such that theprotrusion 3408 is now positioned distally of that length of theouter device 3404. If theinner device 3402 is subsequently retracted again such that theprotrusion 3408 is now positioned proximally to that previously exposed length of device, the flushing solution, particularly one comprising an anticoagulant, will reduce the risk that any thrombus, or activated coagulation factors, will be re-exposed to the blood stream. - In some embodiments, the
protrusion 3408 may prevent the flushing solution from flowing distally beyond the protrusion 3408 (distal or antegrade flow). In some embodiments, theprotrusion 3408 may act as a one-way valve allowing distal flow but not fluid flow proximally past the protrusion 3408 (proximal or retrograde flow). Theprotrusion 3408 may be shaped or otherwise constructed to more easily bend in a distal direction than in a proximal direction to achieve a one-way valve effect. In some embodiments, theprotrusion 3408 may be configured to allow distal fluid flow only upon surpassing a threshold fluid pressure. A flushing fluid could be continually maintained proximal theprotrusion 3408 and forced to flow past theprotrusion 3408 on demand by increasing the fluid pressure, such as with a syringe or other control at a proximal end of thedevice 3400. The flushing fluid may be provided through a separate tube or lumen which is configured to extend into the annular gap. - The flushing fluid may be provided at times when aspiration is not provided through the catheter 10 or the flushing fluid may be provided contemporaneously with aspiration. The flushing fluid may flush the portion of the gap proximal to the
protrusion 3408 and be aspirated via the aspiration provided through the catheter 10. In some implementations, the pressure of the flushing fluid may be sufficient to overpower the suction pressure, at least transiently, and force the one-way fluid seal open to distal flow to flush the portion of the annular gap distal to theprotrusion 3408. In some embodiments, flushing fluid may be provided through the entire catheter 10 so as to flush through theinner device 3402, theouter device 3404, and the annular gap between the inner device and outer device, at times when aspiration is not provided through the catheter. -
FIG. 5 schematically illustrates adevice 3400 comprising a skirt-shapedprotrusion 3408. The skirt-shapedprotrusion 3408 may comprise an annularconical flap 3409 which extends radially outward from theinner device 3402 and distally. Theflap 3409 may be compliant enough to deform in a distal direction under the pressure of the flushing solution, bending toward the axis of theinner device 3402, in order to allow distal fluid flow. Theflap 3409 may be forced under pressure from the proximal blood flow and/or aspiration to deform or extend in a more radial direction, normal to the longitudinal axis of theinner device 3402, so as to form a tighter seal with theouter device 3404. In some embodiments, theannular protrusion 3408 may comprise a non-uniform stiffness around the circumference of theprotrusion 3408. For instance, certain segments of the circumference may be softer or more compliant than othersegments forming flaps 3409 or one-way valves while other portions of the circumference may be sufficiently rigid such that neither distal nor proximal fluid flow is permitted. - The
protrusion 3408 may be the same material or a different material as the portion of the device (e.g., tubular body 16) from which it extends. In some embodiments, theprotrusion 3408 may comprise polyether block amide (e.g., PEBAX®), polyethylene, polyurethane, Tecothane®, nylon, etc. In some embodiments, theprotrusion 3408 may be formed from a softer material than theinner device 3402, or at least an outer layer (e.g., an outer jacket) of theinner device 3402. In some embodiments, theprotrusion 3408 may be formed from a softer material than theouter device 3404 or at least an inner layer (e.g., an inner liner) of theouter device 3404. For example, theprotrusion 3408 may be formed as part of an outer jacket of theinner device 3402. In some embodiments, theprotrusion 3408 may be coextruded with the outer jacket. - In some embodiments, the protrusion may be adhered to the outer jacket, such as with a biocompatible adhesive, melted onto the outer jacket, molded onto the outer jacket, or otherwise adhered to the outer diameter of the
inner device 3402. In some embodiments, theprotrusion 3408 may be formed by a discrete tubular segment of the outer jacket having a larger outer diameter than two adjacent segments of the outer jacket which theprotrusion 3408 is positioned between. In some embodiments, theprotrusion 3408 may be formed as an expanded diameter portion of a tubular segment of the outer jacket. In some embodiments, theprotrusion 3408 may be solid throughout. In some embodiments, theprotrusion 3408 may be at least partially hollow, which may increase the flexibility of theprotrusion 3408. - The
protrusion 3408 may have a cross-section along its circumferential axis (around the outer diameter of the outer device 3404) of any suitable shape. For example, the cross-section may be rectangular, square, rounded, triangular, etc. The cross-section may be symmetric or asymmetric about a proximal-to-distal midline. Theprotrusion 3408 may comprise a proximal surface and a distal surface. In some embodiments, the distal surface may be convex, concave, and/or substantially flat. In some embodiments, the proximal surface may be convex, concave, and/or substantially flat. - The proximal surface and distal surface may have different degrees of stiffness or flexibility. For example, the proximal surface may more easily bend to produce a one-way valve effect as described elsewhere herein. The
protrusion 3408 may be shaped with a hinge feature (e.g., a divot in the distal surface) that allows fluid flow in the distal direction but not the proximal direction. Thinner portions of the cross section may be more flexible than thicker portions of the cross-section. In some embodiments, the cross-section may thin-out towards the outer diameter of theprotrusion 3408 to facilitate bending of theprotrusion 3408 near the point of contact with theouter device 3404 and axial translation of the sealingprotrusion 3408 along the inner surface of theouter device 3404. - In some embodiments, the
protrusion 3408 orother sealing feature 3406, as described elsewhere herein, may be positioned on an inner surface of theouter device 3404. Theprotrusion 3408 may be fabricated in the same or similar manner (e.g., from the inner liner of the outer device 3404). In some embodiments, both theinner device 3402 and theouter device 3402 may compriseprotrusions 3408 orother sealing feature 3406. Aprotrusion 3408 on theouter device 3404 may be positioned to be proximal to, distal to, or axially aligned with aprotrusion 3408 on theinner device 3402 when theextendable device 3400 is in a fully extended position or when theextendable device 3400 is in a fully retracted position. Aprotrusion 3408 on theinner device 3402 may be configured to axially cross over aprotrusion 3408 on theouter device 3404 as theinner device 3402 is axially translated relative to the fixedouter device 3404, or theinner device 3402 andouter device 3404 may be configured such that theprotrusions 3408 remain in their respective proximal/distal spatial relationships. In some embodiments,protrusions 3408 on theinner device 3402 and theouter device 3404 may be configured to serve as stops that abut one another and limit axial translation of theinner device 3402 with respect to theouter device 3404 in a distal and/or proximal direction. - The
inner device 3402 may contain one or more protrusions 3408 (e.g., 1, 2, 3, 4, 5, etc.) and/or theouter device 3404 may contain one or more protrusions 3408 (e.g., 1, 2, 3, 4, 5, etc.).FIG. 6 schematically depicts aninner device 3402 having multiple axially spacedprotrusions 3408 or multiple revolutions of one or two or more helical protrusions spiraling or positioned along a proximal end of theinner device 3402. Indevices 3400 in which theinner device 3402 and theouter device 3404 compriseprotrusions 3408 and at least one of the inner orouter devices multiple protrusions 3408, theprotrusion 3408 may be arranged in any combination of the spatial relationships described elsewhere herein. For example, theinner device 3402 may comprise aprotrusion 3408 surrounded on its proximal and distal sides byprotrusions 3408 on theouter device 3404 or vice-versa. Theinner device 3402 may comprise aprotrusion 3408 and theouter device 3404 may comprisemultiple protrusions 3408 positioned proximally and/or distally of theprotrusion 3408 on the inner device or vice-versa. Some or all of theprotrusions 3408 on theinner device 3402 may be positioned to be axially translatable over some or all of theprotrusions 3408 on theouter device 3408 or vice-versa. - In some embodiments, one or
more protrusions 3408 on theinner device 3402 may be configured to extend distally beyond the distal end of theouter device 3404, such as in a fully extended configuration. In some embodiments, one ormore protrusions 3408 on theinner device 3402 may be configured not to extend distally beyond the distal end of theouter device 3404 such that they remain within the annular gap, such as in a fully extended configuration. In some embodiments, one ormore protrusions 3408 on theouter device 3404 may be configured to extend proximally beyond the proximal end of theinner device 3402, such as in a fully extended configuration. In some embodiments, one ormore protrusions 3408 on theouter device 3404 may be configured not to extend proximally beyond the proximal end of theinner device 3402, such as in a fully extended configuration. - In some embodiments, the
protrusion 3408 may be uniformly distributed around the circumference of theinner device 3402 orouter device 3404 at a given axial position along the length of theinner device 3402 orouter device 3404, forming a simple ring defining a transverse plane that is 90° from the longitudinal axis of the catheter. In other embodiments, theprotrusion 3408 may incline in an axial direction as it circumnavigates the outer circumference of theinner device 3402 or the inner circumference of theouter device 3404. For example, theprotrusion 3408 may shaped as an annular circle (90° to the longitudinal axis), oval (inclined at an angle other than 90°), diamond, or other suitable shape that is slanted along the axial direction such that theprotrusion 3408 forms a proximal tip 3408 a and/or adistal tip 3408 b. -
FIGS. 7A-7F schematically illustrate side views of various configurations of inclined orangled protrusions 3408. In some embodiments, the slantedprotrusion 3408 may form a rounded proximal and/or distal edge as shown inFIG. 7A , showing a proximal tip 3408 a.FIG. 7B , showing adistal tip 3408 b rotationally offset from the proximal tip 3408 a. - In some embodiments, the slanted protrusion may form a pointed tip as shown in
FIG. 7C , showing the proximal tip 3408 a, and 7D, showing thedistal tip 3408 b, in which the tips comprise a chevron-shaped profile. The views inFIGS. 7A and 7C may be substantially rotationally opposite the views inFIGS. 7B and 7D , respectively, such that the proximal tip 3408 a and thedistal tip 3408 b are positioned on substantially opposite sides of theinner device 3402.FIGS. 7E and 7F show examples of side views which may be approximately 90 degrees offset from the views inFIGS. 7A-7D . -
Protrusions 3408 may comprise any combination of the views and shapes depicted as well as other shapes. For example, in some embodiments, theprotrusion 3408 may comprise a rounded proximal tip 3408 a and a pointeddistal tip 3408 b or vice versa. In some embodiments, the protrusion may comprise a proximal tip 3408 a but no defineddistal tip 3408 b (e.g., the protrusion is distributed evenly around at least a portion of the circumference at its distal end) or vice versa. The configuration of the slantedprotrusions 3408, particularly the chevron-shaped profiles, may reduce the force required to axially translate theinner device 3402 relative to theouter device 3404, while maintaining a sealed space. -
FIGS. 8A and 8B schematically illustrate two examples of a spined catheterinner device 3402, similar to those described elsewhere herein, in which a proximal end of the catheter extension tube portion of thedevice 3402 comprises a chevron-shapedprotrusion 3408. Thetubular body 3400 inFIG. 8A comprises a constant internal diameter, which may be approximately 0.71 inches. Thedevice 3400 inFIG. 8B comprises an expanded diameter portion at the proximal end, which may have an internal diameter of about 0.71 inches, and transitions to a reduced diameter portion near the distal diameter, which may have an inner diameter of approximately, 0.35 inches, 0.45 inches, 0.55 inches, or any diameter in a range defined there between.FIGS. 8C-8E illustrate close-up views of an example of chevron-shapedprotrusions 3408 on theinner device 3402. The view inFIG. 8D is approximately 90 degrees offset around the circumference of theinner device 3402 from the view inFIG. 8C .FIG. 8E is a view likeFIG. 8C , but also showing the orientation of the protrusion on the back side of the catheter. - As shown in
FIG. 8D , theprotrusion 3408 may comprise dimensions including awidth 3407 a in an axial direction and an angle θ defined relative to the longitudinal axis of the innertubular body 3402. In some embodiments, thewidth 3407 a of theprotrusion 3408 may be substantially constant around the circumference of theinner device 3402. For example, thewidth 3407 a may be between approximately 0.01 and 0.3 inches, 0.02 and 0.2 inches, 0.03 and 0.1 inches, 0.035 and 0.08 inches, 0.04 and 0.06 inches, or 0.045 and 0.055 inches. In some embodiments, thewidth 3407 a may be larger at and/or near the proximal trailing tip 3408 a and/or the distalleading tip 3408 b of theprotrusion 3408, as shown inFIG. 8C . For example, thewidth 3407 a at these points may be approximately 1.5×, 1.75×, 2×, 2.25×, 2.5×, 2.75×, 3×, 3.25×, 3.5×, 3.75×, 4×, 4.25×, 4.5×, 4.75×, or 5× larger than the width 3407 b at a point where it is the smallest (e.g., halfway between the proximal point 3408 a and thedistal point 3408 b). - For instance, in some embodiments, the
width 3407 a near the proximal point 3408 a and/or thedistal point 3408 b may be between approximately 0.05 and 0.3 inches, 0.1 and 0.2 inches, or 0.11 and 0.13 inches. Thewidth 3407 a may vary in a continuous pattern across the circumference of theinner device 3402. - In some embodiments, the angle θ may be defined via a straight line connecting the proximal tip 3408 a to a
point 3452 on the proximal edge opposite thedistal tip 3408 b or connecting thedistal tip 3408 b to apoint 3452 on the distal edge opposite the proximal tip 3408 a, which in the illustrated embodiment lies on aproximal edge 3409 of the inclined seal. In some embodiments, the angle θ may be defined by a best fit straight line along the proximal and/or distal edge of the protrusion, in the case of nonlinear edges. The other examples ofprotrusions 3408 disclosed herein may have the same or similar dimensions. - In some embodiments, the trailing and/or leading edge of the
protrusion 3408 may form an angle θ relative to the longitudinal axis that is no larger than about 10 degrees, 15 degrees, 20 degrees, 25 degrees, 30 degrees, 35 degrees, 40 degrees, 45 degrees, 50 degrees, 55 degrees, or 60 degrees. In some embodiments, the angle θ may be between about 15 and 45 degrees, 20 and 40 degrees, 20 and 30 degrees, or 30 and 40 degrees.Protrusions 3408 having a lower angle θ may facilitate sliding of theinner device 3402 within theouter device 3404 in an axial direction. - The illustrated
protrusion 3408 is in the form of an inclined annular seal having adistal edge 3450 on the opposite axial end of the seal fromproximal edge 3409. Thedistal edge 3450 may reside on a plane that is substantially parallel to theproximal edge 3409 in an embodiment having aconstant thickness 3407 a, both of which are non perpendicular to the longitudinal axis of the catheter. - The inclined
distal edge 3450 has a first, distal transition or limit atleading point 3408 b and a second,proximal limit 3452 which is axially proximally offset from the first distal limit by at least about 2 mm; at least about 3 mm or 4 mm or more. - The inclined
proximal edge 3409 extends between adistal limit 3454 and a proximal limit 3408 a. As a result of the axial offset andwidth 3407 a of theprotrusion 3408, awindow 3456 may be formed between thedistal limit 3454 andproximal limit 3452 of the opposing edges of the seal depending upon the incline angle of the seal. SeeFIG. 8E . A distal slidingsurface 3458 is thus axially offset from a proximal slidingsurface 3460 by an amount that corresponds to the axial length of thewindow 3456. In the illustrated embodiment, thewindow 3456 has a major axis extending in the catheter longitudinal axis direction. At any point within the window, a line can be drawn transverse through the catheter without intersecting theprotrusion 3408. - The
window 3456 may have a major axis within the range of from about negative 0.5 mm (slight axial overlap of the distal slidingsurface 3458 and proximal sliding surface 3460) to about 4 mm, and in some implementations at least about 1 mm or 2 mm and in some cases within the range of from about 2 mm to about 3 mm. The major axis of thewindow 3456 is about 2.6 mm in one implementation having aseal width 3407 a of about 2 mm and a catheter OD of about 0.086 inches. - An end view of the
distal edge 3450 and orproximal edge 3409 taken along a viewing axis that is perpendicular to the plane of the respective edge can define an ellipse. In one implementation, the ellipse dimensions are 0.086″ in the minor axis direction, which is equal to the OD of the catheter. The ellipse is about 0.2057″ in the major axis direction, about 2 to 2.5 times the catheter diameter. This means the seal inclines at about 30 degrees to the long axis of the catheter. At an incline of about 15 degrees the long axis increases to almost 4 times the catheter diameter. This is rather steep and may be a reasonable limit. At the other extreme a 75 degree angled seal (almost straight across) would not have sufficient axial offset of the opposing sliding surfaces, (desirable to minimize drag) if the seal width was 25% or less of the catheter diameter. This would be an ellipse ratio of only about 1.03. As the seal gets wider, the minimum ratio would climb with the angle dropping off. Thus, ellipse major axis dimensions within the range of from about 1.25 to about 4 times the minor axis dimension will typically be used, often within the range of from about 1.5 to about 3× the minor axis dimension. - Preferably, the trailing edge 3454 (inside the ellipse) of the seal on one side should overlap minimally, or ideally not at all with the leading edge 3452 (inside of the ellipse) of the seal on the opposite side.
- As a consequence of the angled nature of the annular seal, the overall length in the catheter axial direction from
distal tip 3408 b to proximal tip 3408 a will often be at least about 1.5 times or two times thewidth 3407 a. In some implementations, the overall tip to tip length may be at least about 2.5 times or 3 times thewidth 3407 a. Multiples within the range of from about 1.5 times and about 5 times, or from about 2 times and about 3.5 times may be utilized depending upon desired performance. In one implementation having awidth 3407 a of about 2 mm and a catheter OD of about 0.086 inches, the overall axial length from tip to tip is between about 4 mm and about 8 mm, between about 6 mm and about 7 mm and optionally about 6.7 mm. - The overall length may be elongated further by introducing an axial extension segment on each side of the catheter such as at about the midpoint between proximal tip 3408 a and
distal tip 3408 b. In this implementation thedistal edge 3450 for example would not appear as it does in side elevational view (FIG. 8D ) to be a linear edge between 3408 a and 3408 b. Instead, a distally facing segment extending proximally frompoint 3408 b and a distally facing segment extending distally from point 3408 a would be separated by a central segment facing a different angle such as laterally in the case of an axially extending central extension segment. - The chevron configured seal allows for effective sealing inside another tube by not requiring the other (outer) tube to have a friction fit around a full 360 degrees at the same axial location transverse plane. The contact points of the chevron allow the inner and outer tubes to be inclined slightly to each other to relieve the friction of the sealing surface and at the midpoint of the chevron the outer tube can ovalize slightly while never allowing a leak path to form.
- The
protrusions 3408 disclosed herein may be any suitable thickness. For example, theprotrusions 3408 may be no greater than approximately 0.01 mm, 0.025 mm, 0.05 mm, 0.075 mm, 0.1 mm, 0.25 mm, 0.5 mm, 0.75 mm, 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, less than 0.1 mm, more than 5 mm, or a thickness within a range defined there between. In some embodiments, theprotrusions 3408 may have uniform thickness. In some embodiments, the thickness may be between about 0.001 and 0.005 inches, 0.0015 and 0.004 inches, or 0.002 and 0.003 inches. In some embodiments, theprotrusions 3408 may have variable thickness as they extend circumferentially around the circumference of theinner device 3402 orouter device 3404. As described elsewhere herein, theprotrusion 3408 may have an outer diameter that is substantially equal to the inner diameter of theouter device 3404. For example, both diameters may be between about 0.085 and 0.09 inches, 0.086 and 0.089 inches, or 0.087 and 0.088 inches. In some implementations, the outer diameter of theprotrusion 3408 and the inner diameter of theouter device 3404 may vary by less than about 0.002 inches, 0.001 inches, or 0.005 inches. - In some embodiments, the
protrusion 3408 may be formed from the same material as an outer layer of theinner device 3402, such as Pebax®. The protrusion may be formed by extruding the material in a similar way one or more layers of theinner device 3402 are formed. The extruded material may be cut (e.g., diagonally cut) to form the shape of thering having dimensions protrusion 3408 may be positioned around theinner device 3402 and then heated to laminate theprotrusion 3408 to the outer surface of theinner device 3402, such as in a hot box. In some embodiments, theprotrusion 3408 may be adhered to theinner device 3402 using an adhesive, such as a biocompatible adhesive. In some implementations, the protrusion may be post-processed. For example, the protrusion may be shaped by heating in a mold. The mold may be a glass mold. The mold may have an inner diameter approximately equal to the inner diameter of theouter device 3404 or slightly larger. For example, the mold may have an inner diameter of about 0.088 inches to achieve aprotrusion 3408 having a diameter of approximately 0.0874 inches. - In some implementations, the
protrusion 3408 may be molded or otherwise processed prior to attachment of theprotrusion 3408 to theinner device 3408. In some embodiments, theprotrusion 3408 may be attached or formed near the proximal end of theinner device 3402 as described elsewhere herein. For example, theprotrusion 3408 may be formed within 5 cm, 4 cm, 3 cm, or 2 cm from the proximal end of the innertubular body 3402. In some embodiments, as described elsewhere herein, theprotrusion 3408 may be attached or formed on the most proximal Pebax® segment (e.g. a 72D segment). Theprotrusion 3408 may be attached or formed distally to any proximal Vestamid® segments. When attached or formed near the proximal end of theinner device 3402, the protrusion may have a durometer that is the same or less than that of theinner device 3402 at the same location. For example, theprotrusion 3408 may have a durometer between about 45D and 70D, 50D and 65D, or 55D and 60D. For instance, a55D protrusion 3408 may be positioned around a 72D segment of the outer jacket of theinner device 3402. - In some embodiments, the
protrusion 3408 may be a spiral that extends along an axial length of theinner device 3402 and/or theouter device 3404. In some embodiments, the spiral may terminate at either its distal end and/or proximal end in closed circumference rings or connect to closed circumference rings. In some embodiments, the spiral may terminate at its distal end and/or proximal end in an open configuration which may allow some blood to pass through a helical passage formed by the spiral. The spiral may nonetheless impede the flow of blood into the annular gap. In some implementations, the smaller the pitch of the spiral the larger the impediment the spiral may provide against blood ingress. Rotation of theinner device 3402 in a first direction, depending on the direction (e.g., right handed or left-handed) of the spiral, may cause the spiral to expel fluid in a distal direction while rotation in a second direction may draw in blood. Rotation in the first direction may be used to expel a flushing solution as described elsewhere herein. - In some embodiments, the
sealing feature 3406 may be an active feature which expands or otherwise activates to seal the annular gap and/or which can be deactivated to allow flow through the annular gap. Thesealing feature 3406 may be deactivated when theinner device 3402 and theouter device 3404 are axially translated relative to one another so as to allow easier movement (e.g., less friction). Thesealing feature 3406 may be activated when theinner device 3402 and theouter device 3404 are being used in a fixed position, such as a fully retracted and/or fully extended position. - Referring to
FIG. 9 theactive sealing feature 3406 may be anexpandable bulge 3410. In various embodiments, theexpandable bulge 3410 may be activated via a connection extending through thecentral lumen 3401 of aspine 3403 of theinner device 3402, such as thelumen 45 extending through the pull wire 42 described elsewhere herein. Theexpandable bulge 3410 may be mechanically expandable. For example, as schematically illustrated inFIG. 9 , theexpandable bulge 3410 may be formed from a soft or compliant polymer, such as an elastomeric polymer. The softexpandable bulge 3410 may be formed such that in an inactivated or un-expanded state the outer profile of theexpandable bulge 3410 is in a reduced profile configuration such as flush with or in-line with the outer diameter of theinner device 3402. For example, theinner device 3402 may comprise a reduced diameter recess for receiving theexpandable bulge 3410. Theexpandable bulge 3410 may be ring-shaped or cuff-shaped. In some embodiments, theexpandable bulge 3410 may replace an outer layer of the inner device 3410 (e.g., the outer jacket) over a small axial length of theinner device 3410. Theexpandable bulge 3410 may not be adhered or fixed to the outer diameter of theinner device 3402 or it may be partially fixed, such as at a proximal end of theexpandable bulge 3410. - The
expandable bulge 3410 may be coupled to theinner device 3410 in a manner that allows axial compression of theexpandable bulge 3410 along the outer surface of theinner device 3402. In some embodiments, the outer diameter of theexpandable bulge 3410 in an un-activated or un-expanded state may extend beyond the outer diameter of theinner device 3402 but may not extend to the inner diameter of theouter device 3404 such that it does entirely seal the annular gap. In other embodiments, theexpandable bulge 3410 may be applied over a smooth portion of the outer circumference of theinner device 3402. Theexpandable bulge 3410 may be fixed, such as at a proximal end, to theinner device 3402. - As shown in
FIG. 9 , theexpandable bulge 3410 may be positioned at a proximal end of theinner device 3402. Theexpandable bulge 3410 may be sandwiched between a portion of the outer jacket of theinner device 3410 and a proximal structure. The proximal structure may be, for example, a radiopaque ring for determining the location of the proximal end of theinner device 3402. A tension cable orwire 3411 may extend from a proximal end of thedevice 3400 to theexpandable bulge 3410. Thetension cable 3411 may attach to a distal end of theexpandable bulge 3410. Proximal retraction of thetension cable 3411 may apply an axially compressive force to theexpandable bulge 3410 which causes the axial length of theexpandable bulge 3410 to be compressed and the radial diameter of theexpandable bulge 3410 to expand. Full expansion of theexpandable bulge 3410 may increase the outer diameter of theexpandable bulge 3410 to a size such that it is compressed against the inner diameter of theouter device 3404 and forms a fluid seal with the inner diameter of theouter device 3404. - Providing a distally directed counterforce on the
inner device 3402 such as by pushing on the inner device 3402 (e.g., pushing on thespine 3403 through which thetension cable 3411 extends) may facilitate expanding theexpandable bulge 3410 without axially translating theinner device 3402 relative to theouter device 3402, such as pulling theinner device 3410 proximally along with thetension cable 3411. In other embodiments, theexpandable bulge 3410 may be compressed by pushing on a push wire which may be connected to a proximal end of theexpandable bulge 3410. Theexpandable bulge 3410 may be fixed to theinner device 3410 at a distal end of theexpandable bulge 3402. Theexpandable bulge 3402 may be positioned at a distal end or intermediate portion of theinner device 3402. - In some embodiments, the
expandable bulge 3410 may be expandable by non-mechanical means. For example, theexpandable bulge 3410 may comprise a light-sensitive or electrosensitive material, such as a light-sensitive hydrogel and/or an electrosensitive hydrogel. An electric current or light may be passed through the lumen, which may serve as or may comprise an insulator or fiber optic cable. The hydrogel may expand upon the application of light and/or an electric current and may collapse upon removal of the stimuli or vice-versa. In some embodiments, theexpandable bulge 3410 may be inflatable and the lumen may serve as a passage for providing pressurized fluid (e.g. a gas or liquid, such as saline) which serves to inflate theexpandable bulge 3410. Theexpandable bulge 3410 may be inflated and deflated to a controllable extent by controlling the pressure applied to the inflating fluid. - In some embodiments, the
sealing feature 3406 may comprise aflange 3412.FIG. 10 schematically illustrates an example of adevice 3400 comprising aflange 3412. Theflange 3412 may be annular in shape. Theflange 3412 may be located at the distal end of theouter device 3404. In some implementations, theflange 3412 may comprise similar features as theprotrusion 3408 described elsewhere herein. Theflange 3412 may incline radially inward toward theinner device 3402 to form a frusto conical skirt configuration. In some embodiments, theflange 3412 may extend from an inner diameter of theouter device 3404. In some embodiments, theflange 3412 may be coupled to a distal face of theouter device 3404. Theflange 3412 may comprise a soft and/or elastic material. Theflange 3412 may be relatively softer and/or more flexible than theouter device 3404 or one or more layers of theouter device 3404 and/or relatively softer and/or more flexible than theinner device 3402 or one or more layers of theinner device 3402. - In some embodiments, the
flange 3412 may be formed integrally with theouter device 3404. For example, theflange 3412 may be extruded as a part of an inner liner and/or a part of an outer jacket of theouter device 3412. In some embodiments, theflange 3412 may be the same material as a layer of theouter device 3412 but may be formed relatively thinner so that it is more flexible. In some embodiments, theflange 3412 may be formed as a separate component which is coupled to theouter device 3404. For example, theflange 3412 may be adhered to theouter device 3404 or melted or molded onto theouter device 3404. The flange may be a distal segment of an outer jacket of theouter device 3404. Theflange 3412 may be relatively compliant. Theflange 3412 may be configured to extend, in an unbiased configuration, radially inward in a substantially normal relation to the inner surface of theouter device 3404. Theflange 3412 may be configured to extend, in an unbiased configuration, radially inward and somewhat in a distal direction such that it forms an oblique angle with the inner surface of the outer device 304. - The
flange 3412 may comprise an inner diameter in an unbiased configuration which is smaller than the outer diameter of theinner device 3402. In some embodiments, theflange 3412 may be thicker along or near its outer diameter than along or near its inner diameter. In some embodiments, theflange 3412 may comprise uniform thickness. Extending theinner device 3402 past the distal end of theouter device 3404 may cause theflange 3412 to bend in a distal direction such that the inner diameter of theflange 3412 expands to accommodate theinner device 3404 and form a fluid seal along the outer surface of theinner device 3402 as shown inFIG. 10 . An inner-most portion of theflange 3412 may deform to lie substantially flat against the outer surface of theinner device 3402. In some implementations, theflange 3412 may act like a squeegee along the outer surface of theinner device 3404. Theflange 3412 may be made of a lubricious material and/or coated with a lubricious material to promote smooth translation of theinner device 3402 relative to theouter device 3404. - In some embodiments, the
flange 3414 may maintain a flushing fluid proximal to theflange 3414 and/or may act as a one-way valve in the same manner as described with various configurations of theprotrusion 3408 described elsewhere herein. Providing aflange 3414 orother sealing feature 3406 at a distal end of theouter device 3404 may advantageously maximize the volume of the annular gap which is sealed from the physiological environment. In some embodiments, theinner device 3402 may comprise aflange 3412 extending from its outer diameter in a radially outward direction, which may comprise features similar to theflange 3412 extending from theouter device 3402. For example, the outer diameter of theflange 3412 may be larger than the inner diameter of theouter device 3404. Theflange 3412 may be positioned at a proximal end of theinner device 3402. - In some embodiments, the
sealing feature 3406 may comprise an expanded diameter portion of theinner device 3402, such as ahub 3414.FIG. 11 schematically illustrates an example of adevice 3400 comprising ahub 3414. Thehub 3414 may be configured to form a tight interference fit with the inner surface of theouter device 3404. Thehub 3404 may prevent or reduce the amount of contact between a portion of theinner device 3402 distal to and/or proximal to thehub 3414 with theouter device 3404, which may reduce friction and facilitate translation of theinner device 3402 relative to theouter device 3404. - In some embodiments, the
hub 3414 may comprise the same material as an outer jacket of theinner device 3404 or as any other layer of theinner device 3402. In some embodiments, thehub 3414 may be relatively softer and/or more flexible than the remaining length of theinner device 3402. In some embodiments, thehub 3414 may be relatively harder and/or stiffer than the remaining length of theinner device 3402. In some embodiments, thehub 3414 may comprise a uniform material extending between the non-expanded outer diameter of theinner device 3402 and the inner diameter of theouter device 3404. In some embodiments, thehub 3414 may comprise multiple layers between the non-expanded outer diameter of theinner device 3402 and the inner diameter of theouter device 3404. The layers may be of the same or different materials. In some embodiments, one or more outer layers may be softer, more flexible, and/or more lubricious than one or more inner layers. The outer layer or layers may facilitate smooth interaction with theouter device 3404 and the inner layers may provide structural support to the outer layers. In some embodiments, thehub 3414 may be positioned adjacent to a radiopaque ring as illustrated inFIG. 11 , such as distally adjacent to the radiopaque ring. - In some embodiments, the
inner device 3404 may comprise a spine 3403 (e.g., a hypotube spine) as described elsewhere herein. Thespine 3403 may comprise alumen 3401. Thespine 3403 may be positioned along an outer-most diameter of theinner device 3402. Thespine 3403 may merge with thehub 3414 as shown inFIG. 11 . Thelumen 3401 may extend through thehub 3414 and open on a distal face of thehub 3414. In some embodiments, the outer diameter of thelumen 3401 may be flush with the non-expanded outer diameter of theinner device 3402. In some embodiments, the outer diameter of thelumen 3401 may be entirely surrounded by portions of thehub 3414. In some embodiments, a portion of outer diameter of thelumen 3401 may be positioned along the outer diameter of thehub 3414, such that thelumen 3404 forms a groove along an outer surface of thehub 3414. - The
hub 3414 may thereby comprise adistal port 3454 on a lumen extending through the seal which allows delivery of flushing fluid through thelumen 3401 across the seal and into the annular gap. Providing pressure from the proximal end of thelumen 3401 may allow delivery of flushing fluid while preventing proximal fluid flow through the port of thesealing feature 3406. In some embodiments, thelumen 3401 may extend linearly through thehub 3414 such that theport 3454 is collinear with the remainder of thelumen 3401. In some embodiments, the lumen may turn, such as in a circumferential direction, and/or branch off into multiple ports. Multiple ports may be positioned, for example, at different circumferential points around thehub 3414. - In some embodiments, the
sealing feature 3406 may be dynamically responsive to movements of theinner device 3402 and/orouter device 3404. For example, thesealing feature 3406 may comprise spring devices which expand in an unbiased state and contract under force provided by movement of theinner device 3402, for example, and a counter frictional force between theinner device 3402 and theouter device 3404.FIGS. 12A-12C schematically illustrate an example of adevice 3400 comprising aspring sealing feature 3416 which is radially compressed and axially extended by axial movement of theinner device 3402.FIG. 12A depicts thespring sealing feature 3416 in an axially compressed/radially expanded sealed configuration.FIG. 12B depicts thespring sealing feature 3416 in an axially extended/radially compressed non-sealed configuration.FIG. 12C depicts an example of a slidingring 3418 used in thespring sealing feature 3416 ofFIGS. 12A and 12B . - As shown in
FIG. 12A , theinner device 3402 may be coupled to theouter device 3404 by two slidingrings 3418. One slidingring 3418 may be positioned at a distal end of thespring sealing feature 3416 and one slidingring 3418 may be positioned at a proximal end of thespring sealing feature 3416. As shown inFIG. 12C , the slidingring 3418 may comprise an inner annulus 3418 a, anouter annulus 3418 b, and one ormore spokes 3418 c joining the inner annulus 3418 a and theouter annulus 3418 b.Multiple spokes 3418 c may be positioned substantially uniformly around the circumference of the slidingring 3418. Fluid may generally flow through the slidingrings 3418 between thespokes 3418 c. - The inner annulus 3418 a may be configured to form a sliding interference fit with the outer diameter of the
inner device 3402. Theouter annulus 3418 b may be configured to form a sliding interference fit with the inner diameter of theouter device 3404. The inner annulus 3418 a may have a first coefficient of friction with respect to theinner device 3402 and theouter annulus 3418 b may have a second coefficient of friction with respect to theouter device 3404. The first and second coefficients of friction may be the same or one may be larger than the other. Although theouter annulus 3418 is shown as comprising a complete circumference inFIG. 12C , in some embodiments, theouter annulus 3418 b may not extend around the complete circumference. The circumference of theouter annulus 3418 b may be broken up into one or more partial arcuate sections, each section being connected to one ormore spokes 3418 c. Reducing the circumferential coverage of theouter annulus 3418 b may decrease friction between the slidingring 3418 and theouter device 3404 and promote easier sliding of the slidingring 3418 over the inner surface of theouter device 3404. Theinner device 3402 may comprise aridge feature 3420 projecting from the outer surface of theinner device 3402. For example, theridge feature 3420 may be a ring fixed to the outer surface of theinner device 3402. Theridge feature 3420 may be positioned between the proximal and distal slidingrings 3418. Theridge feature 3420 may be configured to abut a proximal side of the distal slidingring 3418 and push the slidingring 3418 in a distal direction along the inner surface of theouter device 3404. Likewise, theridge feature 3420 may be configured to abut a distal side of the proximal slidingring 3418 and push the slidingring 3418 in a proximal direction along the inner surface of theouter device 3404. - The
spring sealing feature 3416 may comprise one or more radially compressible support structures such assprings 3422 extending from around the circumference of the inner annulus 3418 a of the proximal slidingring 3418 to the inner annulus 3418 a of the distal slidingring 3418. For instance, thesprings 3422 may comprise a plurality of spring struts extending parallel to a longitudinal axis of thedevice 3400 from one slidingring 3418 to another. Thespring 3422 may comprise a coil spring wrapping helically around theinner device 3402. Thespring 3422 may comprise a spring mesh. Thespring 3422 may be convex around theinner device 3402 or configured to bulge radially outward, within at least one portion positioned intermediately between the proximal end and distal end of thespring 3422, when in an unbiased or relaxed state, as shown inFIG. 12A . - The spring or springs 3422 may be covered or coated with an elastic membrane or film (not shown) which covers an outer and/or inner surface of the
springs 3422 such that a fluid barrier is formed by the membrane circumferentially around theinner device 3402, the fluid barrier extending from the proximal slidingring 3418 to the distal slidingring 3418. In an unbiased configuration, thespring 3422 and the elastic membrane are compressed against an inner surface of theouter device 3404, as depicted inFIG. 12A , such that the fluid barrier forms a fluid seal around the entire circumference of the inner surface of theouter device 3404. Thespring sealing feature 3416 may inhibit or prohibit distal and proximal fluid flow through or across thespring sealing feature 3416 in a fully expanded configuration. -
FIG. 12B schematically illustrates thedevice 3400 ofFIG. 12A with thespring sealing feature 3416 in an axially extended/radially compressed unsealed configuration during translational movement of theinner device 3402. As shown, inFIG. 12B , theinner device 3402 has been sufficiently translated in a proximal direction such that theridge feature 3420 is pushing against the proximal slidingring 3418. As theinner device 3402 is further translated in a proximal direction, theridge 3420 causes the proximal slidingring 3418 to slide in a proximal direction along the inner surface of theouter device 3404. As the proximal slidingring 3418 slides in a proximal direction it exerts a force on thespring 3422 in the proximal direction. The friction between the distal slidingring 3418 and the inner surface of theouter device 3404 resists, at least partially, the movement of the distal slidingring 3418 along the inner surface of theouter device 3404 and can provide a counter force to the proximal force of the proximal slidingring 3418, placing thespring 3422 in a state of tension. - Under tension, the
spring 3422 may stretch in the axial direction thereby reducing its outer diameter. The outer diameter of thespring 3422 may be reduced such that thespring 3422 and/or elastic membrane no longer contacts the inner surface of theouter device 3404, at least along a portion of the circumference, and allows fluid flow across thespring sealing feature 3416. Fluid may flow between thespokes 3418 c of the proximal and distal slidingrings 3418 to flow across the surface of the fluid barrier formed around theinner device 3402. Removing contact between the membrane-encompassedspring 3422 and the inner surface of theouter device 3402 may reduce overall friction and facilitate axial translation of theinner device 3402 relative to theouter device 3404. In some embodiments, the axial extension of thespring 3422 may reduce the compressive force of thespring sealing feature 3416 against theouter device 3404 but still maintain thespring sealing feature 3416 in contact with theouter device 3404. Reducing the compressive force may reduce friction and facilitate translation of theinner device 3402 with respect to theouter device 3404 while maintaining, at least to a degree, a fluid seal. - When the proximal force on the
inner device 3402 is removed, the tension may be removed from thespring 3422 and thespring 3422 may contract bringing the proximal anddistal rings 3418 closer together. Thespring 3422 may expand to the inner surface of theouter device 3404sealing device 3400, blocking fluid flow across thespring sealing feature 3416. Thespring 3422 may be designed with a spring constant, such that it requires less force to deform thespring 3422 than to overcome the friction resisting sliding between theouter annulus 3418 b and the inner surface of theouter device 3404. Thespring 3422 may be configured to extend before thelagging sliding ring 3418 begins to translate, following the leading slidingring 3418. - In some embodiments, the
spring sealing feature 3416 may use two ridge features 3420, one positioned on a distal side of the distal slidingring 3418 and one positioned on the proximal side of the proximal slidingring 3418, in addition to or alternatively to theintermediate ridge feature 3420. Providing a transient seal that only allows fluid flow during axial translation of the inner device may significantly reduce exposure of the annular gap to proximal blood flow. Providing a transient seal that reduces friction upon axial translation of theinner device 3402 may improve the ability to readily translate theinner device 3402 while generally maintaining a fluid seal. The same tradeoff between friction that seals the annular gap and friction that inhibits smooth axial translation is not necessarily required with a dynamic seal. - Other various configurations of the
sealing feature 3406 may be dynamically responsive to movements of theinner device 3402.FIGS. 13A-13C schematically illustrate an example of adevice 3400 comprising a spring sealing feature 3426 which is compressed by rotational movement of theinner device 3402 relative to theouter device 3404.FIG. 13A depicts thedevice 3400 in a torqued/radially compressed non-sealed configuration.FIG. 13B depicts a cross section of theinner device 3402 inFIG. 13A taken along the longitudinal axis at a point comprising akey feature 3432.FIG. 13C depicts an example of a small diameter ring 3430 used in the spring sealing feature 3426 ofFIGS. 13A and 13B . - As shown in
FIG. 13A , the spring sealing feature 3426 may comprise alarge diameter ring 3428 and a small diameter ring 3430. Thelarge diameter ring 3428 may be positioned proximal to the small diameter ring 3430 or vice versa. Thelarge diameter ring 3428 may be similar to the slidingrings 3418 described elsewhere herein. However, in some embodiments, thelarge diameter ring 3428 may be fixed to the internal diameter of theouter device 3404, as depicted inFIG. 13A , such that thelarge diameter ring 3428 neither translates (e.g., slides) nor rotates with respect to theouter device 3404. The small diameter ring 3430 may extend around the circumference of the inner device and may have an outer diameter that does not extend to or near the inner surface of theouter device 3404. In some embodiments, the outer diameter of the small diameter ring 3430 may be minimized, such as to a size sufficient to couple to a torsion spring 3434. - The
inner device 3402 may comprise one or morekey features 3432 as illustrated inFIG. 13B . The key features 3432 may lock into the small diameter ring at particular circumferential locations.FIG. 13C depicts a small diameter ring comprising a plurality of recesses orgrooves 3433, each being configured to receive one of the key features 3432 depicted inFIG. 13B . The key features 3432 may extend axially along the entire length or a portion of the length of the inner device configured to interact with the spring sealing feature 3426, as shown inFIG. 13A . Theinner device 3402 may be axially translatable (e.g., slidable) within the inner diameter of the small diameter ring 3430. The key features 3432, however, may rotationally lock the small diameter ring 3430 to theinner device 3402 such that the small diameter ring 3430 rotates with theinner device 3432. - A torsion spring 3434 may extend between the
large diameter ring 3428 and the small diameter ring 3430. The torsion spring 3434 may have a convex configuration around theinner device 3402 such that it extends radially outward between thelarge diameter ring 3428 and the small diameter ring 3430 so as to compress against the inner surface of theouter device 3404. The spring sealing device 3426 may comprise an elastic membrane or film coupled to the torsion spring 3434 to form a fluid barrier circumferentially surrounding theinner device 3402 as described elsewhere herein. - Rotation of the small diameter ring 3430 in a first direction (e.g., clockwise or counter clockwise) may cause the torsion spring 3434 to collapse such that the elastic membrane is no longer pressed into contact with the
outer device 3404. The elastic membrane may form a fluid seal around the circumference of the inner surface of theouter device 3404 when compressed against theouter device 3404, similar to the spring sealing feature shown inFIG. 12A . The small diameter ring 3430 may be free to axially translate as needed along the outer surface of the inner device, such as to accommodate the radial compression of the torsion spring 3434. - Rotation of the
inner device 3404 may thereby allow fluid flow across the spring sealing device 3426. Theinner device 3404 may be rotated and maintained in a rotated position to allow axial translation of theinner device 3402 with respect to theouter device 3404 in order to reduce the friction between theinner device 3402 andouter device 3404. Thelarge diameter ring 3428 may be fixed to theouter device 3404 near a distal end of theouter device 3404, maximizing the length of the annular gap that is sealed from blood exposure. - In some embodiments, the small diameter ring 3430 may be fixed to the
inner device 3402 such that it is not axially translatable with respect to theinner device 3402. The small diameter ring 3430 may be an annular projection extending from theinner device 3402. The small diameter ring 3430 may be integral with theinner device 3402. Thelarge diameter ring 3428 may be axially translatable (e.g., slidable) with respect to the inner surface of theouter device 3404. Thelarge diameter ring 3428 may resist or prohibit rotation with respect to the inner surface of theouter device 3404. The spring constant of the torsion spring 3434 may be configured such that less torque is required to collapse the spring than to rotate thelarge diameter ring 3428 with respect to theouter device 3404. The large diameter ring may provide a counter force that allows the torsion spring 3434 to collapse. - In some embodiments, the
large diameter ring 3428 may be mechanically prevented from rotating with respect to theouter device 3404. For example, the large diameter ring may comprise key features and the inner surface of theouter device 3404 may comprises corresponding recesses or grooves, as described elsewhere herein or vice versa. In some embodiments, the torsion spring 3434 and/or the elastic membrane may extend from the small diameter ring to an outer annulus of thelarge diameter ring 3428 or some circumference between an inner diameter and outer diameter of thelarge diameter ring 3428. Rotation of theinner device 3402 may collapse the torsion spring 3434 to allow fluid flow and/or reduce friction between theinner device 3402 andouter device 3404 as described with respect toFIGS. 13A-13C . However, the spring sealing feature 3426 may be axially translatable with respect to theouter device 3404 such that it may move along with theinner device 3402. - Disclosed herein are various embodiments for sealing an annular gap between vascular device such as
device 3400, described elsewhere herein, and a body vessel such as a blood vessel (e.g., a neurovascular artery). Sealing a blood vessel around a catheter device, particularly a catheter configured for the removal (e.g., aspiration) of a blood clot may advantageously prevent blood flow from carrying a clot or fragment of a clot, such as a clot captured on a distal end of the catheter, further downstream. For example, for a device positioned upstream of the clot, such as in a neurovascular artery, the seal between the device and the blood vessel may prevent antegrade blood flow from dislodging a captured blood clot from a distal end of the device and carrying it downstream, which could result in an embolism in a downstream location. - The
device 3400 may comprise avessel sealing feature 3440 positioned on an outer surface of the device 3400 (e.g., on an outer surface of the outer access catheter device 3404).FIG. 14 schematically illustrates an example of adevice 3400 comprising avessel sealing feature 3440. Thevessel sealing feature 3440 may be annular and may extend around the entire circumference of thedevice 3400. Thevessel sealing feature 3440 may be positioned at a distal end of thedevice 3400, near a proximal end of thedevice 3400, or somewhere intermediate the distal end and proximal end. Thevessel sealing feature 3440 may be passive comprising a static structure that seals the vessel or it may be active comprising a dynamic structure that is activated and/or deactivate to transition between a sealing state and a non-sealing state. - The
vessel sealing feature 3440 may comprise the same or similar features asprotrusion 3408 configured to extend around the outer surface of theinner device 3402, except that it is configured to extend around the outer surface of theouter device 3404. Thevessel sealing feature 3440 may form an expanded diameter portion of the device 3400 (or at least of a portion of the device inserted into the vasculature to be occluded by the vessel sealing feature 3440). Thevessel sealing feature 3440 may be extremely compliant such that it may have a diameter large enough to seal a blood vessel of an unknown or variable diameter while being soft and deformable enough to be compressed and placed contact with the blood vessel wall without damaging (e.g., rupturing or tearing) the blood vessel wall or intima. - The
vessel sealing feature 3440 may be formed as a part of an outer jacket as described elsewhere herein. Thevessel sealing feature 3440 may comprise a soft elastomeric polymer. Thevessel sealing feature 3440 may be formed from a same or different material as the device 3400 (e.g., the outer jacket of the device). Thevessel sealing feature 3440 may be a separate component which is coupled to thedevice 3400. For example, thevessel sealing feature 3440 may be a preformed ring, similar to a wide O-ring, which is placed over the outer surface of thedevice 3400. Thedevice 3400 may be configured with a circumferential recess or groove configured to receive thevessel sealing feature 3440. Thevessel sealing feature 3440 may have an inner diameter that is smaller, in an unbiased state, than the outer diameter of the device 3400 (or the recessed diameter of the groove). Thevessel sealing feature 3440 may need to be at least partially expanded (e.g., stretched) in order to position thevessel sealing feature 3440 over thedevice 3400 and the compressive elastic force of thevessel sealing feature 3440 may frictionally secure thevessel sealing feature 3440 to thedevice 3400. - In some embodiments, the
vessel sealing feature 3440 may be additionally or alternatively secured to the device by melting or molding the sealing feature onto thedevice 3400 or using an adhesive (e.g., a biocompatible adhesive). In some embodiments, thevessel sealing feature 3400 may be softer and more flexible or compliant along an outer diameter than along an inner diameter. In some embodiments, thevessel sealing feature 3400 may be thinner along an outer diameter than along an inner diameter. In some implementations, thevessel sealing feature 3440 may be custom-formed in size and/or shape to the anatomy of a particular vessel. The anatomy may be patient-specific. In some embodiments, thevessel sealing feature 3440 is interchangeable such that a custom or otherwise specifically shaped and/or sizedvessel sealing feature 3440 may be replaceably attached to thedevice 3400. In some embodiments, thevessel sealing feature 3440 may be a soft hydrogel. The hydrogel may be configured to swell nominally or not at all in situ. - In some embodiments, the
vessel sealing feature 3440 may be active. Thevessel sealing feature 3440 may comprise the same or similar features as theexpandable bulge 3410 described elsewhere herein. For example, thevessel sealing feature 3440 may comprise a light-sensitive or electrosensitive material, such as a light-sensitive hydrogel and/or an electrosensitive hydrogel. An electric current or light may be passed through an insulator or fiber optic cable to the hydrogel or other active material. The hydrogel may expand upon the application of light and/or an electric current and may collapse upon removal of the stimuli or vice-versa. - A hydrogel may be configured to swell to a controlled or expected volume when exposed to the physiological environment in situ. For example, the hydrogel may be configured to swell in response to body temperature, blood exposure, and/or interaction with a physiological factor, such as an enzyme. In some implementations, the amount of swelling may be controlled by a parameter of the stimulus (e.g, the amount of current or intensity of the light).
- In some embodiments, the
vessel sealing feature 3440 may be inflatable via pressurized fluid (e.g. a gas or liquid, such as saline) which serves to inflate thevessel sealing feature 3440 such as an inflatable balloon. Thevessel sealing feature 3440 may be inflated and deflated to a controllable extent by controlling the pressure applied to the inflating fluid. In some embodiments, thevessel sealing feature 3440 may be configured to be in-line or flush with the outer diameter of thedevice 3400 in an inactivated state. In other embodiments, thevessel sealing feature 3440 may extend slightly beyond the outer diameter of thedevice 3400 in an inactivate state, but not to the extent that it seals the blood vessel or comes into significantly increased contact with the blood vessel creating additional friction. - Any of the catheter shaft or sections of the catheter shaft or telescoping extensions in accordance with the present invention, such as
inner device 3402 orouter device 3404, may comprise a multi-layer construct having a high degree of flexibility and sufficient push ability to reach deep into the cerebral vasculature, such as at least as deep as the petrous, cavernous, or cerebral segment of the internal carotid artery (ICA). - In one example, referring to
FIG. 15 , acatheter 3000, which may be the same or similar todevice 3400, may have an effective length from the manifold to distal tip from about 70 cm to about 150 cm, from about 80 cm to about 140 cm, from about 90 cm to about 130 cm, from about 100 cm to about 120 cm, or from about 105 cm to about 115 cm. The outer diameter of thecatheter 3000 may be from about 0.07 inches to about 0.15 inches, from about 0.08 inches to about 0.14 inches, from about 0.09 inches to about 0.13 inches, from about 0.1 inches to about 0.12 inches, or from about 0.105 inches to about 0.115 inches, and may be lower in a distal segment than in a proximal segment. Theinner diameter 3108 of thecatheter 3000 in a single central lumen embodiment may be greater than or equal to about 0.11 inches, greater than or equal to about 0.1 inches, greater than or equal to about 0.09 inches, greater than or equal to about 0.088 inches, greater than or equal to about 0.08 inches, greater than or equal to about 0.07 inches, greater than or equal to about 0.06 inches, or greater than or equal to about 0.05 inches. Theinner diameter 3108 of thecatheter 3000 in a single central lumen embodiment may be less than or equal to about 0.11 inches, less than or equal to about 0.1 inches, less than or equal to about 0.09 inches, less than or equal to about 0.088 inches, less than or equal to about 0.08 inches, less than or equal to about 0.07 inches, less than or equal to about 0.06 inches, or less than or equal to about 0.05 inches. Referring toFIG. 15 , aninner liner 3014 may be formed by dip coating a mandrel (not shown) to provide a thin walled tubular inside layer of thecatheter body 3000. The dip coating may be produced by coating a wire such as a silver coated copper wire in PTFE. The mandrel may thereafter be axially elongated to reduce diameter, and removed to leave the tubular inner liner. The outside surface of the tubularinner liner 3014 may thereafter be coated with asoft tie layer 3012 such as polyurethane (e.g., Tecoflex™), to produce a layer having a thickness of no more than about 0.005 inches, and in some implementations approximately 0.001 inches. Thetie layer 3012 will generally extend along at least about the most distal 10 cm or 20 cm of thecatheter shaft 3000 generally less than about 50 cm and may in one implementation extend approximately the distal 30 cm of thecatheter shaft 3000, 3100. - A braid such as a 75 ppi stainless steel braid 3010 may thereafter be wrapped around the
inner liner 3014 through a proximal zone up to adistal transition 3011. From thedistal transition 3011 to the distal end of thecatheter 3000, acoil 3024 comprising a shape memory material such as a Nitinol alloy may thereafter be wrapped around theinner liner 3014. In one implementation, the Nitinol coil has a transition temperature below body temperature so that the Nitinol resides in the austinite (springy) state at body temperature. Adjacent loops or filars of thecoil 3024 may be closely tightly wound in a proximal zone with a distal section having looser spacing between adjacent loops. In an embodiment having acoil section 3024 with an axial length of at least between about 20% and 30% of the overall catheter length, (e.g., 28 cm coil length in a 110 cm catheter shaft 3000), at least the distal 1 or 2 or 3 or 4 cm of the coil will have a spacing that is at least about 130%, and in some implementations at least about 150% or more than the spacing in the proximal coil section. In a 110cm catheter shaft 3000 having a Nitinol coil the spacing in the proximal coil may be about 0.004 inches and in the distal section may be at least about 0.006 inches or 0.007 inches or more. In embodiments comprising an extension catheter, the distal extendable section of the catheter may be constructed according to the foregoing. The length of thecoil 3024 may be proportioned to the length of the extendable catheter segment or the total (e.g., extended) length of thecatheter 3000. Thecoil 3024 may extend from a distal end of the extendable segment over at least about 50%, 60%, 70%, 80%, or 90% of the length of the extendable segment. In some embodiments, thecatheter 3000 or the extendable segment may not comprise a braid and thecoil 3024 may extend to the proximal end of the extendable segment (100% of the length). [0082] The distal end of thecoil 3024 can be spaced proximally from the distal end of theinner liner 3014, for example, to provide room for an annularradiopaque marker 3040. Thecoil 3024 may be set back proximally from the distal end, in some embodiments, by approximately no more than 1 cm, 2 cm, or 3 cm. In one embodiment, the distal end of thecatheter 3000 is provided with a beveleddistal surface 3006 residing on a plane having an angle of at least about 10° or 20° and in one embodiment about 30° with respect to a longitudinal axis of thecatheter 3000. Theradiopaque marker 3040 may reside in a plane that is transverse to the longitudinal axis. Alternatively, at least the distally facing edge of the annularradiopaque marker 3040 may be an ellipse, residing on a plane which is inclined with respect to the longitudinal axis to complement the bevel angle of thedistal surface 3006. - After applying the proximal braid 3010, the
distal coil 3024 and theRO marker 3040 anouter Jacket 3020 maybe applied such as a shrink wrap tube to enclose thecatheter body 3000. The outer shrink-wrappedsleeve 3020 may comprise any of a variety of materials, such as polyethylene, polyurethane, polyether block amide (e.g., PEBAX™) nylon or others known in the art. Sufficient heat is applied to cause the polymer to flow into and embed the proximal braid and distal coil. - In one implementation, the outer
shrink wrap jacket 3020 is formed by sequentially advancing a plurality of shorttubular segments catheter 3000 and provide a smooth continuous outer tubular body. The foregoing construction may extend along at least the most distal 10 cm, and preferably at least about the most distal 20 cm, 25 cm, 30 cm, 35 cm, 40 cm, or more than 40 cm of thecatheter body 3000. The entire length of the outershrink wrap jacket 3020 may be formed from tubular segments and the length of the distal tubular segments (e.g., 3022, 3026, 3028, 3030, 3032, 3034, 3036, 3038) may be shorter than the one or more tubular segments forming the proximal portion of the outershrink wrap jacket 3020 in order to provide steeper transitions in flexibility toward the distal end of thecatheter 3000. - The durometer of the outer wall segments may decrease in a distal direction. For example, proximal segments such as 3022 and 3026, may have a durometer of at least about 60 or 70D, with gradual decrease in durometer of successive segments in a distal direction to a durometer of no more than about 35D or 25D or lower. A 25 cm section may have at least about 3 or 5 or 7 or more segments and the
catheter 3000 overall may have at least about 6 or 8 or 10 or more distinct flexibility zones. The distal 1 or 2 or 4 ormore segments finished catheter body 3000. The length of the lower OD section 3004 may be within the range of from about 3 cm to about 15 cm and in some embodiments is within the range of from about 5 cm to about 10 cm such as about 7 or 8 cm, and may be accomplished by providing thedistal segments - Referring to
FIGS. 16A-16B , there is illustrated one example of an outer jacket segment stacking pattern for a progressive flexibility catheter of the type discussed in connection withFIG. 15 . Adistal segment 3038 may have a length within the range of about 1-3 cm, and a durometer of less than about 35D or 30D. An adjacentproximal segment 3036 may have a length within the range of about 4-6 cm, and a durometer of less than about 35D or 30D. An adjacentproximal segment 3034 may have a length within the range of about 4-6 cm, and a durometer of about 35D or less. An adjacentproximal segment 3032 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35D to about 45D (e.g., 40D). An adjacentproximal segment 3030 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 50D to about 60D (e.g., about 55D). An adjacentproximal segment 3028 may have a length within the range of about 1-3 cm, and a durometer within the range of from about 35D to about 50D to about 60D (e.g., about 55D). An adjacentproximal segment 3026 may have a length within the range of about 1-3 cm, and a durometer of at least about 60D and typically less than about 75D. More proximal segments may have a durometer of at least about 65D or 70D. The distal most two or three segments may comprise a material such as Tecothane, and more proximal segments may comprise PEBAX or other catheter jacket materials known in the art. At least three or five or seven or nine or more discrete segments may be utilized, having a change in durometer between highest and lowest along the length of the catheter shaft of at least about 10D, preferably at least about 20D and in some implementations at least about 30D or 40D or more. - In another embodiment, the most distal portion of the
catheter 3000 may comprise a durometer of less than approximately 35D (e.g., 25D) to form a highly flexible distal portion of the catheter and have a length between approximately 25 cm and approximately 35 cm. In other embodiments, the length may be between approximately 15 cm and approximately 25 cm. The distal portion may comprise one or more tubular segments of the same durometer (e.g., segment 3038) or of different durometers. In some embodiments, one or more of the distal most segments may comprise a polyether-based thermoplastic polyurethane (e.g., Tecothane®). More proximal segments may comprise a polyether block amide (e.g., PEBAX®). A series of proximally adjacent tubular segments to the distal portion may form a transition region between a proximal stiffer portion of thecatheter 3000 and the distal highly flexible portion of the catheter. The series of tubular segments forming the transition region may have the same or substantially similar lengths, such as approximately 1 cm. The relatively short length of the series of tubular segments may provide a steep drop in durometer over the transition region. For example, the transition region may have a proximal tubular segment 3036 (proximally adjacent the distal portion) having a durometer of approximately 35D. An adjacentproximal segment 3034 may have a durometer of approximately 55D. An adjacentproximal segment 3032 may have a durometer of approximately 63D. An adjacentproximal segment 3030 may have a durometer of approximately 72D. One or more of the segments within the transition region may comprise a length between about 1 and 4 cm. For example, the transition region may comprise aproximal segment 3036 approximately 4 cm and 35D, anadjacent segment 3034 approximately 3 cm and 37D, anadjacent segment 3032 approximately 1 cm and 47D, anadjacent segment 3030 approximately 1 cm and 55D, anadjacent segment 3028 approximately 1 cm and 63D, and anadjacent segment 3026 approximately 1 cm and 72D. In some embodiments, the length of the distal portion of thecatheter 3000, including the highly flexible distal portion and the transition region, may be between about 25-30 cm, between about 30-35 cm, between about 35 to 40 cm, or between about 40-45 cm. More proximal segments may comprise a durometer or durometers greater than approximately 72D and may extend to the proximal end of the catheter or extension catheter segment. For instance, an extension catheter segment may comprise a proximal portion greater than approximately 72D between about 1 cm and about 3 cm. In some embodiments, the proximal portion may be about 2 cm long. In some embodiments, the most distal segments (e.g., 3038-3030) or at least the transition region may comprise PEBAX® and more proximal segments may comprise a generally stiffer material, such as Vestamid®. - The inner diameter of the
catheter 3000 or catheter extension segment may be between approximately 0.06 and 0.08 inches, between approximately 0.065 and 0.075 inches, or between 0.068 and 0.073 inches. In some embodiments, the inner diameter is approximately 0.071 inches. In some embodiments, the distal most portion may taper to a decreased inner diameter as described elsewhere herein. The taper may occur approximately between the distal highly flexible portion and the transition region (e.g., over the most proximal portion of the distal highly flexible portion). The taper may be relatively gradual (e.g., occurring over approximately 10 or more cm) or may be relatively steep (e.g., occurring over less than approximately 5 cm). The inner diameter may taper to an inner diameter between about 0.03 and 0.06 inches. For example, the inner diameter may be about 0.035 inches, about 0.045 inches, or about 0.055 inches at the distal end of thecatheter 3000. In some embodiments, the inner diameter may remain constant, at least over the catheter extension segment. In some embodiments, thecoil 3024 may extend from a distal end of thecatheter 3000 along the highly flexible distal portion ending at the distal end of the transition region. In other embodiments, thecoil 3024 may extend from a distal end of the catheter to the proximal end of the transition region, to a point along the transition region, or proximally beyond the transition region. In other embodiments, thecoil 3024 may extend the entire length of thecatheter 3000 or catheter extension segment as described elsewhere herein. The braid 3010, when present, may extend from the proximal end of thecoil 3024 to the proximal end of thecatheter 3000 or catheter extension segment. - The catheters of the present invention may be composed of any of a variety of biologically compatible polymeric resins having suitable characteristics when formed into the tubular catheter body segments. Exemplary materials include polyvinyl chloride, polyethers, polyamides, polyethylenes, polyurethanes, copolymers thereof, and the like. In one embodiment, both the
proximal body segment 33 anddistal body segment 34 will comprise a polyvinyl chloride (PVC), with the proximal body segment being formed from a relatively rigid PVC and the distal body segment being formed from a relatively flexible, supple PVC. Optionally, the proximal body segment may be reinforced with a metal or polymeric braid or other conventional reinforcing layer. - Although the present invention has been described in terms of certain preferred embodiments, it may be incorporated into other embodiments by persons of skill in the art in view of the disclosure herein. The scope of the invention is therefore not intended to be limited by the specific embodiments disclosed herein, but is intended to be defined by the full scope of the following claims.
- It is understood that this disclosure, in many respects, is only illustrative of the numerous alternative device embodiments of the present invention. Changes may be made in the details, particularly in matters of shape, size, material and arrangement of various device components without exceeding the scope of the various embodiments of the invention. Those skilled in the art will appreciate that the exemplary embodiments and descriptions thereof are merely illustrative of the invention as a whole. While several principles of the invention are made clear in the exemplary embodiments described above, those skilled in the art will appreciate that modifications of the structure, arrangement, proportions, elements, materials and methods of use, may be utilized in the practice of the invention, and otherwise, which are particularly adapted to specific environments and operative requirements without departing from the scope of the invention. In addition, while certain features and elements have been described in connection with particular embodiments, those skilled in the art will appreciate that those features and elements can be combined with the other embodiments disclosed herein.
- When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
- Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
- Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
- Although the terms “first” and “second” may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
- Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise”, and variations such as “comprises” and “comprising” means various components can be co-jointly employed in the methods and articles (e.g., compositions and apparatuses including device and methods). For example, the term “comprising” will be understood to imply the inclusion of any stated elements or steps but not the exclusion of any other elements or steps.
- As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical values given herein should also be understood to include about or approximately that value, unless the context indicates otherwise. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Any numerical range recited herein is intended to include all sub-ranges subsumed therein. It is also understood that when a value is disclosed that “less than or equal to” the value, “greater than or equal to the value” and possible ranges between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the value “X” is disclosed the “less than or equal to X” as well as “greater than or equal to X” (e.g., where X is a numerical value) is also disclosed. It is also understood that the throughout the application, data is provided in a number of different formats, and that this data, represents endpoints and starting points, and ranges for any combination of the data points. For example, if a particular data point “10” and a particular data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
- Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
- The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/074,378 US20230165596A1 (en) | 2018-07-06 | 2022-12-02 | Sealed neurovascular extendable catheter |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862694796P | 2018-07-06 | 2018-07-06 | |
US16/503,899 US11517335B2 (en) | 2018-07-06 | 2019-07-05 | Sealed neurovascular extendable catheter |
US18/074,378 US20230165596A1 (en) | 2018-07-06 | 2022-12-02 | Sealed neurovascular extendable catheter |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/503,899 Continuation US11517335B2 (en) | 2018-07-06 | 2019-07-05 | Sealed neurovascular extendable catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230165596A1 true US20230165596A1 (en) | 2023-06-01 |
Family
ID=69059962
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/503,899 Active 2040-01-27 US11517335B2 (en) | 2018-07-06 | 2019-07-05 | Sealed neurovascular extendable catheter |
US18/074,378 Pending US20230165596A1 (en) | 2018-07-06 | 2022-12-02 | Sealed neurovascular extendable catheter |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/503,899 Active 2040-01-27 US11517335B2 (en) | 2018-07-06 | 2019-07-05 | Sealed neurovascular extendable catheter |
Country Status (2)
Country | Link |
---|---|
US (2) | US11517335B2 (en) |
WO (1) | WO2020010310A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11819228B2 (en) | 2019-12-18 | 2023-11-21 | Imperative Care, Inc. | Methods and systems for treating a pulmonary embolism |
US12042160B2 (en) | 2018-05-01 | 2024-07-23 | Incept, Llc | Catheter having angled tip |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3419528B1 (en) | 2016-02-24 | 2023-06-07 | Incept, LLC | Enhanced flexibility neurovascular catheter |
WO2018129194A1 (en) | 2017-01-06 | 2018-07-12 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
CA3157362A1 (en) | 2019-10-15 | 2021-04-22 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
US11633272B2 (en) | 2019-12-18 | 2023-04-25 | Imperative Care, Inc. | Manually rotatable thrombus engagement tool |
US20210315598A1 (en) | 2019-12-18 | 2021-10-14 | Imperative Care, Inc. | Methods of placing large bore aspiration catheters |
US12023457B2 (en) * | 2020-02-20 | 2024-07-02 | C. R. Bard, Inc. | Support structures for drainage tubes |
WO2021183444A1 (en) | 2020-03-10 | 2021-09-16 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
CN111282134B (en) * | 2020-03-19 | 2022-09-16 | 南京普微森医疗科技有限公司 | Flexible reinforced neurovascular catheter structure |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
EP4210802A4 (en) * | 2020-09-14 | 2024-10-16 | Imperative Care Inc | Self centering low friction extendable neurovascular catheter |
CN112190815B (en) * | 2020-10-21 | 2022-07-19 | 郑州大学第一附属医院 | Catheter intervention device with adjustable hardness |
US20220125454A1 (en) * | 2020-10-23 | 2022-04-28 | Vicora, Inc. | Actuated thrombectomy device |
US12011186B2 (en) | 2021-10-28 | 2024-06-18 | Neuravi Limited | Bevel tip expandable mouth catheter with reinforcing ring |
Family Cites Families (557)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3605750A (en) | 1969-04-07 | 1971-09-20 | David S Sheridan | X-ray tip catheter |
US3884242A (en) | 1971-03-29 | 1975-05-20 | Mpc Kurgisil | Catheter assembly |
US3890976A (en) | 1972-10-26 | 1975-06-24 | Medical Products Corp | Catheter tip assembly |
US3965901A (en) | 1974-10-03 | 1976-06-29 | American Hospital Supply Corporation | Suction catheter |
US4030503A (en) | 1975-11-05 | 1977-06-21 | Clark Iii William T | Embolectomy catheter |
US4319580A (en) | 1979-08-28 | 1982-03-16 | The Board Of Regents Of The University Of Washington | Method for detecting air emboli in the blood in an intracorporeal blood vessel |
US4628168A (en) | 1980-05-14 | 1986-12-09 | Shiley, Inc. | Dielectric heating device for heating cannula members |
DE3020041A1 (en) | 1980-05-24 | 1981-12-03 | Sartorius GmbH, 3400 Göttingen | FILTRATION DEVICE FOR CONCENTRATING LIQUID MEDIA |
US4611594A (en) | 1984-04-11 | 1986-09-16 | Northwestern University | Medical instrument for containment and removal of calculi |
US4617019A (en) | 1984-09-28 | 1986-10-14 | Sherwood Medical Company | Catheter |
DE3442736C2 (en) | 1984-11-23 | 1987-03-05 | Tassilo Dr.med. 7800 Freiburg Bonzel | Dilatation catheter |
US4619274A (en) | 1985-04-18 | 1986-10-28 | Advanced Cardiovascular Systems, Inc. | Torsional guide wire with attenuated diameter |
US4810582A (en) | 1985-11-12 | 1989-03-07 | Tyndale Plains-Hunter Ltd. | Hydrophilic polyurethane composition |
US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
US4739768B2 (en) | 1986-06-02 | 1995-10-24 | Target Therapeutics Inc | Catheter for guide-wire tracking |
US4767399A (en) | 1986-12-05 | 1988-08-30 | Fisher Scientific Group Inc. Dba Imed Corporation | Volumetric fluid withdrawal system |
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
US4923462A (en) | 1987-03-17 | 1990-05-08 | Cordis Corporation | Catheter system having a small diameter rotatable drive member |
US4898575A (en) | 1987-08-31 | 1990-02-06 | Medinnovations, Inc. | Guide wire following tunneling catheter system and method for transluminal arterial atherectomy |
US5217705A (en) | 1987-09-25 | 1993-06-08 | Neorx Corporation | Method of diagnosing blood clots using fibrin-binding proteins |
US4844064A (en) | 1987-09-30 | 1989-07-04 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument with end and side openings |
ES2047586T3 (en) | 1988-03-04 | 1994-03-01 | Angiomed Ag | PROCEDURE AND DEVICE TO REMOVE DEPOSITS OF MATERIAL IN VESSELS AND LIVING BODIES. |
US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
DE8900059U1 (en) | 1989-01-04 | 1989-05-24 | Schneider (Europe) AG, Zürich | Catheter for the treatment of arterial thrombosis |
US5226909A (en) | 1989-09-12 | 1993-07-13 | Devices For Vascular Intervention, Inc. | Atherectomy device having helical blade and blade guide |
US5120323A (en) | 1990-01-12 | 1992-06-09 | Schneider (Usa) Inc. | Telescoping guide catheter system |
US5527292A (en) | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
US5103827A (en) | 1990-12-14 | 1992-04-14 | Medasonics, Inc. | Apparatus for and a method of distinguishing ultrasound signals returned from bubbles and particles moving in a fluid from signals due to ultrasound transducer motion |
US5916192A (en) | 1991-01-11 | 1999-06-29 | Advanced Cardiovascular Systems, Inc. | Ultrasonic angioplasty-atherectomy catheter and method of use |
US5290247A (en) | 1991-05-21 | 1994-03-01 | C. R. Bard, Inc. | Intracoronary exchange apparatus and method |
US5234416A (en) | 1991-06-06 | 1993-08-10 | Advanced Cardiovascular Systems, Inc. | Intravascular catheter with a nontraumatic distal tip |
US5423846A (en) | 1991-10-21 | 1995-06-13 | Cathco, Inc. | Dottering auger catheter system |
US5308327A (en) | 1991-11-25 | 1994-05-03 | Advanced Surgical Inc. | Self-deployed inflatable retractor |
US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
US5407432A (en) | 1992-03-30 | 1995-04-18 | Pameda N.V. | Method of positioning a stent |
WO1993019679A1 (en) | 1992-04-07 | 1993-10-14 | The Johns Hopkins University | A percutaneous mechanical fragmentation catheter system |
US5328472A (en) | 1992-07-27 | 1994-07-12 | Medtronic, Inc. | Catheter with flexible side port entry |
FR2696924B1 (en) | 1992-08-06 | 1995-01-06 | Domilens Laboratoires | Surgical instrument for the in situ fragmentation of a living material, in particular a phaco-fragmentation or phaco-emulsification instrument. |
WO1994003230A1 (en) | 1992-08-07 | 1994-02-17 | Boston Scientific Corporation | Support catheter assembly |
US5243997A (en) | 1992-09-14 | 1993-09-14 | Interventional Technologies, Inc. | Vibrating device for a guide wire |
US5474563A (en) | 1993-03-25 | 1995-12-12 | Myler; Richard | Cardiovascular stent and retrieval apparatus |
US5417697A (en) | 1993-07-07 | 1995-05-23 | Wilk; Peter J. | Polyp retrieval assembly with cauterization loop and suction web |
US6858024B1 (en) | 1994-02-14 | 2005-02-22 | Scimed Life Systems, Inc. | Guide catheter having selected flexural modulus segments |
JP2735393B2 (en) | 1994-03-03 | 1998-04-02 | ターゲット セラピュウティクス,インコーポレイテッド | Method and apparatus for detecting disconnection of intravascular embolization device |
US5466222A (en) | 1994-03-30 | 1995-11-14 | Scimed Life Systems, Inc. | Longitudinally collapsible and exchangeable catheter |
US5454795A (en) | 1994-06-27 | 1995-10-03 | Target Therapeutics, Inc. | Kink-free spiral-wound catheter |
US5549119A (en) | 1994-09-13 | 1996-08-27 | Cordis Corporation | Vibrating tip catheter |
DE19504261A1 (en) | 1995-02-09 | 1996-09-12 | Krieg Gunther | Angioplasty catheter for dilating and / or opening blood vessels |
US5441051A (en) | 1995-02-09 | 1995-08-15 | Hileman; Ronald E. | Method and apparatus for the non-invasive detection and classification of emboli |
EP0817595B1 (en) | 1995-03-28 | 2002-06-12 | Straub Medical AG | Catheter for detaching abnormal deposits in human blood vessels |
US5873882A (en) | 1995-03-28 | 1999-02-23 | Straub Medical Ag | Catheter for detaching abnormal deposits from blood vessels in humans |
US5662622A (en) | 1995-04-04 | 1997-09-02 | Cordis Corporation | Intravascular catheter |
US5702373A (en) | 1995-08-31 | 1997-12-30 | Target Therapeutics, Inc. | Composite super-elastic alloy braid reinforced catheter |
US5658263A (en) | 1995-05-18 | 1997-08-19 | Cordis Corporation | Multisegmented guiding catheter for use in medical catheter systems |
US5591187A (en) | 1995-07-14 | 1997-01-07 | Dekel; Moshe | Laparoscopic tissue retrieval device and method |
US5776141A (en) | 1995-08-28 | 1998-07-07 | Localmed, Inc. | Method and apparatus for intraluminal prosthesis delivery |
US5569178A (en) | 1995-10-20 | 1996-10-29 | Henley; Julian L. | Power assisted suction lipectomy device |
US5895398A (en) | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US5885209A (en) | 1996-02-02 | 1999-03-23 | Green; Anthony D. | Endoscopic working channel and method of making same |
US6022336A (en) | 1996-05-20 | 2000-02-08 | Percusurge, Inc. | Catheter system for emboli containment |
SE505822C2 (en) | 1996-05-23 | 1997-10-13 | Elekta Ab | Device for injecting a substance into a body, especially human or animal |
US5782811A (en) | 1996-05-30 | 1998-07-21 | Target Therapeutics, Inc. | Kink-resistant braided catheter with distal side holes |
US5899892A (en) | 1996-05-31 | 1999-05-04 | Scimed Life Systems, Inc. | Catheter having distal fiber braid |
US5827242A (en) | 1996-06-21 | 1998-10-27 | Medtronic, Inc. | Reinforced catheter body and method for its fabrication |
US5735816A (en) | 1996-07-23 | 1998-04-07 | Medtronic, Inc. | Spiral sheath retainer for autoperfusion dilatation catheter balloon |
US6221038B1 (en) | 1996-11-27 | 2001-04-24 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
US5690613A (en) | 1996-12-06 | 1997-11-25 | Medtronic, Inc. | Rapid exchange high pressure transition for high pressure catheter with non-compliant balloon |
US6582440B1 (en) | 1996-12-26 | 2003-06-24 | Misonix Incorporated | Non-clogging catheter for lithotrity |
US5843103A (en) | 1997-03-06 | 1998-12-01 | Scimed Life Systems, Inc. | Shaped wire rotational atherectomy device |
US20020026145A1 (en) | 1997-03-06 | 2002-02-28 | Bagaoisan Celso J. | Method and apparatus for emboli containment |
US6355016B1 (en) | 1997-03-06 | 2002-03-12 | Medtronic Percusurge, Inc. | Catheter core wire |
US6059745A (en) | 1997-05-20 | 2000-05-09 | Gelbfish; Gary A. | Thrombectomy device and associated method |
US6228046B1 (en) | 1997-06-02 | 2001-05-08 | Pharmasonics, Inc. | Catheters comprising a plurality of oscillators and methods for their use |
US5951539A (en) | 1997-06-10 | 1999-09-14 | Target Therpeutics, Inc. | Optimized high performance multiple coil spiral-wound vascular catheter |
US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6090118A (en) | 1998-07-23 | 2000-07-18 | Mcguckin, Jr.; James F. | Rotational thrombectomy apparatus and method with standing wave |
WO1999004826A1 (en) | 1997-07-24 | 1999-02-04 | The Australian National University | Method for detection of fibrin clots |
US5891114A (en) | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
US5935112A (en) | 1997-10-15 | 1999-08-10 | Stevens; Brian W. | Hemostasis valve with catheter/guidewire seals |
US5908435A (en) | 1997-10-23 | 1999-06-01 | Samuels; Shaun L. W. | Expandable lumen device and method of use |
US6221006B1 (en) | 1998-02-10 | 2001-04-24 | Artemis Medical Inc. | Entrapping apparatus and method for use |
US20100030256A1 (en) | 1997-11-12 | 2010-02-04 | Genesis Technologies Llc | Medical Devices and Methods |
US6183432B1 (en) | 1997-11-13 | 2001-02-06 | Lumend, Inc. | Guidewire and catheter with rotating and reciprocating symmetrical or asymmetrical distal tip |
US6824550B1 (en) | 2000-04-06 | 2004-11-30 | Norbon Medical, Inc. | Guidewire for crossing occlusions or stenosis |
US6796976B1 (en) | 1998-03-06 | 2004-09-28 | Scimed Life Systems, Inc. | Establishing access to the body |
IE980241A1 (en) | 1998-04-02 | 1999-10-20 | Salviac Ltd | Delivery catheter with split sheath |
US6666874B2 (en) | 1998-04-10 | 2003-12-23 | Endicor Medical, Inc. | Rotational atherectomy system with serrated cutting tip |
US6482217B1 (en) | 1998-04-10 | 2002-11-19 | Endicor Medical, Inc. | Neuro thrombectomy catheter |
US6511492B1 (en) | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
US6740104B1 (en) | 1998-05-15 | 2004-05-25 | Advanced Cardiovascular Systems, Inc. | Enhanced catheter with alignment means |
US6368316B1 (en) | 1998-06-11 | 2002-04-09 | Target Therapeutics, Inc. | Catheter with composite stiffener |
US6285903B1 (en) | 1998-06-30 | 2001-09-04 | Eclipse Surgical Technologies, Inc. | Intracorporeal device with radiopaque marker |
AU3378499A (en) * | 1998-06-30 | 2000-01-17 | Gynecare, Inc | Endometrial balloon ablation catheter having heater |
US6214036B1 (en) | 1998-11-09 | 2001-04-10 | Cordis Corporation | Stent which is easily recaptured and repositioned within the body |
US6196972B1 (en) | 1998-11-11 | 2001-03-06 | Spentech, Inc. | Doppler ultrasound method and apparatus for monitoring blood flow |
US6591472B1 (en) | 1998-12-08 | 2003-07-15 | Medtronic, Inc. | Multiple segment catheter and method of fabrication |
EP1008358B1 (en) | 1998-12-09 | 2002-09-18 | JMS Co., Ltd. | Infusion filter |
US6165199A (en) | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
WO2000043061A1 (en) | 1999-01-20 | 2000-07-27 | Boston Scientific Limited | Intravascular catheter with composite reinforcement |
US6171295B1 (en) | 1999-01-20 | 2001-01-09 | Scimed Life Systems, Inc. | Intravascular catheter with composite reinforcement |
AU2315500A (en) | 1999-01-28 | 2000-08-18 | Ansamed Limited | Catheter with an expandable end portion |
US6350271B1 (en) | 1999-05-17 | 2002-02-26 | Micrus Corporation | Clot retrieval device |
DE60037025T2 (en) | 1999-06-02 | 2008-09-11 | Microtransform, Inc., Hillsborough | INTRAKORPORAL CLOSURE DEVICE |
US6355027B1 (en) | 1999-06-09 | 2002-03-12 | Possis Medical, Inc. | Flexible microcatheter |
US6458139B1 (en) | 1999-06-21 | 2002-10-01 | Endovascular Technologies, Inc. | Filter/emboli extractor for use in variable sized blood vessels |
US6179859B1 (en) | 1999-07-16 | 2001-01-30 | Baff Llc | Emboli filtration system and methods of use |
WO2001007101A1 (en) | 1999-07-23 | 2001-02-01 | Tfx Medical Extrusion Products | Catheter device having multi-lumen reinforced shaft and method of manufacture for same |
WO2001032104A1 (en) | 1999-11-03 | 2001-05-10 | Endocare, Inc. | Method of loading a stent on a delivery catheter |
US7037267B1 (en) | 1999-11-10 | 2006-05-02 | David Lipson | Medical diagnostic methods, systems, and related equipment |
DE19959230C1 (en) | 1999-12-08 | 2001-04-05 | Fresenius Medical Care De Gmbh | Two-sheet pouch, used as disposable haemodialysis container, comprises top and bottom closed by convex weld seams and is repeatedly folded parallel to its vertical axis |
US6206852B1 (en) | 1999-12-15 | 2001-03-27 | Advanced Cardiovascular Systems, Inc. | Balloon catheter having a small profile catheter |
US6579246B2 (en) | 1999-12-22 | 2003-06-17 | Sarcos, Lc | Coronary guidewire system |
US6520934B1 (en) | 1999-12-29 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Catheter assemblies with flexible radiopaque marker |
WO2001049341A2 (en) | 1999-12-31 | 2001-07-12 | Bacchus Vascular Inc. | Method and system for re-infusing filtered bodily aspirates |
US6394976B1 (en) | 2000-01-31 | 2002-05-28 | Intraluminal Therapeutics, Inc. | Catheter for controlling the advancement of a guide wire |
JP3915862B2 (en) | 2000-02-09 | 2007-05-16 | テルモ株式会社 | catheter |
US6554820B1 (en) | 2000-03-08 | 2003-04-29 | Scimed Life Systems, Inc. | Composite flexible tube for medical applications |
US6719717B1 (en) | 2000-03-17 | 2004-04-13 | Advanced Research & Technology Institute, Inc. | Thrombectomy treatment system and method |
US7713227B2 (en) | 2000-03-20 | 2010-05-11 | Michael Wholey | Method and apparatus for medical device for aspiration of thromboemobolic debris |
US6514273B1 (en) | 2000-03-22 | 2003-02-04 | Endovascular Technologies, Inc. | Device for removal of thrombus through physiological adhesion |
US6468301B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US6638268B2 (en) | 2000-04-07 | 2003-10-28 | Imran K. Niazi | Catheter to cannulate the coronary sinus |
US6468219B1 (en) | 2000-04-24 | 2002-10-22 | Philip Chidi Njemanze | Implantable telemetric transcranial doppler device |
IL136213A0 (en) | 2000-05-17 | 2001-05-20 | Xtent Medical Inc | Selectively expandable and releasable stent |
US6890315B1 (en) | 2000-05-23 | 2005-05-10 | Chf Solutions, Inc. | Method and apparatus for vein fluid removal in heart failure |
KR100387384B1 (en) | 2000-07-26 | 2003-06-12 | 규 호 이 | Embolic material detachment detection system and method and assembly for embolic treatments |
US6613017B1 (en) | 2000-08-08 | 2003-09-02 | Scimed Life Systems, Inc. | Controlled depth injection device and method |
US6776770B1 (en) | 2000-09-07 | 2004-08-17 | Advanced Research & Technology Institute | Thromboaspiration valve-filter device and methods |
US6524303B1 (en) | 2000-09-08 | 2003-02-25 | Stereotaxis, Inc. | Variable stiffness magnetic catheter |
CA2424306A1 (en) | 2000-10-18 | 2002-04-25 | Nmt Medical, Inc. | Medical implant delivery system |
US20060100530A1 (en) | 2000-11-28 | 2006-05-11 | Allez Physionix Limited | Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters |
US6554827B2 (en) | 2000-12-11 | 2003-04-29 | Scimed Life Systems, Inc. | Radio frequency ablation system |
US6533751B2 (en) | 2001-01-09 | 2003-03-18 | Andrew Cragg | Micro catheter and guidewire system having improved pushability and control |
US6673023B2 (en) | 2001-03-23 | 2004-01-06 | Stryker Puerto Rico Limited | Micro-invasive breast biopsy device |
US20020156459A1 (en) | 2001-04-20 | 2002-10-24 | Scimed Life Systems, Inc | Microcatheter with improved distal tip and transitions |
US20020156460A1 (en) | 2001-04-20 | 2002-10-24 | Scimed Life Systems, Inc | Microcatheter with improved distal tip and transitions |
US7635342B2 (en) | 2001-05-06 | 2009-12-22 | Stereotaxis, Inc. | System and methods for medical device advancement and rotation |
US20020188314A1 (en) | 2001-06-07 | 2002-12-12 | Microvena Corporation | Radiopaque distal embolic protection device |
US6818013B2 (en) | 2001-06-14 | 2004-11-16 | Cordis Corporation | Intravascular stent device |
DE20110121U1 (en) | 2001-06-19 | 2002-12-05 | B. Braun Melsungen Ag, 34212 Melsungen | catheter |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
JP4570873B2 (en) | 2001-10-03 | 2010-10-27 | ボストン サイエンティフィック リミテッド | Medical device with polymer-coated inner lumen |
US20030088266A1 (en) | 2001-11-02 | 2003-05-08 | Bowlin Gary L. | Method of fusing electroprocessed matrices to a substrate |
AU2002367387B2 (en) | 2001-12-26 | 2009-05-21 | Yale University | Vascular access device |
US7029482B1 (en) | 2002-01-22 | 2006-04-18 | Cardica, Inc. | Integrated anastomosis system |
US7335216B2 (en) | 2002-01-22 | 2008-02-26 | Cardica, Inc. | Tool for creating an opening in tissue |
US7223274B2 (en) | 2002-01-23 | 2007-05-29 | Cardica, Inc. | Method of performing anastomosis |
US7087026B2 (en) | 2002-03-21 | 2006-08-08 | Radiant Medical, Inc. | Devices and methods for measuring blood flow rate or cardiac output and for heating or cooling the body |
US7232452B2 (en) | 2002-07-12 | 2007-06-19 | Ev3 Inc. | Device to create proximal stasis |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US7309334B2 (en) | 2002-07-23 | 2007-12-18 | Von Hoffmann Gerard | Intracranial aspiration catheter |
US20070225614A1 (en) | 2004-05-26 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
US20040045645A1 (en) | 2002-09-10 | 2004-03-11 | Scimed Life Systems, Inc. | Shaped reinforcing member for medical device and method for making the same |
US7060051B2 (en) | 2002-09-24 | 2006-06-13 | Scimed Life Systems, Inc. | Multi-balloon catheter with hydrogel coating |
US20070043333A1 (en) | 2002-10-03 | 2007-02-22 | Scimed Life Systems, Inc. | Method for forming a medical device with a polymer coated inner lumen |
AU2003277361A1 (en) | 2002-10-10 | 2004-05-04 | Micro Therapeutics, Inc. | Wire braid-reinforced microcatheter |
US6814746B2 (en) | 2002-11-01 | 2004-11-09 | Ev3 Peripheral, Inc. | Implant delivery system with marker interlock |
US20040138693A1 (en) | 2003-01-14 | 2004-07-15 | Scimed Life Systems, Inc. | Snare retrievable embolic protection filter with guidewire stopper |
US8016752B2 (en) | 2003-01-17 | 2011-09-13 | Gore Enterprise Holdings, Inc. | Puncturable catheter |
JP2004275435A (en) | 2003-03-14 | 2004-10-07 | Terumo Corp | Catheter |
US7001369B2 (en) | 2003-03-27 | 2006-02-21 | Scimed Life Systems, Inc. | Medical device |
DE602004010895T2 (en) | 2003-04-02 | 2008-12-11 | Boston Scientific Ltd., St. Michael | REMOVABLE AND RETRACTABLE STENT ARRANGEMENT |
US20040199201A1 (en) | 2003-04-02 | 2004-10-07 | Scimed Life Systems, Inc. | Embolectomy devices |
US7413563B2 (en) | 2003-05-27 | 2008-08-19 | Cardia, Inc. | Flexible medical device |
AU2004255154B2 (en) | 2003-06-10 | 2009-08-20 | Lumend, Inc. | Catheter systems and methods for crossing vascular occlusions |
US20050004553A1 (en) | 2003-07-02 | 2005-01-06 | Medtronic Ave, Inc. | Sheath catheter having variable over-the-wire length and methods of use |
EP1670534B1 (en) | 2003-07-02 | 2010-01-27 | Cook Incorporated | Coaxial Catheters |
JP2007503918A (en) | 2003-09-04 | 2007-03-01 | セカント メディカル エルエルシー | Intravascular snare for capturing and removing arterial emboli |
US8034003B2 (en) | 2003-09-11 | 2011-10-11 | Depuy Mitek, Inc. | Tissue extraction and collection device |
US7588555B2 (en) | 2003-09-24 | 2009-09-15 | Enpath Medical, Inc. | Bi-directional catheter assembly and method therefor |
US20050103332A1 (en) | 2003-11-17 | 2005-05-19 | Bruce Gingles | Airway exchange catheter |
ES2390273T3 (en) | 2003-11-21 | 2012-11-08 | Silk Road Medical, Inc. | Apparatus for the treatment of a carotid artery |
US8382739B2 (en) | 2003-12-02 | 2013-02-26 | Boston Scientific Scimed, Inc. | Composite medical device and method of forming |
US7763011B2 (en) | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
US20050153309A1 (en) | 2003-12-22 | 2005-07-14 | David Hoon | Method and apparatus for in vivo surveillance of circulating biological components |
CA2554257C (en) | 2004-01-23 | 2014-11-18 | Iscience Surgical Corporation | Composite ophthalmic microcannula |
US20050182386A1 (en) | 2004-02-17 | 2005-08-18 | Steen Aggerholm | Catheter with stiffening element |
US8157792B2 (en) | 2004-02-26 | 2012-04-17 | Haemonetics Corporation | Wound drainage suction relief |
MX2009004020A (en) | 2004-03-04 | 2009-04-27 | Catheter for sucking, fragmenting removing material extractable from blood vessels. | |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US7686825B2 (en) | 2004-03-25 | 2010-03-30 | Hauser David L | Vascular filter device |
US8535293B2 (en) | 2004-04-13 | 2013-09-17 | Gyrus Acmi, Inc. | Atraumatic ureteral access sheath |
US8235968B2 (en) | 2004-04-13 | 2012-08-07 | Gyrus Acmi, Inc. | Atraumatic ureteral access sheath |
AU2005247490B2 (en) | 2004-05-25 | 2011-05-19 | Covidien Lp | Flexible vascular occluding device |
US7815627B2 (en) | 2004-05-27 | 2010-10-19 | Abbott Laboratories | Catheter having plurality of stiffening members |
US20060030835A1 (en) | 2004-06-29 | 2006-02-09 | Sherman Darren R | Catheter shaft tubes and methods of making |
WO2006024040A2 (en) | 2004-08-25 | 2006-03-02 | Microvention, Inc. | Thermal detachment system for implantable devices |
US9655633B2 (en) | 2004-09-10 | 2017-05-23 | Penumbra, Inc. | System and method for treating ischemic stroke |
US7931659B2 (en) | 2004-09-10 | 2011-04-26 | Penumbra, Inc. | System and method for treating ischemic stroke |
US20060064036A1 (en) | 2004-09-21 | 2006-03-23 | Cook Incorporated | Variable flexibility wire guide |
US7306585B2 (en) | 2004-09-30 | 2007-12-11 | Engineering Resources Group, Inc. | Guide catheter |
JP2006102222A (en) | 2004-10-06 | 2006-04-20 | Sekisui Chem Co Ltd | Detachable balloon catheter |
US7621904B2 (en) | 2004-10-21 | 2009-11-24 | Boston Scientific Scimed, Inc. | Catheter with a pre-shaped distal tip |
WO2006050191A2 (en) | 2004-11-01 | 2006-05-11 | Medical Components, Inc. | Universal catheter tunneler |
US20060217664A1 (en) | 2004-11-15 | 2006-09-28 | Hattler Brack G | Telescoping vascular dilator |
US7879011B2 (en) | 2004-11-18 | 2011-02-01 | Silk Road Medical, Inc. | Endoluminal delivery of anesthesia |
US20060111649A1 (en) | 2004-11-19 | 2006-05-25 | Scimed Life Systems, Inc. | Catheter having improved torque response and curve retention |
US20080086110A1 (en) | 2004-11-19 | 2008-04-10 | Galdonik Jason A | Extendable Device On An Aspiration Catheter |
US9775963B2 (en) | 2010-11-03 | 2017-10-03 | Biocardia, Inc. | Steerable endoluminal devices and methods |
AU2006236275B2 (en) | 2005-04-20 | 2011-06-02 | Cook Medical Technologies Llc | Internal joint for medical devices |
US7806871B2 (en) | 2005-05-09 | 2010-10-05 | Boston Scientific Scimed, Inc. | Method and device for tissue removal and for delivery of a therapeutic agent or bulking agent |
US9014786B2 (en) | 2005-05-11 | 2015-04-21 | Eyoca Medical Ltd. | Device and method for opening vascular obstructions |
US7771358B2 (en) | 2005-05-20 | 2010-08-10 | Spentech, Inc. | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
US20120078140A1 (en) | 2005-06-24 | 2012-03-29 | Penumbra, Inc. | Method and Apparatus for Removing Blood Clots and Tissue from the Patient's Head |
US20120330196A1 (en) | 2005-06-24 | 2012-12-27 | Penumbra Inc. | Methods and Apparatus for Removing Blood Clots and Tissue from the Patient's Head |
US7938820B2 (en) | 2005-08-18 | 2011-05-10 | Lumen Biomedical, Inc. | Thrombectomy catheter |
US8021351B2 (en) | 2005-08-18 | 2011-09-20 | Medtronic Vascular, Inc. | Tracking aspiration catheter |
US20070060888A1 (en) | 2005-09-06 | 2007-03-15 | Kerberos Proximal Solutions, Inc. | Methods and apparatus for assisted aspiration |
US20080188928A1 (en) | 2005-09-16 | 2008-08-07 | Amr Salahieh | Medical device delivery sheath |
US7850623B2 (en) | 2005-10-27 | 2010-12-14 | Boston Scientific Scimed, Inc. | Elongate medical device with continuous reinforcement member |
CN101394955B (en) | 2005-11-17 | 2012-07-18 | 微排放器公司 | Three-dimensional complex coil |
WO2007058668A1 (en) | 2005-11-18 | 2007-05-24 | Imarx Therapeutics, Inc. | Ultrasound apparatus and method to treat an ischemic stroke |
US20070185521A1 (en) | 2005-12-05 | 2007-08-09 | Cook Incorporated | Rapid exchange assembly |
CA2633866A1 (en) | 2005-12-30 | 2007-07-12 | C.R. Bard Inc. | Embolus blood clot filter removal system and method |
US20070208302A1 (en) | 2006-01-26 | 2007-09-06 | Webster Mark W | Deflection control catheters, support catheters and methods of use |
US20090227992A1 (en) | 2006-02-02 | 2009-09-10 | Releaf Medical Ltd | Shock-Wave Generating Device, Such as for the Treatment of Calcific Aortic Stenosis |
US7608063B2 (en) | 2006-02-23 | 2009-10-27 | Medrad, Inc. | Dual lumen aspiration catheter system |
US9615832B2 (en) | 2006-04-07 | 2017-04-11 | Penumbra, Inc. | Aneurysm occlusion system and method |
US20120150147A1 (en) | 2010-12-08 | 2012-06-14 | Penumbra, Inc. | System and method for treating ischemic stroke |
US8048032B2 (en) | 2006-05-03 | 2011-11-01 | Vascular Solutions, Inc. | Coaxial guide catheter for interventional cardiology procedures |
US7905877B1 (en) | 2006-05-12 | 2011-03-15 | Micrus Design Technology, Inc. | Double helix reinforced catheter |
US7558622B2 (en) | 2006-05-24 | 2009-07-07 | Bao Tran | Mesh network stroke monitoring appliance |
US7803136B2 (en) | 2006-06-05 | 2010-09-28 | Schatz Richard A | Myocardial injector |
AU2007260653B2 (en) | 2006-06-15 | 2013-01-24 | Microvention, Inc. | Embolization device constructed from expansible polymer |
US20080097251A1 (en) | 2006-06-15 | 2008-04-24 | Eilaz Babaev | Method and apparatus for treating vascular obstructions |
WO2008091584A2 (en) | 2007-01-22 | 2008-07-31 | Cv Devices, Llc | Devices, systems and methods for an epicardial cardiac monitoring system |
KR20090049051A (en) | 2006-06-30 | 2009-05-15 | 아테로메드, 아이엔씨. | Atherectomy devices and methods |
AU2007269829B2 (en) | 2006-07-05 | 2012-04-05 | Cook Medical Technologies Llc | Suction clip |
WO2008017998A2 (en) | 2006-08-11 | 2008-02-14 | Koninklijke Philips Electronics, N.V. | Ultrasound system for cerebral blood flow imaging and microbubble-enhanced blood clot lysis |
US8394078B2 (en) | 2006-10-04 | 2013-03-12 | Medrad, Inc. | Interventional catheters incorporating an active aspiration system |
WO2008057554A1 (en) | 2006-11-08 | 2008-05-15 | Cook Incorporated | Thrombus removal device |
JP5221032B2 (en) | 2006-12-11 | 2013-06-26 | 株式会社グツドマン | Insertion aid, catheter assembly and catheter set |
WO2008089282A2 (en) | 2007-01-16 | 2008-07-24 | Silver James H | Sensors for detecting subtances indicative of stroke, ischemia, infection or inflammation |
WO2008095492A2 (en) | 2007-02-05 | 2008-08-14 | Aarhus Universitet | A method for diagnosing atherosclerotic plaques by measurement of cd36 |
WO2008101206A2 (en) | 2007-02-15 | 2008-08-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter and method of manufacture |
CN101652155B (en) | 2007-04-03 | 2012-09-19 | 尼普洛株式会社 | Thrombus-aspiration catheter |
US8945141B2 (en) | 2007-04-05 | 2015-02-03 | W.L. Gore & Associates, Inc. | Implant recovery device |
US7927309B2 (en) | 2007-05-29 | 2011-04-19 | Cordis Corporation | Expandable sheath introducer |
US20080312639A1 (en) | 2007-06-13 | 2008-12-18 | Jan Weber | Hardened polymeric lumen surfaces |
EP2203209B1 (en) | 2007-06-26 | 2015-08-19 | Roxwood Medical, Inc. | Catheter apparatus for treating vasculatures |
US8157760B2 (en) | 2007-07-18 | 2012-04-17 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
US8858490B2 (en) | 2007-07-18 | 2014-10-14 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
US9669191B2 (en) | 2008-02-05 | 2017-06-06 | Silk Road Medical, Inc. | Interventional catheter system and methods |
US20090030400A1 (en) | 2007-07-25 | 2009-01-29 | Arani Bose | System and method for intracranial access |
EP2175782B1 (en) | 2007-07-27 | 2016-09-07 | MicroVention, Inc. | Detachable coil incorporating stretch resistance |
US20090043330A1 (en) | 2007-08-09 | 2009-02-12 | Specialized Vascular Technologies, Inc. | Embolic protection devices and methods |
WO2009054968A1 (en) | 2007-10-22 | 2009-04-30 | Atheromed, Inc. | Atherectomy devices and methods |
US20090209857A1 (en) | 2007-11-06 | 2009-08-20 | Frank Secretain | Method and system for identifying and quantifying particles in flow systems |
US9144383B2 (en) | 2007-12-13 | 2015-09-29 | The Board Of Trustees Of The University Of Arkansas | Device and method for in vivo noninvasive magnetic manipulation of circulating objects in bioflows |
US9451884B2 (en) | 2007-12-13 | 2016-09-27 | Board Of Trustees Of The University Of Arkansas | Device and method for in vivo detection of clots within circulatory vessels |
US8734374B2 (en) | 2007-12-20 | 2014-05-27 | Angiodynamics, Inc. | Systems and methods for removing undesirable material within a circulatory system during a surgical procedure |
CA2710146C (en) | 2007-12-21 | 2017-03-28 | Microvention, Inc. | System and method for locating detachment zone of a detachable implant |
BRPI0821070B1 (en) | 2007-12-21 | 2018-10-23 | Microvention Inc | implantation device and method for preparing a hydrogel filament for implantation in an animal |
WO2009091990A1 (en) | 2008-01-18 | 2009-07-23 | Ev3 Inc . | Angled tip catheter |
US20090234321A1 (en) | 2008-03-12 | 2009-09-17 | James Edward Shapland | Visualization of coronary vein procedure |
WO2009146128A1 (en) | 2008-04-03 | 2009-12-03 | William Cook Europe Aps | Implant release mechanism |
US8062316B2 (en) | 2008-04-23 | 2011-11-22 | Avinger, Inc. | Catheter system and method for boring through blocked vascular passages |
US20100125253A1 (en) | 2008-11-17 | 2010-05-20 | Avinger | Dual-tip Catheter System for Boring through Blocked Vascular Passages |
BRPI0911923B8 (en) | 2008-05-02 | 2021-06-22 | Sequent Medical Inc | device for treating a cerebral aneurysm |
US8974411B2 (en) | 2008-05-21 | 2015-03-10 | Becton, Dickinson And Company | Conical diffuser tip |
US8070694B2 (en) | 2008-07-14 | 2011-12-06 | Medtronic Vascular, Inc. | Fiber based medical devices and aspiration catheters |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US8574245B2 (en) | 2008-08-13 | 2013-11-05 | Silk Road Medical, Inc. | Suture delivery device |
US9731094B2 (en) | 2008-08-20 | 2017-08-15 | Cook Medical Technologies Llc | Introducer sheath having dual reinforcing elements |
US8343136B2 (en) | 2008-08-26 | 2013-01-01 | Cook Medical Technologies Llc | Introducer sheath with encapsulated reinforcing member |
US8864792B2 (en) | 2008-08-29 | 2014-10-21 | Rapid Medical, Ltd. | Device and method for clot engagement |
US8758364B2 (en) | 2008-08-29 | 2014-06-24 | Rapid Medical Ltd. | Device and method for clot engagement and capture |
WO2010030418A1 (en) | 2008-09-10 | 2010-03-18 | Micro-Dose Life Sciences Llc | Anti-fever botanical composition and uses thereof |
US8485969B2 (en) | 2008-09-18 | 2013-07-16 | Jeffrey Grayzel | Medical guide element with diameter transition |
CN102159132B (en) | 2008-09-22 | 2015-11-25 | 奇塔医疗公司 | For determining the system and method for blood flow |
US9566188B2 (en) | 2008-11-07 | 2017-02-14 | Abbott Medical Optics Inc. | Automatically switching different aspiration levels and/or pumps to an ocular probe |
CH699981A2 (en) | 2008-11-27 | 2010-05-31 | Straub Medical Ag | Catheter for aspirating, fragmenting and out transport of removable material from blood vessels. |
US8725249B2 (en) | 2008-12-09 | 2014-05-13 | Nephera Ltd. | Stimulation of the urinary system |
CA2746094A1 (en) | 2008-12-10 | 2010-06-17 | Microvention, Inc. | Microcatheter |
US9199064B2 (en) | 2008-12-18 | 2015-12-01 | Invatec S.P.A. | Catheter guide |
EP2379129B1 (en) | 2008-12-23 | 2017-09-13 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
WO2010076818A1 (en) | 2008-12-30 | 2010-07-08 | Invatec S.P.A. | Blood clot removal device |
US8361095B2 (en) | 2009-02-17 | 2013-01-29 | Cook Medical Technologies Llc | Loop thrombectomy device |
KR20110139698A (en) | 2009-03-09 | 2011-12-29 | 스미토모 베이클리트 컴퍼니 리미티드 | Catheter and method of manufacturing catheter |
US20100241155A1 (en) | 2009-03-20 | 2010-09-23 | Acclarent, Inc. | Guide system with suction |
EP2419166B1 (en) | 2009-04-15 | 2017-11-22 | MicroVention, Inc. | Implant delivery system |
EP3708201A1 (en) | 2009-04-23 | 2020-09-16 | Fresenius Medical Care Deutschland GmbH | Clot catcher, external functional device, blood circuit and treatment device |
WO2010126786A1 (en) | 2009-05-01 | 2010-11-04 | Cook Incorporated | Aspiration catheter with thrombus removing device |
US8517955B2 (en) | 2009-05-08 | 2013-08-27 | Broncus Medical Inc. | Tissue sampling devices, systems and methods |
US20110082373A1 (en) | 2009-06-04 | 2011-04-07 | Gurley John C | Methods and apparatus for the detection of cardiopulmonary defects |
US9278201B2 (en) | 2009-06-15 | 2016-03-08 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
US8795317B2 (en) | 2009-07-08 | 2014-08-05 | Concentric Medical, Inc. | Embolic obstruction retrieval devices and methods |
US8057497B1 (en) | 2009-07-28 | 2011-11-15 | Seshadri Raju | Thrombectomy removal device kit |
US20130006225A1 (en) | 2009-08-05 | 2013-01-03 | Rocin Laboratories, Inc. | Twin-type cannula assemblies for hand-held power-assisted tissue aspiration instruments |
CH701695A1 (en) | 2009-08-27 | 2011-02-28 | Straub Medical Ag | Catheter with protection system for aspirating, fragmenting and out pumping of removable material from hollow bodies or vessels, in particular of the human or animal body. |
WO2011025966A1 (en) | 2009-08-31 | 2011-03-03 | Boston Scientific Scimed, Inc. | Recanalization device with expandable cage |
WO2011032038A2 (en) | 2009-09-11 | 2011-03-17 | Onset Medical Corporation | Expandable cerebrovascular sheath and method of use |
JP2013505068A (en) | 2009-09-16 | 2013-02-14 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | Body temperature changes in the mammalian body |
WO2011038017A1 (en) | 2009-09-22 | 2011-03-31 | Penumbra, Inc. | Manual actuation system for deployment of implant |
US9375223B2 (en) | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US11039845B2 (en) | 2009-10-06 | 2021-06-22 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110106200A1 (en) | 2009-10-29 | 2011-05-05 | Medtronic, Inc. | Stroke risk monitoring system including implantable medical device |
US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
US20130131710A1 (en) | 2010-01-11 | 2013-05-23 | Assis Medical Ltd. | Device system and method for reshaping tissue openings |
US10342570B2 (en) | 2014-02-03 | 2019-07-09 | Medinol Ltd. | Device for traversing vessel occlusions and method of use |
US8545552B2 (en) | 2010-02-26 | 2013-10-01 | Silk Road Medical, Inc. | Systems and methods for transcatheter aortic valve treatment |
US20110238041A1 (en) | 2010-03-24 | 2011-09-29 | Chestnut Medical Technologies, Inc. | Variable flexibility catheter |
EP2558005B1 (en) | 2010-04-13 | 2022-03-30 | MIVI Neuroscience, Inc | Embolectomy devices for treatment of acute ischemic stroke condition |
AU2011240927B2 (en) | 2010-04-14 | 2015-07-16 | Microvention, Inc. | Implant delivery device |
US10238362B2 (en) | 2010-04-26 | 2019-03-26 | Gary And Mary West Health Institute | Integrated wearable device for detection of fetal heart rate and material uterine contractions with wireless communication capability |
US9023070B2 (en) | 2010-05-13 | 2015-05-05 | Rex Medical, L.P. | Rotational thrombectomy wire coupler |
US8764779B2 (en) | 2010-05-13 | 2014-07-01 | Rex Medical, L.P. | Rotational thrombectomy wire |
US8663259B2 (en) | 2010-05-13 | 2014-03-04 | Rex Medical L.P. | Rotational thrombectomy wire |
US9387077B2 (en) | 2010-05-27 | 2016-07-12 | Medtronic Vascular Galway | Catheter assembly with prosthesis crimping and prosthesis retaining accessories |
CN102946815B (en) | 2010-06-14 | 2015-07-15 | 科维蒂恩有限合伙公司 | Material removal device |
US10238833B2 (en) | 2010-08-12 | 2019-03-26 | C. R. Bard, Inc. | Access port and catheter assembly including catheter distal portion stability features |
BR112013003333B1 (en) | 2010-08-12 | 2021-12-28 | C.R. Bard, Inc | CATHETER SET INCLUDING DISTAL PORTION STABILITY CHARACTERISTICS |
WO2012021406A2 (en) | 2010-08-12 | 2012-02-16 | Silk Road Medical, Inc. | Systems and methods for treating a carotid artery |
CN106011233A (en) | 2010-08-13 | 2016-10-12 | 莫尔豪斯医学院 | Biomarkers for stroke |
JP5934219B2 (en) | 2010-09-03 | 2016-06-15 | ユニヴァーシティ オブ ワシントン | Neurosurgical device and related systems and methods |
CN103118584B (en) | 2010-09-22 | 2016-06-22 | 阿克拉伦特公司 | For treating the equipment of disease of nasal sinus |
US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
EP2627370B1 (en) | 2010-10-14 | 2021-09-15 | Medtronic, Inc | Cannular device and method of manufacture |
US10238456B2 (en) | 2010-10-14 | 2019-03-26 | Corindus, Inc. | Occlusion traversal robotic catheter system |
US9107691B2 (en) | 2010-10-19 | 2015-08-18 | Distal Access, Llc | Apparatus for rotating medical devices, systems including the apparatus, and associated methods |
JP5984068B2 (en) | 2010-11-21 | 2016-09-06 | ペリクス,ロバート | Tissue extraction apparatus and method of use |
DE102010053111B4 (en) | 2010-12-01 | 2012-10-25 | Acandis Gmbh & Co. Kg | Arrangement with a device for supplying a medical functional element |
EP2648658B1 (en) | 2010-12-06 | 2018-10-24 | Covidien LP | Vascular remodeling device |
US9867725B2 (en) | 2010-12-13 | 2018-01-16 | Microvention, Inc. | Stent |
US9737646B2 (en) | 2011-03-23 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | Small vessel stent and methods of use |
US9724491B2 (en) | 2011-04-05 | 2017-08-08 | Thermopeutix, Inc. | Microcatheter with distal tip portion and proximal solution lumen |
US10722683B2 (en) | 2011-04-05 | 2020-07-28 | Thermopeutix, Inc. | Microcatheter with distal tip portion and proximal solution lumen |
CA2834616C (en) | 2011-04-29 | 2018-01-02 | Evysio Medical Devices Ulc | Endovascular prosthesis and delivery device |
CN103547222B (en) | 2011-05-11 | 2016-02-10 | 柯惠有限合伙公司 | Vascular remodeling device |
US9345856B2 (en) * | 2011-05-16 | 2016-05-24 | Brainlab Ag | Medical catheter with reduced backflow |
EP2524653A1 (en) | 2011-05-17 | 2012-11-21 | Carag AG | Occluder |
WO2013003757A2 (en) | 2011-06-30 | 2013-01-03 | The Spectranetics Corporation | Reentry catheter and method thereof |
US9039715B2 (en) | 2011-07-11 | 2015-05-26 | Great Aspirations Ltd. | Apparatus for entrapping and extracting objects from body cavities |
US8676301B2 (en) | 2011-07-14 | 2014-03-18 | Med Works Limited | Guide wire incorporating a handle |
US9486605B2 (en) | 2011-07-15 | 2016-11-08 | Cook Medical Technologies Llc | Introducer sheath with braided filament securement mechanism |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US10327790B2 (en) | 2011-08-05 | 2019-06-25 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US8787944B2 (en) | 2011-08-18 | 2014-07-22 | Rivada Research, Llc | Method and system for providing enhanced location based information for wireless handsets |
EP3485824A3 (en) | 2011-10-04 | 2019-08-07 | Angioworks Medical B.V. | Devices for percutaneous endarterectomy |
US9119625B2 (en) | 2011-10-05 | 2015-09-01 | Pulsar Vascular, Inc. | Devices, systems and methods for enclosing an anatomical opening |
CN103957825B (en) | 2011-10-13 | 2018-12-07 | 阿瑟罗迈德公司 | Atherectomy device, system and method |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US8771341B2 (en) | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
EP2776108B1 (en) | 2011-11-09 | 2019-07-17 | Boston Scientific Scimed, Inc. | Guide extension catheter |
DE102011120004B3 (en) | 2011-11-30 | 2013-03-14 | Universitätsklinikum Freiburg | Device for detaching wall-shaped thrombi from a body vessel |
EP2800529B1 (en) | 2012-01-04 | 2023-06-07 | Rapid Medical Ltd. | Braided devices for assisting medical treatments |
US20160081825A1 (en) | 2012-01-04 | 2016-03-24 | Rapid Medical Ltd. | Heat-treated braided intravascular devices and methods |
WO2013111700A1 (en) | 2012-01-23 | 2013-08-01 | テルモ株式会社 | Medical tube, catheter, and method for producing medical tube |
WO2013116521A2 (en) | 2012-01-31 | 2013-08-08 | Boston Scientific Scimed, Inc. | Guide extension catheter |
US10028854B2 (en) | 2012-02-02 | 2018-07-24 | Covidien Lp | Stent retaining systems |
WO2013119332A2 (en) | 2012-02-09 | 2013-08-15 | Stout Medical Group, L.P. | Embolic device and methods of use |
JP6149855B2 (en) | 2012-02-28 | 2017-06-21 | 住友ベークライト株式会社 | Medical equipment |
US9439791B2 (en) | 2012-03-16 | 2016-09-13 | Microvention, Inc. | Stent and stent delivery device |
WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
CN102698328B (en) | 2012-06-08 | 2014-12-03 | 李广成 | Double-container balanced lavaging device for hematoma remover |
JP6480327B2 (en) | 2012-06-14 | 2019-03-06 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Polymer therapeutic composition |
US8948832B2 (en) | 2012-06-22 | 2015-02-03 | Fitbit, Inc. | Wearable heart rate monitor |
US9211132B2 (en) | 2012-06-27 | 2015-12-15 | MicoVention, Inc. | Obstruction removal system |
US9445828B2 (en) | 2012-07-05 | 2016-09-20 | Cognition Medical Corp. | Methods, devices, and systems for postconditioning with clot removal |
US8684963B2 (en) | 2012-07-05 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Catheter with a dual lumen monolithic shaft |
JP5676054B2 (en) | 2012-07-10 | 2015-02-25 | パナソニックIpマネジメント株式会社 | CONTROL DEVICE AND OPERATION METHOD FOR INSERTION DEVICE, INSERTION DEVICE HAVING CONTROL DEVICE, CONTROL PROGRAM FOR INSERTION DEVICE, AND INTEGRATED ELECTRONIC CIRCUIT FOR CONTROLLING INSERTION DEVICE |
EP2874690B1 (en) | 2012-07-17 | 2021-03-24 | Boston Scientific Scimed, Inc. | Guide extension catheter |
JP6050045B2 (en) | 2012-07-20 | 2016-12-21 | テルモ株式会社 | Coronary catheter |
EP2882350B1 (en) | 2012-08-13 | 2019-09-25 | MicroVention, Inc. | Shaped removal device |
US9597171B2 (en) | 2012-09-11 | 2017-03-21 | Covidien Lp | Retrieval catheter with expandable tip |
US9504476B2 (en) | 2012-10-01 | 2016-11-29 | Microvention, Inc. | Catheter markers |
WO2014062696A1 (en) | 2012-10-15 | 2014-04-24 | Microvention, Inc. | Polymeric treatment compositions |
US9044575B2 (en) | 2012-10-22 | 2015-06-02 | Medtronic Adrian Luxembourg S.a.r.l. | Catheters with enhanced flexibility and associated devices, systems, and methods |
CN104755021B (en) | 2012-10-23 | 2017-12-29 | 皇家飞利浦有限公司 | For the apparatus and method for the vital sign information for obtaining biology |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
CN107252518B (en) | 2012-11-13 | 2020-04-14 | 泰尔茂株式会社 | Catheter tube |
US8784434B2 (en) | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
ES2780395T3 (en) | 2012-11-21 | 2020-08-25 | Amgen Inc | Drug delivery device |
US9539022B2 (en) | 2012-11-28 | 2017-01-10 | Microvention, Inc. | Matter conveyance system |
CN109157223A (en) | 2012-12-04 | 2019-01-08 | 皇家飞利浦有限公司 | For obtaining the device and method of the vital sign information of biology |
US20140163367A1 (en) | 2012-12-07 | 2014-06-12 | Covidien Lp | Microcatheter |
DE102012112732B4 (en) | 2012-12-20 | 2019-06-19 | Acandis Gmbh | Medical device, system with such a device and manufacturing method |
US20160256255A9 (en) | 2013-02-22 | 2016-09-08 | Jianlu Ma | Design and methods for a device with blood flow restriction feature for embolus removal in human vasculature |
WO2014133897A1 (en) | 2013-03-01 | 2014-09-04 | Boston Scientific Scimed, Inc. | Guide extension catheter with a retractable wire |
US10531971B2 (en) | 2013-03-12 | 2020-01-14 | Abbott Cardiovascular System Inc. | Balloon catheter having hydraulic actuator |
US9370639B2 (en) | 2013-03-12 | 2016-06-21 | Cook Medical Technologies, LLC | Variable stiffness catheter |
US11154313B2 (en) | 2013-03-12 | 2021-10-26 | The Volcano Corporation | Vibrating guidewire torquer and methods of use |
US10383691B2 (en) | 2013-03-13 | 2019-08-20 | The Spectranetics Corporation | Last catheter with helical internal lumen |
US9883885B2 (en) | 2013-03-13 | 2018-02-06 | The Spectranetics Corporation | System and method of ablative cutting and pulsed vacuum aspiration |
WO2014140978A1 (en) | 2013-03-14 | 2014-09-18 | Koninklijke Philips N.V. | Device and method for obtaining vital sign information of a subject |
KR20150139865A (en) | 2013-03-15 | 2015-12-14 | 잔소르스 엘엘씨 | Health monitoring, surveillance and anomaly detection |
US20140271718A1 (en) | 2013-03-15 | 2014-09-18 | University Of Florida Research Foundation Incorporated | Novel type 1 diabetes vaccines, and methods of use |
EP2968853B1 (en) | 2013-03-15 | 2020-02-12 | QXMedical, LLC | Boosting catheter |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
JP6636908B2 (en) | 2013-03-15 | 2020-01-29 | テルモ株式会社 | Embolism prevention device |
WO2014141226A1 (en) | 2013-03-15 | 2014-09-18 | National University Of Ireland | A device suitable for removing matter from inside the lumen and the wall of a body lumen |
WO2014151209A1 (en) | 2013-03-18 | 2014-09-25 | Virginia Commonwealth Univerisity | Dynamic aspiration methods and systems |
WO2014160613A1 (en) | 2013-03-29 | 2014-10-02 | Silk Road Medical, Inc, | Systems and methods for aspirating from a body lumen |
US20140330286A1 (en) | 2013-04-25 | 2014-11-06 | Michael P. Wallace | Methods and Devices for Removing Obstructing Material From the Human Body |
EP2956197B1 (en) | 2013-05-07 | 2017-02-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable medical device having multiple curve profiles |
US9629978B2 (en) | 2013-05-20 | 2017-04-25 | Clph, Llc | Catheters with intermediate layers and methods for making them |
US10322260B2 (en) | 2013-05-30 | 2019-06-18 | Terumo Kabushiki Kaisha | Treatment method for treating lower limbs using multi-member catheter assembly |
US20150335288A1 (en) | 2013-06-06 | 2015-11-26 | Tricord Holdings, Llc | Modular physiologic monitoring systems, kits, and methods |
WO2014203336A1 (en) | 2013-06-18 | 2014-12-24 | 住友ベークライト株式会社 | Medical device and method for manufacturing medical device |
WO2015008288A1 (en) | 2013-07-17 | 2015-01-22 | Glucocheck Ltd. | Blood sampling device and methods |
KR102129536B1 (en) | 2013-08-06 | 2020-07-03 | 삼성전자주식회사 | Mobile terminal and method for controlling the mobile terminal |
US9474639B2 (en) | 2013-08-27 | 2016-10-25 | Covidien Lp | Delivery of medical devices |
EP3046952B1 (en) | 2013-09-19 | 2021-05-12 | Terumo Corporation | Polymer particles |
BR112016005768B1 (en) | 2013-09-19 | 2021-09-21 | Microvention, Inc | POLYMER FILMS |
EP3057523A4 (en) | 2013-10-16 | 2016-10-19 | Medwerks Llc | Atraumatic medical device |
US9913961B2 (en) | 2013-10-24 | 2018-03-13 | St. Jude Medical, Cardiology Division, Inc. | Flexible catheter shaft and method of manufacture |
US10695025B2 (en) | 2013-11-07 | 2020-06-30 | The Board Of Trustees Of The Leland Stanford Junior University | Wearable ultrasonic device for circulating tumor cell detection |
KR102287781B1 (en) | 2013-11-08 | 2021-08-06 | 테루모 가부시키가이샤 | Polymer particles |
US10639061B2 (en) | 2013-11-11 | 2020-05-05 | Cook Medical Technologies Llc | Devices and methods for modifying veins and other bodily vessels |
US10278592B2 (en) | 2013-12-09 | 2019-05-07 | Samsung Electronics Co., Ltd. | Modular sensor platform |
EP3082930B1 (en) | 2013-12-20 | 2019-07-17 | Boston Scientific Scimed, Inc. | Integrated catheter system |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US9789283B2 (en) | 2014-02-03 | 2017-10-17 | Medinol Ltd. | Catheter tip assembled with a spring |
US9999355B2 (en) | 2014-02-12 | 2018-06-19 | Koninklijke Philips N.V. | Device, system and method for determining vital signs of a subject based on reflected and transmitted light |
US20160066921A1 (en) | 2014-02-21 | 2016-03-10 | Neuravi Limited | DEVICE AND METHOD FOR ENDOVASCULAR TREATMENT OF ANEURYSMS USING EMBOLIC ePTFE |
US20150269825A1 (en) | 2014-03-20 | 2015-09-24 | Bao Tran | Patient monitoring appliance |
US9820761B2 (en) | 2014-03-21 | 2017-11-21 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
US9241699B1 (en) | 2014-09-04 | 2016-01-26 | Silk Road Medical, Inc. | Methods and devices for transcarotid access |
US9433427B2 (en) | 2014-04-08 | 2016-09-06 | Incuvate, Llc | Systems and methods for management of thrombosis |
JP5954748B2 (en) | 2014-04-25 | 2016-07-20 | 朝日インテック株式会社 | catheter |
JP6344762B2 (en) | 2014-05-21 | 2018-06-20 | 朝日インテック株式会社 | catheter |
US10792056B2 (en) | 2014-06-13 | 2020-10-06 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
WO2015189354A1 (en) * | 2014-06-13 | 2015-12-17 | Neuravi Limited | Devices for removal of acute blockages from blood vessels |
US10478127B2 (en) | 2014-06-23 | 2019-11-19 | Sherlock Solutions, LLC | Apparatuses, methods, processes, and systems related to significant detrimental changes in health parameters and activating lifesaving measures |
US10265086B2 (en) | 2014-06-30 | 2019-04-23 | Neuravi Limited | System for removing a clot from a blood vessel |
JP2017520324A (en) | 2014-07-01 | 2017-07-27 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Multilayer braid end |
US10456552B2 (en) | 2014-07-28 | 2019-10-29 | Mayank Goyal | System and methods for intracranial vessel access |
US20160030079A1 (en) | 2014-08-01 | 2016-02-04 | Patrick Cohen | Cannula assembly |
WO2016020922A2 (en) | 2014-08-07 | 2016-02-11 | Perflow Medical Ltd. | Aneurysm treatment device and method |
US9801643B2 (en) | 2014-09-02 | 2017-10-31 | Cook Medical Technologies Llc | Clot retrieval catheter |
EP3215208B1 (en) | 2014-11-07 | 2023-08-09 | Boston Scientific Scimed, Inc. | Medical device having an atraumatic distal tip |
US20160135829A1 (en) | 2014-11-13 | 2016-05-19 | Angiodynamics, Inc. | Systems and methods for en bloc removal of undesirable material from passageways |
WO2016081950A1 (en) | 2014-11-21 | 2016-05-26 | Microvention, Inc. | Improved reinforced balloon catheter |
US9943321B2 (en) | 2014-12-16 | 2018-04-17 | Penumbra, Inc. | Methods and devices for removal of thromboembolic material |
US20160166265A1 (en) | 2014-12-16 | 2016-06-16 | Penumbra Inc. | Methods and Devices for Removal of Thromboembolic Material |
US10518066B2 (en) | 2015-01-09 | 2019-12-31 | Mivi Neuroscience, Inc. | Medical guidewires for tortuous vessels |
EP4115854A1 (en) | 2015-01-12 | 2023-01-11 | Microvention, Inc. | Stent |
ES2577288B8 (en) | 2015-01-13 | 2019-01-10 | Anaconda Biomed S L | Device for thrombectomy |
JP2018510669A (en) | 2015-01-19 | 2018-04-19 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Device, system, and method for skin detection |
US20160213396A1 (en) | 2015-01-22 | 2016-07-28 | Cook Medical Technologies Llc | Catheter with an auger and method of use thereof |
AU2016214072A1 (en) | 2015-02-06 | 2017-07-27 | Rapid Medical Ltd. | Systems and methods for intravascular obstruction removal |
US9987028B2 (en) | 2015-02-12 | 2018-06-05 | Cook Medical Technologies Llc | Partially covered braided funnel aspiration catheter |
CA2977072A1 (en) | 2015-02-24 | 2016-09-01 | Silk Road Medical, Inc. | Suture delivery device |
US20160242893A1 (en) | 2015-02-25 | 2016-08-25 | Microvention, Inc. | Stent And Filter |
EP3261702A2 (en) | 2015-02-26 | 2018-01-03 | Stryker Corporation | Surgical instrument with articulation region |
WO2016141350A1 (en) | 2015-03-04 | 2016-09-09 | Microvention, Inc. | Drug delivery device |
WO2016143846A1 (en) | 2015-03-11 | 2016-09-15 | テルモ株式会社 | Foreign object removal device |
US9907880B2 (en) | 2015-03-26 | 2018-03-06 | Microvention, Inc. | Particles |
ES2759930T3 (en) | 2015-04-10 | 2020-05-12 | Silk Road Medical Inc | Methods and systems for establishing retrograde carotid arterial blood flow |
ES2929709T3 (en) | 2015-04-30 | 2022-12-01 | Silk Road Medical Inc | Systems for the treatment of transcatheter aortic valve |
ES2721304T3 (en) | 2015-05-26 | 2019-07-30 | Teleflex Innovations S A R L | Fixing guide wire |
EP3302676B1 (en) | 2015-05-29 | 2023-07-12 | Microvention, Inc. | Catheter circuit |
US10398874B2 (en) | 2015-05-29 | 2019-09-03 | Covidien Lp | Catheter distal tip configuration |
WO2016201250A1 (en) | 2015-06-11 | 2016-12-15 | Microvention, Inc. | Expansile device for implantation |
US10631893B2 (en) | 2015-07-10 | 2020-04-28 | Warsaw Orthopedic, Inc. | Nerve and soft tissue removal device |
US10888280B2 (en) | 2016-09-24 | 2021-01-12 | Sanmina Corporation | System and method for obtaining health data using a neural network |
WO2017019563A1 (en) | 2015-07-24 | 2017-02-02 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
US20170028170A1 (en) | 2015-07-28 | 2017-02-02 | Andrew Ho, M.D., Inc. | Guide catheter extension device and methods of use for cardiology procedures |
US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
WO2017025775A1 (en) | 2015-08-11 | 2017-02-16 | Latvijas Universitate | Device for adaptive photoplethysmography imaging |
EP3334354B1 (en) | 2015-08-11 | 2021-03-03 | Terumo Corporation | System for implant delivery |
US10463386B2 (en) | 2015-09-01 | 2019-11-05 | Mivi Neuroscience, Inc. | Thrombectomy devices and treatment of acute ischemic stroke with thrombus engagement |
US20170072163A1 (en) | 2015-09-11 | 2017-03-16 | Cathera, Inc. | Catheter shaft and associated devices, systems, and methods |
US20170072165A1 (en) | 2015-09-11 | 2017-03-16 | Cathera, Inc. | Catheter shaft and associated devices, systems, and methods |
US11253292B2 (en) | 2015-09-13 | 2022-02-22 | Rex Medical, L.P. | Atherectomy device |
EP3349689B1 (en) | 2015-09-18 | 2023-12-27 | Microvention, Inc. | Implant retention, detachment, and delivery system |
CN108260342B (en) | 2015-09-18 | 2021-07-30 | 微仙美国有限公司 | Releasable delivery system |
EP4327786A3 (en) | 2015-09-18 | 2024-05-01 | Terumo Corporation | Pushable implant delivery system |
JP6816127B2 (en) | 2015-09-18 | 2021-01-20 | テルモ株式会社 | Vascular prosthesis |
US10639456B2 (en) | 2015-09-28 | 2020-05-05 | Microvention, Inc. | Guidewire with torque transmission element |
EP4079237A1 (en) | 2015-09-28 | 2022-10-26 | Stryker Corporation | Mechanical thrombectomy apparatuses |
US20170100142A1 (en) * | 2015-10-09 | 2017-04-13 | Incuvate, Llc | Systems and methods for management of thrombosis |
WO2017066149A1 (en) | 2015-10-12 | 2017-04-20 | Northwestern University | Ambulatory blood pressure and vital sign monitoring apparatus, system and method |
EP3367907B1 (en) | 2015-10-28 | 2020-12-09 | Koninklijke Philips N.V. | Device for suv determination in emission tomography |
US20170119409A1 (en) | 2015-10-31 | 2017-05-04 | Neurovasc Technologies, Inc. | Embolus Removal Device with Blood Flow Restriction and Related Methods |
US10413226B2 (en) | 2015-11-09 | 2019-09-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Noncontact monitoring of blood oxygen saturation using camera |
US20170147765A1 (en) | 2015-11-19 | 2017-05-25 | Penumbra, Inc. | Systems and methods for treatment of stroke |
US10716915B2 (en) | 2015-11-23 | 2020-07-21 | Mivi Neuroscience, Inc. | Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems |
US10617509B2 (en) | 2015-12-29 | 2020-04-14 | Emboline, Inc. | Multi-access intraprocedural embolic protection device |
US20170189033A1 (en) | 2016-01-06 | 2017-07-06 | Microvention, Inc. | Occlusive Embolic Coil |
KR20180137604A (en) | 2016-02-10 | 2018-12-27 | 마이크로벤션, 인코포레이티드 | Devices for vascular occlusion |
WO2017139696A1 (en) | 2016-02-10 | 2017-08-17 | Microvention, Inc. | Intravascular treatment site access |
EP3419528B1 (en) | 2016-02-24 | 2023-06-07 | Incept, LLC | Enhanced flexibility neurovascular catheter |
CN109152586B (en) | 2016-03-03 | 2022-02-25 | 波士顿科学国际有限公司 | Accessory device for catheter |
US10583270B2 (en) | 2016-03-14 | 2020-03-10 | Covidien Lp | Compound curve navigation catheter |
EP3457954A4 (en) | 2016-05-18 | 2020-01-08 | Microvention, Inc. | Embolic containment |
JP2019521723A (en) | 2016-05-26 | 2019-08-08 | メリット・メディカル・システムズ・インコーポレイテッドMerit Medical Systems,Inc. | Expandable introducer assembly |
JP6803929B2 (en) | 2016-06-01 | 2020-12-23 | マイクロベンション インコーポレイテッドMicrovention, Inc. | Improved reinforced balloon catheter |
JP6750045B2 (en) | 2016-06-10 | 2020-09-02 | テルモ株式会社 | Vascular occluder |
US20190200871A1 (en) | 2016-06-24 | 2019-07-04 | Koninklijke Philips N.V. | System and method for vital signs detection |
US10980555B2 (en) | 2016-07-12 | 2021-04-20 | Cardioprolific Inc. | Methods and devices for clots and tissue removal |
KR102460052B1 (en) | 2016-07-26 | 2022-10-31 | 뉴라비 리미티드 | A thrombus recovery system to remove an occlusive thrombus from a blood vessel |
US11202582B2 (en) | 2016-08-09 | 2021-12-21 | Koninklijke Philips N.V. | Device for use in blood oxygen saturation measurement |
CN109561843B (en) | 2016-08-09 | 2022-07-15 | 皇家飞利浦有限公司 | Apparatus, system and method for monitoring peripheral arterial perfusion of a subject |
US20180042623A1 (en) | 2016-08-11 | 2018-02-15 | Stanley Batiste | Blood Clot Aspiration Catheter |
US11350825B2 (en) | 2016-08-25 | 2022-06-07 | Vivonics, Inc. | Contactless system and method for measuring and continuously monitoring arterial blood pressure |
US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
US10610668B2 (en) | 2016-10-05 | 2020-04-07 | Becton, Dickinson And Company | Catheter with an asymmetric tip |
US11305048B2 (en) | 2016-10-19 | 2022-04-19 | Medtec Medical, Inc. | Electronic vacuum regulator device |
US9775730B1 (en) | 2016-11-02 | 2017-10-03 | Walzman Innovations, Llc | Flow-diverting covered stent |
TW201825137A (en) | 2016-11-25 | 2018-07-16 | 日商住友電木股份有限公司 | Catheter and process for producing catheter |
CN108245292B (en) | 2016-12-29 | 2019-11-08 | 先健科技(深圳)有限公司 | Conveying device and transportation system |
WO2018129194A1 (en) | 2017-01-06 | 2018-07-12 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
US10905853B2 (en) | 2017-01-17 | 2021-02-02 | DePuy Synthes Products, Inc. | System and method for delivering a catheter |
AU2018210353B2 (en) | 2017-01-20 | 2023-09-28 | Route 92 Medical, Inc. | Single operator intracranial medical device delivery systems and methods of use |
US10912919B2 (en) | 2017-01-23 | 2021-02-09 | Edwards Lifesciences Corporation | Expandable sheath |
US20180228502A1 (en) | 2017-02-13 | 2018-08-16 | Penumbra, Inc. | Dual lumen hypotube catheter |
CN110573092B (en) | 2017-02-24 | 2023-04-18 | 因赛普特斯医学有限责任公司 | Vasoocclusive devices and methods |
US11123098B2 (en) | 2017-02-28 | 2021-09-21 | Angiosafe, Inc. | Device and method for centering and crossing a vascular occlusion |
EP3603726B1 (en) | 2017-03-29 | 2024-02-21 | Terumo Kabushiki Kaisha | Catheter assembly |
WO2018193601A1 (en) | 2017-04-20 | 2018-10-25 | 朝日インテック株式会社 | Catheter |
EP3632494A4 (en) | 2017-05-26 | 2021-03-17 | Sumitomo Bakelite Co., Ltd. | Catheter |
US11432835B2 (en) | 2017-06-07 | 2022-09-06 | Penumbra, Inc. | Apparatus and methods for clot aspiration |
US20190029825A1 (en) | 2017-07-31 | 2019-01-31 | Boston Scientific Scimed, Inc. | Introducer system with expandable capabilities |
JP7006020B2 (en) | 2017-08-25 | 2022-01-24 | 住友ベークライト株式会社 | Catheter and catheter kit |
US20190070387A1 (en) | 2017-09-02 | 2019-03-07 | Mayank Goyal | System and methods for accessing and treating cerebral venous sinus thrombosis |
US10105154B1 (en) | 2017-11-09 | 2018-10-23 | Pebble Hill Partners, Llc | Basket for a catheter device |
CN108013918B (en) | 2017-12-26 | 2018-06-29 | 微创心脉医疗科技(上海)有限公司 | One kind takes bolt conduit |
CA3089554A1 (en) | 2018-01-25 | 2019-08-01 | Ischemicure Ltd. | Devices, systems and methods to remove blood clots |
WO2019147414A1 (en) | 2018-01-26 | 2019-08-01 | Smith & Nephew, Inc. | Tissue collection and delivery device and methods of use thereof |
WO2019178165A1 (en) | 2018-03-12 | 2019-09-19 | Xtract Medical | Devices and methods for removing material from a patient |
EP3539486A1 (en) | 2018-03-13 | 2019-09-18 | The University of Toledo | Minimally invasive thrombectomy |
CA3095844A1 (en) | 2018-05-01 | 2019-11-07 | Incept, Llc | Devices and methods for removing obstructive material from an intravascular site |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
US20200289136A1 (en) | 2018-05-17 | 2020-09-17 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
CN115920204A (en) | 2018-05-17 | 2023-04-07 | 92号医疗公司 | Aspiration catheter system and method of use |
US10716880B2 (en) | 2018-06-15 | 2020-07-21 | Incuvate, Llc | Systems and methods for aspiration and monitoring |
WO2019246583A1 (en) | 2018-06-21 | 2019-12-26 | Nasser Rafiee | Guidewires and related methods and systems |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
DE102018212091A1 (en) | 2018-07-19 | 2020-01-23 | Siemens Healthcare Gmbh | Determination of a load-optimized MR sequence |
US10531883B1 (en) | 2018-07-20 | 2020-01-14 | Syntheon 2.0, LLC | Aspiration thrombectomy system and methods for thrombus removal with aspiration catheter |
EP3806757B1 (en) | 2018-07-24 | 2024-10-09 | Penumbra, Inc. | Apparatus and methods for controlled clot aspiration |
EP3836855B1 (en) | 2018-08-13 | 2024-09-25 | Inari Medical, Inc. | System for treating embolism and associated devices and methods |
US20210001141A1 (en) | 2018-10-22 | 2021-01-07 | Joovv, Inc. | Photobiomodulation therapy systems and devices |
US11020014B2 (en) | 2018-11-30 | 2021-06-01 | Microsoft Technology Licensing, Llc | Photoplethysmogram device with skin temperature regulator |
TR201900192A2 (en) | 2019-01-08 | 2019-02-21 | 18 Mart Üni̇versi̇tesi̇rektörlüğü | INTERNAL MOVING ASPIRATION CATHETER |
US20200297972A1 (en) | 2019-02-27 | 2020-09-24 | Imperative Care, Inc. | Catheter with seamless flexibility transitions |
US20200345979A1 (en) | 2019-03-22 | 2020-11-05 | Yince Loh | Transradial Access Systems Particularly Useful for Cerebral Access |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
EP3998966A4 (en) | 2019-07-19 | 2023-08-23 | Elixir Medical Corporation | Devices and methods for aspiration of thrombus |
WO2021067264A1 (en) | 2019-10-01 | 2021-04-08 | Incept, Llc | Embolic retrieval catheter |
JP7339355B2 (en) | 2019-10-03 | 2023-09-05 | 朝日インテック株式会社 | medical tubular body |
CA3157362A1 (en) | 2019-10-15 | 2021-04-22 | Imperative Care, Inc. | Systems and methods for multivariate stroke detection |
KR20220071259A (en) | 2019-11-08 | 2022-05-31 | 아사히 인텍크 가부시키가이샤 | catheter |
GB201917184D0 (en) | 2019-11-26 | 2020-01-08 | Univ Sheffield | Guiding device for a vascular catheter |
US11426076B2 (en) | 2019-11-27 | 2022-08-30 | Vivonics, Inc. | Contactless system and method for assessing and/or determining hemodynamic parameters and/or vital signs |
CN110916768A (en) | 2019-11-29 | 2020-03-27 | 昆山金泰医疗科技有限公司 | High-efficient spiral shell rotary-cut bolt device |
US20210315598A1 (en) | 2019-12-18 | 2021-10-14 | Imperative Care, Inc. | Methods of placing large bore aspiration catheters |
WO2021127004A1 (en) | 2019-12-18 | 2021-06-24 | Imperative Care, Inc. | Methods and systems for treating venous thromboembolic disease |
CN115916314A (en) | 2020-05-22 | 2023-04-04 | 祥丰医疗私人有限公司 | Pre-shaped medical device |
JP2023536209A (en) | 2020-05-27 | 2023-08-24 | エンブレイス メディカル エルティーディー. | Vascular access catheter |
US20220047849A1 (en) | 2020-08-11 | 2022-02-17 | Imperative Care, Inc. | Catheter with a preset curve |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
-
2019
- 2019-07-05 WO PCT/US2019/040691 patent/WO2020010310A1/en active Application Filing
- 2019-07-05 US US16/503,899 patent/US11517335B2/en active Active
-
2022
- 2022-12-02 US US18/074,378 patent/US20230165596A1/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12042160B2 (en) | 2018-05-01 | 2024-07-23 | Incept, Llc | Catheter having angled tip |
US11819228B2 (en) | 2019-12-18 | 2023-11-21 | Imperative Care, Inc. | Methods and systems for treating a pulmonary embolism |
Also Published As
Publication number | Publication date |
---|---|
WO2020010310A1 (en) | 2020-01-09 |
US11517335B2 (en) | 2022-12-06 |
US20200008820A1 (en) | 2020-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230165596A1 (en) | Sealed neurovascular extendable catheter | |
US11766539B2 (en) | Enhanced flexibility neurovascular catheter | |
US12042160B2 (en) | Catheter having angled tip | |
US11395665B2 (en) | Devices and methods for removing obstructive material, from an intravascular site | |
US20220211975A1 (en) | Neurovascular catheter | |
US20190159912A1 (en) | Method and device for treating a target site in a vascular body channel | |
US8231600B2 (en) | Intracranial aspiration catheter | |
US8425549B2 (en) | Systems and methods for removing obstructive matter from body lumens and treating vascular defects | |
US20090163851A1 (en) | Occlusive material removal device having selectively variable stiffness | |
US20230211122A1 (en) | Self centering low friction extendable neurovascular catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE STROKE PROJECT, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ABOYTES, MARIA;REEL/FRAME:063908/0908 Effective date: 20170619 Owner name: IMPERATIVE CARE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YANG, YI;YEE, BRANDON;ROUE, CHAD C.;AND OTHERS;SIGNING DATES FROM 20191003 TO 20191007;REEL/FRAME:061978/0406 Owner name: IMPERATIVE CARE, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:THE STROKE PROJECT, INC.;REEL/FRAME:062063/0145 Effective date: 20171221 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |